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Summary 
 
The area of structural biology covers a broad range of different techniques 
and methods that are used to obtain valuable information on the protein of 
interest. This thesis describes the expression and purification properties as 
well as biochemical and functional aspects of several proteins. The first 
section provides insight in the crystal structure of the protein Dimethylarginine 
Dimethylaminohydrolase-1 (DDAH-1) of bovine brain. The second part of the 
thesis covers the work on membrane proteins including the ABC transporter 
superfamily and the protein CitS, a member of the 2-hydroxycarboxylate 
transporter family. 
 
DDAH metabolizes methylated arginine derivatives, which are naturally 
occurring inhibitors of all three isoforms of nitric oxide synthases (NOS). Since 
DDAH activity regulates nitric oxide concentration, the protein emerges as 
promising drug target. Crystal structures of DDAH 1 of bovine brain were 
solved, including DDAH 1 alone and in complex with Zn2+, L- citrulline, L-
homocysteine or S-nitroso L-homocysteine. The later forms a covalent bond 
with the active site cysteine and, therefore, is an endogenous suicide inhibitor. 
The high-resolution structures with resolutions up to 1.08 Å provided valuable 
insights into (i) the structure of the binding pocket, (ii) the active site and a 
flexible loop region that is important for the binding of the substrate, and (iii) 
the coordination sphere of the Zn2+ ion that is exclusively present in 
eukaryotic DDAH at high and low pH values. Homology modeling of the 
isoenzyme DDAH-2 revealed differences in the binding pocket of the two 
enzymes. These variations might prove to be useful for the development of 
isoform specific drugs against DDAH leading to tissue specific regulation of 
nitric oxide synthases. 
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The second part of the thesis covers the work that was done in the field of 
membrane proteins. Two classes of transport systems, ABC transporters and 
2-hydroxycarboxylate transporters were analyzed, where the work on ABC 
transporters mainly dealt with the expression, solubilization and purification of 
these proteins. Present in all genomes, starting from simple archea to bacteria 
and complex eukaryotes, ABC transporters enclose a huge superfamily of 
membrane proteins with more than 2000 family members. The versatile 
functions include the regulation of cellular processes, the import of nutrients 
and the export of peptides or toxic substances. The family members share a 
common mechanistic principle: The chemical energy, stored in the phosphate 
ester bond of the ATP molecule, is used to facilitate the transport of the 
substrate across the membrane. ABC transporters of various origins were 
selected to enhance the chance of obtaining the large quantities of purified 
protein required for crystallographic studies. Analysis of expression, 
solubilization and purification efficiencies resulted in three different transport 
systems that were analyzed in further biochemical experiments. ATP binding 
or ATP hydrolysis experiments in conjunction with FT-IR confirmed the 
presence of folded material in the detergent micelle. The oligomeric state of 
the proteins in the presence of different detergents was assessed by size 
exclusion chromatography studies either with or without a subsequent static 
light scattering analysis. Initial crystallization experiments with the purified 
ABC transporter were conducted. 
 
The second project in the field of membrane proteins covers the work on the 
protein CitS and in this thesis the focus lies on the crystallization of the protein 
and the analysis of the recorded X-ray data. The transporter CitS belongs to 
the 2-hydroxycarboxylate-transporter family and facilitates the simultaneous 
uptake of sodium ions and citrate, enabling the bacterium Klebsiella 
Pneumoniae to use citrate as sole carbon and energy source. 
Characterization of the purified protein by size exclusion chromatography and 
static light scattering revealed a dimeric assembly of the protein in solution. 
The protein crystallized in space group P21 and the crystals diffracted up to 
3.6 Å. The self-rotation function of the native data set showed presumably 2 
dimeric proteins that assemble in a tetramer in the crystals. No homologues of 
Summary 
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the protein are characterized structurally so far and therefore phases have to 
be determined experimentally in order to solve the structure. Multiple methods 
were considered to obtain the phase information: (i) soaking or co-
crystallization of the crystals with heavy atoms, and (ii) co-crystallization of the 
membrane protein with artificial binding partners to obtain initial phase 
information of the complex by molecular replacement. In an effort to co-
crystallize Fab fragments or designed ankyrin repeat proteins with the 
membrane protein, crystals of a complex of CitS with an ankyrin were 
obtained. These crystals diffract up to 4 Å and belong to space group P1 
containing presumably 8 molecules in the unit cell. The tetramer present in 
crystals of CitS in space group P21 is absent in the crystals of the complex. 
The binding molecules alone were characterized structurally and the structure 
solution and refinement of the twinned crystals of the Fab fragment f3p4 at 
1.9 Å resolution is reported. Determination of the phases and the structure 
solution of the membrane protein CitS, either alone or in complex with the 
artificial binding proteins is in progress. 
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Zusammenfassung 
 
Die Strukturbiologie umfaßt eine Vielzahl verschiedener Techniken und 
Methoden, mit denen wertvolle Informationen über Proteine bestimmt werden 
können. Die vorliegende Doktorarbeit beschreibt die Herstellung und 
Reinigung sowie die biochemischen und funktionellen Eigenschaften 
mehrerer Proteine. Die Arbeit ist in zwei Teile gegliedert, wobei der erste 
Abschnitt die Röntgenstrukturanalyse des Proteins Dimethylarginin 
Dimethylaminohydrolase-1 (DDAH-1) beinhaltet. Der zweite Abschnitt der 
Arbeit befaßt sich mit Membranproteinen, im Speziellen mit ABC Transportern 
und CitS, einem Mitglied der 2-Hydroxycarboxylat Transporter Familie. 
 
Methylierte Argininderivate sind natürlich vorkommende Inhibitoren der drei 
Isoformen der Stickstoffmonoxidsynthase (nitric oxide synthase), welche von 
DDAH abgebaut werden. Da DDAH die Stickstoffmonoxid Konzentration 
beeinflußt, ist das Protein ein vielversprechendes Zielmolekül für die 
Entwicklung neuer Medikamente. Die Kristallstruktur der DDAH-1 aus 
Rinderhirn wurde als freies Enzym und im Komplex mit Zn2+, L-Citrullin, 
L-Homocystein oder S-Nitroso L-Homocystein gelöst. S-Nitroso 
L-Homocystein ist ein Suizid Inhibitor der DDAH, da es eine kovalente 
Bindung mit dem Cystein des Reaktionszentrums eingeht. Die 
hochaufgelösten Strukturen mit einer Auflösung von bis zu 1.08 Å gewähren 
einen detaillierten Einblick in die Funktionsweise des Enzyms. Unsere 
Arbeiten gaben Aufschluß über: (i) die Bindungstasche, (ii) das 
Reaktionszentrum und einem beweglichen Teil des Proteins, der für die 
Substratbindung von Bedeutung ist, und (iii) die Koordination des Zn2+ Ions 
welche bei verschiedenen pH Werten bestimmt werden konnte. Ein Modell 
des Isoenzyms DDAH 2 zeigt die Unterschiede in den Bindungstaschen der 
beiden Enzyme auf. Diese Unterschiede könnten sich bei der Entwicklung 
spezifischer Inhibitoren gegen die verschiedenen Isoformen der DDAH als 
nützlich erweisen, welche eine zelltyp-abhängige Regulation der 
Stickstoffmonoxidsynthasen erlauben würden. 
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Im zweiten Teil der Arbeit werden die Experimente beschrieben, die an 
Membranproteinen ausgeführt wurden. Zwei Klassen von Membran 
Transportproteinen wurden bearbeitet: ABC Transporter aus verschiedenen 
Organismen und der 2-Hydroxycarboxylat Transporter aus Klebsiella 
Pneumoniae. Die ABC Transporter wurden im Bezug der Expression, 
Solubilisierung und Aufreinigung biochemisch untersucht. ABC Transporter 
gibt es in allen Genomen, von einfachen Archaebakterien, über Bakterien bis 
zu komplexen Eukaryonten. Sie bilden eine größten Familien unter den 
Membranproteinen mit mehr als 2000 Proteinen. Ihre vielfältigen Funktionen, 
darunter die Regulation von Zellprozessen, der Import von Nährstoffen und 
der Export von Peptiden oder toxischen Substanzen haben ein gemeinsames 
mechanistisches Prinzip; die chemische Energie, welche in der 
Phosphoesterbindung des ATP Moleküls gespeichert ist, wird verwendet um 
den Transport der Substrate durch die Membran zu ermöglichen. Eine 
Auswahl von ABC Transportern von verschiedenen Organismen wurde 
getroffen, um die Chance zu erhöhen, große Mengen an aufgereinigtem 
Protein zu erhalten, welche für kristallographische Experimente benötigt 
werden. Nach Expressions-, Löslichkeits- und Aufreinigungsexperimenten 
verblieben drei verschiedene ABC Transportsysteme, welche anschließend 
detaillierter biochemisch analysiert werden konnten. ATP bindende oder 
hydrolysierende Experimente in Verbindung mit FT-IR bestätigten, daß 
gefaltetes Protein in den Detergenzmizellen vorhanden war. Der oligomere 
Zustand des Proteins wurde in Gegenwart von verschiedenen Detergenzien 
durch Gelfiltration, entweder mit oder ohne gekoppelter Statische 
Lichtstreuungs Analyse ermittelt. Kristallisationsexperimente mit den 
aufgereinigten ABC Transportern wurden durchgeführt. 
 
Die Arbeiten mit dem Membranprotein CitS aus Klebsiella Pneumoniae 
betrafen hauptsächlich die Kristallisation und die Analyse der mit 
Röntgendiffraktionsdaten. Der Transporter CitS gehört zur 2-
Hydroxycarboxylat Familie und ermöglicht den parallelen Import von Natrium 
Ionen und Citrat, was dem Bakterium Klebsiella pneumoniae erlaubt mit Citrat 
als einzige Kohlenstoff- und Energiequelle zu überleben. Das Protein wurde in 
Escherichia Coli exprimiert, in Detergenz solubilisiert, und anschließend 
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aufgereinigt. Die nachfolgende Charakterisierung mittels Gelfiltration und 
statischer Lichtstreuung ließ erkennen, daß das Protein in Lösung als Dimer 
vorliegt. Das Protein kristallisierte in der Raumgruppe P21. Die Kristalle 
streuten bis 3.6 Å. Die Eigenrotationsfunktion des nativen Datensatzes wies 
auf 2 dimere Proteine hin, welche sich im Kristall zu einem Tetramer 
zusammenlagerten. Homologe des Proteins wurden strukturell bis jetzt nicht 
charakterisiert, daher müssen für die Röntgenstruktur die Phasen 
experimentell ermittelt werden. Verschiedene Methoden die 
Phaseninformation zu erhalten wurden angewandt: (i) Inkubation oder Co-
Kristallisation mit Schwermetallen, (ii) Co-Kristallisation des Membranproteins 
mit einem künstlich hergestellten Bindungspartner welche es ermöglichen, 
erste Phaseninformationen zu erhalten und die Struktur danach durch 
Molekularen Ersatz zu lösen. CitS wurde im Komplex mit den Fab-
Fragmenten f3p4 und fm4p3 und den Ankyrin Proteinen cp34h_15 und Na1F 
kristallisiert. Kristalle von CitS im Komplex mit dem Ankyrin cp34h_15 konnten 
gezüchtet werden und streuten bis 4 Å. Sie gehören zur Raumgruppe P1 und 
haben wahrscheinlich 8 Komplexmoleküle in der Einheitszelle. Ein Tetramer, 
wie in den CitS-Kristallen der Raumgruppe P21 gefunden, konnte hier nicht 
beobachtet werden. Die Bindungspartner f3p4, cp34h_15 und Na1F ohne 
CitS wurden strukturell charakterisiert und die Strukturaufklärung des 
verzwillingten Kristalls des Fab-Fragmentes f3p4, welcher bis 1.9 Å streute, 
werden hier erläutert. Die Bestimmung der Phasen und die strukturelle 
Aufklärung des Membranproteins CitS, mit und ohne Bindungspartner, sind 
noch in Arbeit. 
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Chapter A - DDAH 
 
The protein dimethylarginine dimethylaminohydrolase-1 (Dimethylarginase-1, 
DDAH-1) hydrolyzes methyl derivatives of arginine, molecules that are known 
to inhibit nitric oxide synthases. The relationship between the two enzymes 
enables an indirect regulation of nitric oxide levels in the cells. Active 
dimethylarginine dimethylaminohydrolase promotes a higher activity of nitric 
oxide synthases and therefore leads to higher nitric oxide levels. This work 
describes various crystallographic structures of the isoform I of bovine 
dimethylarginine dimethylaminohydrolase. 
 
A.1 Introduction to Dimethylarginine 
Dimethylaminohydrolase 
A.1.1 Nitric Oxide 
 
Research in the last decade established the gaseous free radical nitric oxide 
(NO) as a molecule involved in signaling of different important biological 
processes. It is a major signaling molecule in neurons and in primary defense 
mechanisms against microorganisms in macrophages. Furthermore NO is 
involved in the endothelium dependent regulation of blood flow and blood 
pressure as well as in the inhibition of the activation of blood platelets 
(Bruckdorfer, 2005). 
 
NO is synthesized enzymatically from the amino acid L-arginine in a number 
of tissues by different isoforms of the enzyme nitric oxide synthase (NOS). 
The different isoforms of NOS have been well characterized and three 
isoforms are predominant: inducible NOS (iNOS/NOS II), endothelial NOS 
(eNOS/NOS III) and neuronal NOS (nNOS/NOS I). Although these names are 
frequently used, they are misleading since there is no strict division of the 
isoforms and cells often express more than one isoenzyme. iNOS produces 
large amounts of NO during immune and inflammatory responses and is 
induced transcriptionally. NF-κB, which is activated by cytokines and 
lipopolysaccharides, induces the expression of the gene encoding iNOS and, 
Introduction - Dimethylarginine Dimethylaminohydrolase I 
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therefore, leads to an elevated level of NO. In contrast, eNOS and nNOS are 
constitutively expressed and are activated by calmodulin (CaM) and calcium. 
nNOS and eNOS produce NO at a lower levels than iNOS. They are involved 
in hormonal and neuronal signaling as well as in the regulation of blood flow 
and blood pressure. 
 
The human isoforms have a molecular weight between 130 and 160 kDa and 
contain a central CaM binding site, which separates the N-terminal oxygenase 
domains and the C-terminal reductase domain (Figure 1). 
 
 
 
Figure 1: General structure overview of the three isoform of NOS. NOS I (nNOS), NOS II 
(iNOS) and NOS III (eNOS) with their oxidation N-terminal domains and the reductive C-
terminal domains. Between the two domains is the binding site for calmodulin that activates 
the NOS. 
 
The active enzymes are homodimers with a Zn2+ atom bound at the interface 
of their N-terminal domains (Figure 2). Although the specific process of NO 
production includes various oxido/reductive steps, requiring a large number of 
cofactors bound to specific binding sites in the enzymes, the production of NO 
and conversion of L-arginine to L-citrulline with the reaction intermediate N-
hydroxy-L-arginine can be summarized by the reaction 
 
L-arginine + 2 NADPH + O2 → L-citrulline + NO + 2 NADP+ 
 
The N-terminal oxygenase domain contains the binding sites of the two 
cofactors heme–Fe and the tetrahydrobiopterin as well as the binding pocket 
of the substrate L-arginine (Figure 2), whereas the C-terminal reductase 
domain binds flavin mononucleotide (FMN), flavin adenine dinucleotide (FAD) 
and nicotine adenine dinucleotide phosphate (NADPH). The connecting CaM 
domain regulates the electron flow between the reductase and the oxygenase 
domain and therefore regulates the production of NO. 
Introduction - Dimethylarginine Dimethylaminohydrolase I 
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Figure 2: Oxygenase domain of iNOS (PDB ID: 1NLI). For enzymatic activity, nitric oxide 
synthase (NOS) enzymes have to form a homodimer. The dimer interface locates a Zn2+ 
atom, which is necessary for full activity (magenta). The substrate arginine, the co-factors 
tetrahydrobiopterin and the heme group are shown in white, yellow and red, respectively. 
 
The half-life of only a few seconds illustrates the high reactivity of the NO 
radical in vivo. However, since NO is soluble in both aqueous and lipid media, 
it readily diffuses through the cytoplasm and plasma membranes reacting with 
the cell itself, or those adjacent where it is synthesized. NO reacts with 
oxygen and water to produce nitrates and nitrites. NO toxicity is linked to its 
ability to combine with superoxide anions (O2-) to form peroxynitrite (ONOO-), 
an oxidizing free radical, which reacts with proteins and nucleotides and in 
addition, enables lipid peroxidation (Szabo 2003). In the mitochondria, 
peroxynitrite acts on the respiratory chain (I-IV) complex and manganese 
superoxide dismutase (MnSOD), to generate superoxide anions and 
hydrogen peroxide, respectively. In macrophages the high toxicity of the NO is 
used as part of the non specific immune defense mechanism against invading 
microorganisms (Vallance & Leiper, 2002). 
 
A direct reaction between NO and proteins has been observed in many cases. 
NO reacts for example with the iron atom of the haem moiety in the active site 
of the enzyme guanylyl cyclase (GC), activating the enzyme a thousand fold. 
The resulting increase in levels of the signaling molecule cyclic GMP 
produced by GC initiates the physiological actions similar to other hormones. 
Introduction - Dimethylarginine Dimethylaminohydrolase I 
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Alternative reactions of NO include direct modification of proteins via 
S-nitrosylation, nitration of thiol groups and aromatic amino acids. In vivo it 
has been demonstrated that NO reacts with thiols to form S-nitrosothiols, such 
as S-nitrosocysteine and S-nitrosoglutathione and it is also present bound to 
plasma albumin (Al-Sa'doni & Ferro, 2000). Proteins can be activated upon 
NO modification, e.g. guanylyl cyclase, thioredoxin or prostaglandin H 
synthase (Hanafy et al., 2001, Haendeler et al., 2002, Goodwin et al., 1998) 
or deactivated e.g., aconitase, dimethylarginine dimethylaminohydrolase, 
ribonucleotide reductase or NOS itself (Drapier & Hibbs, 1996, Leiper et al., 
2002, Guittet et al., 1998, Mitchell et al., 2005, Gow et al., 2004). Protein 
modifications by NO are even evident in inflammatory processes and play a 
role in apoptosis by inhibition of caspase-3 through S-nitrosylation of the 
active site cysteine (Rossig et al., 1999). 
 
The high toxicity of NO demands strict control and regulation of its levels and 
of tissues where the radicals are produced. The localization and expression of 
the different isoforms reflects the various roles of NO. eNOS, involved in the 
regulation of vascular tone, is docked to the plasma membrane by the 
hydrophobic anchors myristic and palmitic acid. nNOS contains a PDZ 
domain that targets the protein to sites in nerve synapses. The two enzymes 
eNOS and nNOS are activated upon binding of calmodulin, which is triggered 
by Ca2+. In contrast, Ca2+ cannot regulate iNOS, since the affinity of iNOS to 
CaM is higher and the two proteins form a stable complex in presence or 
absence of Ca2+. iNOS is transcriptionally regulated and induced in various 
cells in response to the stimulation by bacteria or cytokines (Vallance & 
Leiper, 2002). Other factors that influence the bioavailability of NO are the 
numerous co-factors involved in the synthesis of NO and it is clear that any 
deficiency will influence the activity of NOS (Vallance & Chan, 2001). 
Furthermore the activity of NOS may in part be determined by the presence of 
naturally occurring inhibitors. The substrate analogues of L-arginine, e.g. the 
methylated arginine derivatives are well known to inhibit all three isoforms of 
NOS. 
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Posttranslational modifications of proteins include methylation of arginine side 
chains. The enzymes protein-arginine-N-methyltransferases (PRMT) transfer 
methyl groups from S-adenosyl-L-methionine to the guanidinium group of L-
arginine. The modifications by PRMT include a transfer of one or two methyl 
groups to the substrate. Three forms of methylated arginines are known in 
eukaryotes and they are produced by two classes of PRMT: Type I enzymes 
produce Nω-monomethylarginine (MMA) and asymmetric Nω, Nω-
dimethylarginine (ADMA) whereas proteins belonging to type II also catalyze 
the formation of MMA and symmetric Nω, Nω`- dimethylarginine (Figure 3) 
(Bedford & Richard, 2005). Proteolysis of methylated proteins produces the 
free methylarginines, since these modified residues are not re-incorporated 
during translation. The free methylarginines MMA and ADMA, but not SDMA, 
are inhibitors of all three isoforms of NOS. The pool size of arginine 
derivatives is controlled by renal secretion or metabolism by the enzyme 
dimethylarginine dimethylaminohydrolase, which hydrolyzes MMA and ADMA, 
but not SDMA. ADMA is metabolized >90 % by DDAH whereas SDMA is 
mainly lost in the urine (Tran et al., 2003). 
 
 
Figure 3: Methylated arginine derivatives. Type I & II PRMTs convert L-arginine to 
monomethylated L-arginine. Type I enzymes produce asymmetric dimethylated L-arginine 
whereas symmetric dimethylated L-arginine is produced by type II enzymes. 
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A.1.2 Family of Arginine Modifying Enzymes 
 
DDAH belongs to the family of arginine-modifying or substituted arginine-
modifying enzymes (Shirai et al., 2001, Murray-Rust et al., 2001, Das et al., 
2004). The enzymes belonging to this class share low sequence identity, but 
the overall fold of the active site and the corresponding active site residues 
are well conserved. The bacterial enzyme arginine deiminase (ADI) catalyzes 
the deimination of the guanidine group of L-arginine to produce ammonia and 
L-citrulline, which is the first step of the generation of ATP by the arginine 
deiminase pathway (Galkin et al., 2004, Das et al., 2004). The C-terminal 
domain of the Ca2+ dependent protein peptidylarginine deiminase (PAD), a 
protein involved in the conversion of protein arginine residues to citrulline, 
belongs to this group of enzymes (Arita et al., 2004). PAD catalyzes the 
deimination of both arginine and MMA but not ADMA and SDMA to citrulline 
(Bedford & Richard, 2005). Note, that this conversion protects the arginine 
side chains from the methylation by the enzyme PRMT (Bedford & Richard, 
2005). Enzymes that also belong to this class of enzyme are the L-
arginine: glycin amidinotransferase (AT) and the enzyme 
L arginine: inosamine-phosphate amidinotransferase (IPAT). AT is involved in 
the first step of the creatine biosynthesis (Humm et al., 1997) and IPAT 
catalyzes reactions involved in the biosynthesis of the streptomycin family of 
antibiotics (Fritsche et al., 1998). All enzymes of this class share a common 
fold, which consists of a repetitive ββαβ module arranged in cyclic 5-fold 
pseudo symmetry (Figure 4).  
 
Although the enzymes bind their substrates in different orientations, (Murray-
Rust et al., 2001, Das et al., 2004) they all share a common catalytic 
mechanism and their catalytic cysteine-histidine-aspartate (glutamate, 
respectively) triads superimpose well onto each other. Superimposition of the 
different structures shows that substrate binding is similar in DDAH and ADI. 
Although the guanidine carbon atoms and the scissile C-N bond overlay in the 
enzyme AT, the binding of the substrate is different. 
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Figure 4: Ribbon representation of members of the arginine or substituted arginine 
modifying enzyme superfamily. Picture shows ADI, AT and the C-terminal domain of PAD4 
from left to the right, respectively (Das et al., 2004, Humm et al., 1997, Arita et al., 2004). The 
blades are colored from the N to the C-terminus in blue, green, yellow, orange and red, 
respectively. Gray helices and β-strands are additional insertions in the protein sequences. 
Note that the last β-strand at the C-terminus interacts with the first three-stranded β-sheet. 
 
The enzymes that modify free arginine or derivatives of free arginine bury 
their substrates completely in the active site, whereas the substrate of PAD4 
is protein bound and projects only partly into the active site of the enzyme. 
The substrates of the different enzymes ADI, AT, PAD, and DDAH are very 
similar and the different reaction schemes are shown in Figure 5. 
 
 
 
Figure 5: Reactions catalyzed by different enzymes of the arginine or derivatives of 
arginine modifying enzymes. Although PAD4 utilizes protein bound arginine, the overall 
reaction compared to ADI is similar. Both transfer an oxygen atom to L-arginine and thereby 
produce ammonia (two right panels). DDAH catalyzes the reaction of methylated arginine to 
citrulline and methylamine (upper left image) whereas AT transfers the amidino moiety from 
arginine to glycine to produce ornithine and guanidinoacetate (lower left scheme).  
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A.2 Dimethylarginine Dimethylaminohydrolase I 
 
The enzyme L-Nω, Nω -dimethylarginine dimethylaminohydrolase 
(EC 3.5.3.18) was discovered and characterized by Ogawa et al (Ogawa et 
al., 1989, 1987). The enzyme catalyzes the hydrolysis of ADMA to L-citrulline 
and dimethylamine or the conversion of MMA to citrulline and 
monomethylamine (Figure 5). 
Activity of the enzyme was found in the kidney, pancreas, liver, and brain with 
a substrate preference of ADMA over MMA (Ogawa et al., 1987). Further 
studies on the distribution of DDAH in different tissues as well as the similar 
substrate specificity supported the idea that DDAH might be a regulator of 
NOS (Bogumil et al., 1998, Kimoto et al., 1993, Tran et al., 2000). 
Pharmacological studies on DDAH showed that an inhibition of DDAH leads 
to an increase in the concentration ADMA. The inhibitor has no direct effect 
on eNOS but causes endothelium-dependent contraction of aortic rings. This 
effect was reversed by L-arginine. These findings supported the idea that 
inhibition of DDAH leads to an accumulation of ADMA and thereby decreases 
the activity of NOS (MacAllister et al., 1996). 
 
Two isoforms of the enzyme, DDAH I and DDAH II, have been identified in 
eukaryotes (Tran et al., 2000, Leiper et al., 1999). Both isoforms share a 
functional homology but they differ in their tissue distribution. DDAH I is 
mainly expressed in the brain and kidney whereas DDAH II is predominantly 
present in the heart, spleen, thymus, peripheral leukocytes, lymph node and 
fetal tissues. The different tissue distribution of the two DDAH isoforms and 
their correlation with NOS expression pattern led to the assumption that 
DDAH I might control the activity of iNOS and that DDAH II regulates the 
ADMA concentration to modulate the activity of eNOS and iNOS (Tran et al., 
2000, Bogumil et al., 1998). 
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A.3   Structure of the Mammalian NOS Regulator 
Dimethylarginine Dimethylaminohydrolase (DDAH-1):       
A Basis for the Design of Specific Inhibitors 
Daniel Frey, Oliver Braun, Christophe Briand, Milan Vašák  
and Markus G. Grütter 
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Chapter B - Membrane Proteins 
 
B.1 Introduction to Membrane Proteins 
 
Living organisms, from simple species to complex multicellular systems are 
formed from cells. Membranes, envelopes built up by lipids, achieve 
separation from the environment and distinguish between the inside and 
outside of the cell. Lipid molecules are hydrophobic molecules with polar head 
groups and long non-polar hydrocarbon tails. Depending on the molecules 
and the lipid composition, they build different high molecular assemblies. 
Monolayers of lipids form ball shaped micelles, whereas the membranes of 
the cells are generated from bilyers of lipids. Although there are proteins that 
enhance the diffusion capability of water through the membranes, lipid 
bilayers generally allow water and hydrophobic substances to diffuse freely 
into the cell. In contrast, polar substances are blocked and cannot pass the 
membrane and therefore need special “holes” to cross this barrier. The 
membranes of prokaryotes comprise one or two bilayers, which are separated 
by the periplasm. Higher organisms, like eukaryotes contain a cell wall and in 
addition, several organelles inside the cell, which are also enclosed by 
membranes, for example the nuclei, mitochondria, or the endoplasmatic 
reticulum. 
Interaction with the environment or other compartments inside the cell across 
membranes is central to cell physiology, including uptake of nutrients, 
elimination of waste products, energy generation, signaling and secretion of 
peptides. Similarly to the chemical reactions that take place inside the cell, 
these processes across membranes require the presence of proteins. Located 
close to or inside the lipid bilayer, these proteins are called membrane 
proteins. 
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B.2 Membrane Protein Classification 
 
Analysis of genomic data revealed that 30% of all proteins encoded on the 
genome of an organism interact with the lipid bilayers and are therefore called 
membrane proteins. Classification of these proteins is based on the different 
types of interaction with the membrane. In general, there are four subgroups: 
integral proteins which span the lipid layer several times, monotopic proteins 
that dip into the membrane but do not cross it, proteins anchored with one 
transmembrane helix and proteins that are anchored by post translational 
modifications with lipid molecules or glycosyl-phosphatidylinositol anchors 
(Figure 6). Depending on the secondary structure elements, which are used 
to span the membrane, the integral proteins are divided in α-helical or β-barrel 
transmembrane proteins. The latter are called porins and cross the 
membranes with an even number of β-strands generating a β-barrel, which 
creates an aqueous pore in the membrane. Members of the α-helical 
subgroup are for example: bacteriorhodopsin, a light driven proton pump that 
generates the energy for survival of Halobacterium salinarum (Luecke et al., 
1999); G-protein coupled receptors, which mediate signaling across the 
membrane (Lundstrom, 2005); K+ or Cl- channels (Zhou et al., 2001, Dutzler 
et al., 2003), which selectively allow transport of these ions through the 
membrane and photosystem I and II (Loll et al., 2005, Ferreira et al., 2004, 
Jordan et al., 2001, Fromme et al., 2001), the bases of photosynthesis and 
therefore life as we know it. Examples of β-barrel proteins are the Omp family 
of Escherichia coli which includes proteases like OmpT (Vandeputte-Rutten et 
al., 2001) or anchoring proteins like OmpA (Pautsch & Schulz, 1998), 
unspecific pores like MspA from Mycobacterium smegmatis (Faller et al., 
2004), specific transport pores like LamB and ScrY (Buchanan, 1999) and 
active transporters like FepA, FecA, FhuA and BtuB (Locher et al., 1998, 
Ferguson et al., 2002, Chimento et al., 2003, Buchanan, 1999), which use the 
proton gradient from the inner membrane to transport iron or vitamin B12 
across the outer membrane. The location of the two subtypes of integral 
membrane proteins is strictly conserved, α-helical proteins are found 
exclusively in the inner membrane whereas β-barrels are located in the outer 
Introduction – Membrane Proteins 
 29 
membrane of gram positive prokaryotes. Monotopic membrane proteins, 
including prostaglandin synthase (Picot et al., 1994) and oxidosqualene 
cyclase (Thoma et al., 2004), dip into only one leaflet of the membrane and 
import or extrude their hydrophilic substrates or products directly from or into 
the membrane. 
Although membrane proteins represent a significant proportion of the 
genome, the structural data available is extremely limited. Only 106 different 
membrane proteins have been characterized structurally whereas the number 
of all entries in the Protein Data Bank exceeds 40000. The low proportion of 
membrane proteins reflects the low amount of expressed and purified material 
generally obtained and their amphipathic surface, which requires detergents 
to maintain the proteins in solution. A prerequisite of the structural 
determination of proteins by X-ray is the availability of protein crystals, where 
a small unit repeats several ten thousand times in all three dimensions to form 
a single crystal. This formation requires repetitive and unique protein-protein 
interactions between the molecules. For integral membrane proteins this area 
of interaction is rather limited, due to the fact that most of the protein surface 
is covered by detergent molecules and therefore not accessible for these 
specific interactions. 
 
 
Figure 6: Schematic representations of different membrane protein classes. From left to 
the right, proteins that are anchored with one transmembrane helix, integral membrane 
proteins where α-helices cross the membrane or β-strands forming a β-barrel, monotopic 
proteins that dip into one leaflet of the lipid bilayer but do not cross them and a protein that is 
bound to the membrane via a GPI anchor.  
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B.3 Transport Proteins 
 
The uptake of molecules by a cell requires the involvement of a 
transmembrane transport system that enables the entry of the substrate into 
the cytoplasm of the cell. The different transport systems identified so far, are 
classified into five groups that are categorized according to the transport 
process and their energy-coupling source.  
 
Channels and pores build up group one of the transporter classification 
system (TC, http://www.tcdb.org/). They are passive transporters that facilitate 
the energy independent diffusion of small solutes across the membrane. They 
allow the diffusion of solutes across the membrane until equal concentration 
of the substrate is established. The outer membrane protein MsbA of 
mycobacterium smegmatis, consisting of two consecutive β-barrels, belongs 
to this family (Niederweis, 2003, Faller et al., 2004). It enables the passive 
transport of small molecules across the membrane of the bacterium. 
Channels that show higher specificity towards the transported molecule are 
e.g. the glycerol facilitator GlpF of E.coli or the KirBac1.1 of Burkholderia 
pseudomallei. The selectivity of these systems allows the passive and specific 
diffusion of glycerol or potassium across the membrane thereby excluding the 
transport of water molecules or sodium ions, respectively (Fu et al., 2000, Kuo 
et al., 2003, Enkvetchakul et al., 2004). Aquaporins, mediating the fast 
exchange of water molecules in and out of the cell are also members of this 
class of transport systems (Heymann & Engel, 2000). 
 
Electrochemical potential driven transporters, also called secondary carrier-
type facilitators, belong to the second category. The mediated transport event 
is coupled either to the proton motif force (pmf) or sodium motif force (smf). 
These transporters are further subdivided as uniporters, proteins that facilitate 
the transport of a single species either by diffusion or in a membrane 
potential-dependent driven process if the solute is charged, symporters that 
couple the transport of two or more species in the same direction and 
antiporters which transfer two or more solutes in opposite direction across the 
membrane. Prominent examples of this family are the lactose permease of 
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E.coli that couples the uptake of H+ and β-galactosides (Abramson et al., 
2003) or the resistance-nondulation-cell division (RND) family that use the 
pmf to catalyze the substrate efflux in a H+ antiport mechanism (Sobczak & 
Lolkema, 2005b). 
 
Primary active transporters form the third group of the transport classification 
system. They utilize either chemical energy or light to generate a solute or 
ion-concentration gradient. The chemical energy transport can be P-P 
hydrolysis dependent, decarboxylation dependent, methyltransfer-dependent 
or oxidoreduction dependent. A member of this class of transporter is the ABC 
transporter superfamily, which uses the chemical energy stored in the 
phosphate bonds of ATP. This family will be discussed in more detailed in the 
next section. Other members are bacteriorhodopsin or the oxaloacetate 
decarboxylase Na+ pump of Klebsiellia pneumoniae, which use light to 
generate a proton gradient or a decarboxylation reaction to create a sodium 
ion gradient, respectively. 
 
Proteins belonging to the group of translocation transport systems make up 
the fourth category. This group of transporters differs from all the others since 
it is the only family, which modifies the substrate while it is transported. The 
translocators so far characterized are found exclusively in bacteria and belong 
to the phosphoenolpyruvate: sugar phosphotransferase systems. Here, the 
extracellular sugar is phosphorylated during transport and ends up as 
phosphate-sugar solute in the cytoplasm. 
 
Systems, which enable an electron flow across the membranes, belong to the 
last and fifth group of the TC system. The electrons, which are generated in 
the cytosol, have to cross the membrane to reach their acceptor molecules. 
Well-characterized members are the DsbB and DsbD oxidoreducatase 
systems of E.coli. The DsbB pathway transfers electrons from periplasmic 
dithiol proteins to quinones in the bacterial membrane. The reduced quinones 
further reduce cytoplasmic acceptors like O2, fumarate or nitrate. Transport of 
electrons from the cytosol to the periplasmic space is mediated by the DsbD 
system, where the electrons are transported from the cytosolic protein 
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thioredoxin to the acceptor protein DsbC in the periplasm. The transport of 
electrons is achieved by disulfide shuffling between the membrane protein 
DsbD and the protein DsbC in the periplasm, which in the end reduces the 
target proteins (Raina & Missiakas, 1997, Stirnimann et al., 2006). 
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B.4 Detergents 
 
The complex nature of the lipid bilayer hinders many studies and experiments 
involving membrane proteins. It is, therefore, desirable to transfer the protein 
of interest to a more tractable environment. The new environment must 
stabilize the protein during its removal from the lipid bilayer, conserve its 
function and accommodate for the hydrophobic and hydrophilic nature of 
membrane proteins. The amphipathic structure of membrane proteins 
requires buffer systems that prevent interactions of the hydrophobic 
transmembrane segment with the surrounding polar water molecules. This 
border must be occupied by molecules that can interact with both the 
hydrophobic segments and the hydrophilic water and, thus, these molecules 
should also exhibit an amphipathic nature. Such molecules are detergents. 
Like fatty acids, they consists of a polar head group and a hydrophobic tail 
and are therefore capable of masking the hydrophobic surface of the 
membrane protein, which is normally embedded in the lipid bilayer, and 
simultaneously interact with the polar water molecules. These interactions 
prevent aggregation of the membrane protein molecules and keep them in 
solution. 
 
Detergents are grouped into 4 different classes according to their chemical 
nature (Figure 7). Ionic detergents contain a positive or negative charge 
depending on their polar head group. In addition they contain a hydrophobic 
backbone that can be either linear or more complex e.g. steroid derivatives 
(Figure 7 a and b). The bile salts have a polar and an apolar face and 
therefore, they rather form kidney shaped aggregates unlike the spherical 
micelles formed by other detergents (Seddon et al., 2004). Non-ionic 
detergents contain hydrophilic polar head groups of polyoxyethylene or 
glycosidic nature and a linear hydrophobic non-polar alkyl chain (Figure 7 c). 
Zwitterionic detergents have polar head groups with opposite charges, thus 
creating an overall electro neutral molecule and a linear or bulky hydrophobic 
alkyl chain (Figure 7 d). 
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The nature of the detergent molecule has tremendous effects on protein 
stability, activity and crystallization behavior. In general, the non-ionic 
detergents are considered as mild detergents, disrupting lipid-lipid interactions 
but not protein-protein interactions and are therefore most suitable for 
solubilizing a protein whilst retaining its function. Nevertheless, smaller alkyl 
chains of the non-ionic detergents often deactivate or denature the protein. 
Ionic detergents with linear alkyl chains for example SDS are harsh and often 
denature the proteins whereas the ionic bile salts are considered to be mild 
detergents (Seddon et al., 2004). Despite this generalization, individual 
membrane proteins behave differently with the various classes of detergents 
and the best detergent suitable for each experiment must be determined 
experimentally. 
 
Each detergent is characterized by several physical properties including the 
critical micelle concentration (CMC), the critical micelle temperature (CMT), 
the Kraft point, the cloud point and the aggregation number. The CMC is the 
maximal monomer concentration of the detergent in solution. Above this 
concentration the detergent forms micelles: globular aggregates of 
monomers. In these micelles the polar head groups of the detergent cover the 
majority of the surface and the hydrophobic tails of the detergent are on the 
inside. At low temperatures the detergents are mostly insoluble in water and 
form crystalline material. Upon raising the temperature, more and more 
monomers are dissolved in the solvent and at a certain temperature the 
concentration of monomers is high enough to form micelles. This temperature 
is called CMT. The Kraft point is the temperature in the phase diagram at 
which monomers, crystalline material and micelles coexist in equilibrium and it 
is, for most detergents, identical to the CMT. Solvents that contain non-ionic 
detergents undergo an additional phenomenon at the cloud point. Above this 
temperature the solution separates into a detergent rich phase and a 
detergent depleted phase. Finally, the aggregation number is defined as the 
number of monomers of detergent that are present in the formed micelle. 
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Parameters like the concentration of the detergent, the length of the alkyl 
chain, the ionic strength, the temperature, the pH value and the nature of the 
salt present influence the behavior and properties of the detergent in the 
solution. Ionic detergents show low aggregation numbers that depend on the 
ionic strength and composition of the solution whereas the aggregation 
numbers of non-ionic detergents are less influenced by the ionic strength. 
 
 
Figure 7: Examples of different detergents. 
Taken from Seddon et al. (Seddon et al., 2004). 
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B.5 Crystallization of Membrane Proteins 
 
A prerequisite of a successful structure determination by X-ray is the 
availability of protein crystals. The formation of well-ordered crystals requires 
intermolecular interactions of a protein molecule to an adjacent one. These 
interactions must be specific and strong enough to build a three-dimensional 
ordered crystal. Unlike soluble proteins, which can use their entire surface to 
interact with the adjacent molecule, membrane proteins have only a limited 
hydrophilic surface area. One type of crystals can be obtained by adding lipids 
to the purified protein detergent mixture and removing the detergent. The so 
formed 2D crystals are in principle reconstituted biomembranes and are used 
with great success in electron microscopy (Stahlberg et al., 2001). In crystals 
used for X-ray structure determination of membrane proteins the molecules 
arrange themselves to adopt one of the following types of crystal systems 
(Ostermeier & Michel, 1997). Type I crystals contain hydrophobic and 
detergent mediated contacts that align the individual protein molecules into 
two dimensional arrays. These 2D layers are then stacked on top of each 
other by polar contacts mediated by the hydrophilic parts of the protein. Due 
to this packing, these crystals often show anisotropic diffraction behavior. 
Figure 8 shows examples of membrane proteins crystallized in the different 
types of lattices. 
 
 
Figure 8: Crystal types of membrane proteins. Left image: Type I crystal packing of 
bacteriorhodopsin (PDB 1C3W). The red membrane embedded parts form a 2D lattice that is 
connected by polar interactions of the hydrophilic part (green and yellow). Center and right 
images: Crystal packing of a mechanosensitive channel (PDB 1MSL) type II packing. The red 
membrane spanning parts of the protein are not involved in crystals contacts. The green 
hydrophilic parts of the protein exclusively form the intermolecular interactions. The images 
are correlated by a 90° rotation. 
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Crystals of bacteriorhodopsin (Luecke et al., 1999), which crystallized with 
Type I packing, were obtained by crystallization in lipidic cubic phases, a 
method explored by Landau & Rosenbusch (Landau & Rosenbusch, 1996). 
Type II crystals build the 3D lattice exclusively by hydrophilic contacts 
between their surface exposed loops and residues. Crystals of Type II are 
more common and are found for example in the crystal structure of the 
mechanosensitive channel (Chang et al., 1998). 
 
Several problems arise during the attempts to crystallize a membrane protein: 
(i) the stability of the membrane protein in the solubilized state, (ii) removal of 
structurally important lipids, (iii) the presence of the micelle around the 
hydrophobic belt of the protein, and (iv) the limited availability of hydrophilic 
regions suitable for crystal contacts. The problem of stability or loss of 
function was reported for the protein P-glycoprotein, which upon extraction 
from its natural environment exhibited a reduced or complete loss of function 
that could only be restored by reconstitution into a lipid bilayer or upon 
addition of lipids to the detergent protein mixture (Callaghan et al., 1997). An 
effect of lipids on the crystallization behavior of several proteins has been 
reported, e.g. for LacY, cytochrome b6f and bacteriorhodopsin (Guan et al., 
2006, Zhang et al., 2003, Belrhali et al., 1999). The choice of the detergent is 
crucial, since the belt of detergent molecules must allow the close proximity of 
the hydrophilic parts. Larger detergents may interfere with the packing 
arrangement but detergents with a shorter alkyl chain are harsher to the 
protein and might denature it partly. 
 
One way to increase the possibility of crystallizing a membrane protein is to 
increase the hydrophilic surface. This can be achieved by selecting a 
homologous protein containing longer surface exposed loops or by 
crystallizing of membrane protein in complex with a soluble protein. 
Crystallization of membrane proteins with their naturally occurring soluble 
interaction partners would therefore be desirable. However, these complexes 
should exhibit high affinity and homogeneity, the binding protein must be 
known and should be easily obtainable and show low internal flexibility 
(Ostermeier & Iwata, 2003). Since most of the naturally occurring complexes 
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do not fulfill these requirements, Ostermeier et al (Ostermeier et al., 1995) 
used synthetic complexes to increase the chances to obtain a crystal structure 
of the membrane protein of interest. Antibodies or fragments of antibodies 
have been used to determine crystal structures of soluble proteins, membrane 
proteins and DNA complexes (Kovari et al., 1995). Co-crystallization of 
integral membrane proteins with antibodies was first employed by the 
laboratory of H. Michel (Ostermeier et al., 1995, Iwata et al., 1995, Hunte & 
Michel, 2002, Hunte et al., 2000). In their experiments they used monoclonal 
Fv fragments. Proteolyic cleavage of an antibody generates two domains: the 
Fab and the Fc region. Fab fragments contain variable and constant domains 
of both heavy and light chains (Figure 9). The smallest fragment, Fv, consists 
of the two variable domains of the light and heavy chains. The structure of the 
CLC channel of E.coli (Dutzler et al., 2003) solved to a resolution of 2.5 Å, 
gives some insights into the packing of an antibody membrane protein 
complex (Figure 10). The Fab fragments that bind the channel at the 
periplasmic side exclusively form the crystallographic contacts. 
 
 
Figure 9: Position of CDR in a Fab molecule. A: The green cartoon represents the two Ig 
domains of the light chain with the CDRs marked in red. The constant and variable domains 
both consist of an Ig fold: the light chain is shown in green and the heavy chain in light blue. 
The CDRs are marked in red and blue respectively. The right picture is rotated by 90° around 
the central hinge region. B: Surface representation of the Fab f3p4 with the same orientation 
as in A. 
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Figure 10: Structure and packing of CLC channel of E.coli. The dimer of the membrane 
protein and the two bound Fab fragments are shown in blue and green respectively. The Fab 
fragment binds to the periplasmic side of the transporter in a 1:1 stoichiometry. The center 
and right images illustrate the packing of the crystal. The CLC dimer is solely connected to 
the Fab fragment (center) visualized upon deletion of the Fab protein (right). No 
crystallographic contacts of adjacent dimer molecules are seen. PDB entry: 1OTS. 
 
 
Designed ankyrin repeat proteins (DARPins), recently developed by Binz and 
co-workers (Binz et al., 2004), are an additional possibility for complex 
generation. The generated combinatorial libraries can be used to probe for 
binding against different target molecules using ribosome or phage display. 
The modular architecture of the DARPins is built from 33-amino acids repeats 
consisting of a β-turn, two antiparallel α-helices followed by a loop connecting 
to the β-turn of the next repeat. The inner repeats (typically 2-3) are flanked 
by an N- and C-terminal capping repeat to shield the hydrophobic core from 
the solvent (Figure 11). The six randomized positions (X2, X3, X5, X13, X14, and 
X33) in the internal repeats generate a binding groove that is located in stable 
secondary structural elements. The highly diverse libraries contain synthetic 
binders with binding affinities that are comparable to antibody complexes 
(Huber et al., 2007, Kohl et al., 2003). 
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Complexes of DARPins with various binding proteins have been reported and 
structurally characterized. These complexes include structurally unaltered 
target molecules, e.g. maltose binding protein, and target molecules that were 
inhibited upon formation of the DARPin complexes, e.g. APH (Kohl et al., 
2005, Amstutz et al., 2005) or Caspase-2 (Schweizer et al., 2007). A complex 
of DARPin molecules with the membrane protein AcrB, which is the most 
effective multi drug resistance protein of E.coli, was reported by Sennhauser 
et al. (Sennhauser et al., 2006). AcrB consist of three identical protein chains 
that build an asymmetric trimer of 340 kDa. Two DARPin molecules bind to 
the periplasmatic side of AcrB, thereby inhibiting the function as shown in in 
vivo experiments Figure 12 
 
  
Figure 11: Structure of a designed Ankyrin molecule. Structure of a DARPin molecule 
(Kohl et al., 2003). The variable positions are shown in stick representation. The blue N-
terminal and red C-terminal capping repeats are constant to all library members. A surface 
representation with the variable positions shown in red is drawn on the right side. 
 
 
Figure 12: AcrB-DARPin complex. View along the pseudo three-fold axis of AcrB in the 
direction of the cytosol. The two DARPin molecules are shown in red and the three chains of 
AcrB are shown in blue, green and orange. 
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Chapter C - ABC Transporters 
C.1 Introduction to ABC Transporters  
 
ABC (ATP-binding-cassette) transporters form one of the largest protein 
families with more than 2000 different protein sequences. They are present in 
all kingdoms of life ranging from simple prokaryotes to eukaryotes to 
mammals. The importance of this family is shown by the fact that almost 5 % 
of the genome of Escherichia coli encodes for ABC transporters (Higgins & 
Linton, 2004, Linton & Higgins, 1998), which may reflect the great ability of 
this organism to survive in different environments. The human genome 
encodes for at least 48 ABC transporters which transport substances out of 
the cell, but are also involved in intracellular transport processes among 
different compartments. Eukaryotic ABC transporters are classified in 7 
classes, ABCA, ABCB, ABCC, ABCD, ABCE, ABCF and ABCG based on 
gene structure (half or full transporter), domain arrangement and sequence 
homology in the nucleotide binding (NBD) and transmembrane domains 
(TMD). It should be noted that ABCE and ABCF do not contain membrane 
domains, but these proteins share homology in the NBD with other ABC 
proteins and are therefore categorized in this super family of proteins. Most of 
the ABC transporters are involved in genetic diseases (Igarashi et al., 2004) 
and indeed it is hard to study any physiological system in depth without 
identifying the role for an ABC transporter (Higgins & Linton, 2004). Some 
known diseases, which are coupled to a malfunction of an ABC transporter, 
are listed in Table 1. 
 
Most of the ABC proteins are active transporters utilizing the stored energy in 
ATP to translocate specific substances across the cell membranes, but some 
are involved in activities other than transport, e.g., regulation or targeting of 
other non ABC proteins. Bacterial ABC transporters can be classified as in- or 
exporters whereas their mammalian counterparts are in general export 
systems. Imported substances can be small ions, for example iron or nickel 
which are transported with the help of chelators such as siderophores, 
vitamins, for example vitamin B12, which serve as a cofactor for a number of 
enzymes, or all kinds of nutrients such as amino acids or sugars.  
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Table 1: Human diseases associated with ABC transporter 
Transporter Function Disease 
ABCB1 (MDR1) 
ABCC1 (MRP1) 
ABCG2 (MXR) 
Drug resistance Cancer 
ABCC7 (CFTR) Chloride channel Cystic fibrosis 
ABCA4 (ABCR) Rod photoreceptor 
retinoid transport 
Stargard disease and age-related 
macular degeneration 
ABCA1 (ABC1) Cholestorol and 
phospholipids transport 
Tangier disease and familial HDL 
deficiency 
ABCB11 (SPGP,Bsep) 
ABCB4 (MDR2) 
Bile-salt transport Progressive familial intrahepatic 
cholestasis 
ABCC2 (MRP2) Bile acid transport Dubin-Johnson syndrome 
ABCC6 (MRP6) Unknown Pseudoxanthoma elasticum 
ABCC8 (SUR1) 
ABCC9 (SUR2) 
Targeting and regulation 
of Kir6.2 
Persistent hypoglycemia of infancy 
ABCB7 (ABC7) Iron transport Sideroblastic anemia and ataxia 
ABCD1 (ALD) Very long chain fatty 
acids transport 
Adrenoleukodystrophy 
ABCG5, ABCG8 Sterol transport Sitosterolemia 
ABCB2 (Tap1) 
ABCB3 (Tap2) 
Peptide transport Immune deficiency 
Data taken from Gottesman & Ambudkar (Gottesman & Ambudkar, 2001) and Stefkova et 
al (Stefkova et al., 2004) 
 
Almost all of these importers contain, beside the actual ABC system, an 
additional protein, which is necessary for the transport process. These 
proteins, located in the periplasm of the prokaryotes, bind the substrate and 
direct it to the transport system where transport across the inner membrane 
takes place. In contrast to the highly specific importers, the export systems 
contain proteins, which have broader substrate specificity and translocate a 
large number of substances across the membrane. Export systems contain 
members involved in cell membrane maintenance such as the E.coli MsbA 
that uses the energy of ATP to invert lipids in the two layers of the inner 
membrane. Other export systems are the well studied Phospho-glycoprotein 
(PGP), a multidrug export system in humans, which extrudes hydrophobic 
substances of the cytosol or membrane out of the cell and confers multidrug 
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resistance to cancer cells, the multidrug resistance-associated proteins (MRP) 
or the transporter associated with antigen processing (TAP; (Abele & Tampe, 
2004), a transport system that plays a major role in immune defense. TAP 
transports antigen peptides into the endoplasmatic reticulum, where the MHC 
type I complex binds these peptides and presents them after export to the cell 
surface to T-cells. 
 
Some ABC systems are not involved in transport activity but rather ATP 
binding or ATP hydrolysis induces conformational changes that regulate other 
cellular processes, for example K+ channel regulation of Kir6.2 via the 
sulfonylurea receptor Sur1 (Huopio et al., 2002, Chan et al., 2003) or Cl- 
channels such as the cystic fibrosis transmembrane conductance regulator 
(CFTR). CFTR is itself a Cl- ion channel, but regulates a number of other Cl- 
channels and helps in combating bacterial infections in the lung (Ko & 
Pedersen, 2001). Other ABC transporter family members, which are not 
involved in transport and even lack the TMD are, for example the two DNA 
repair proteins MutS and Rad50 (Higgins & Linton, 2004). 
 
C.1.1 Sequence Similarity 
 
Considering all the different activities of ABC transporters, it is not surprising 
that the overall sequence similarity of these proteins is rather low. TMDs 
share no or only low sequence similarity among the different ABC proteins 
and species, although they all share the hydrophobic character necessary to 
span the membrane. In general, the polypeptides span the membrane twelve 
times although up to 20 transmembrane helices are observed (Locher et al., 
2002, Abele & Tampe, 2004). The low sequence identity in the TMDs might 
be explained by the different specificities of the transporter. The pore forming 
subunits of the transport proteins define the substrate specificity and therefore 
the sequence variability of these domains of the protein is explicable. 
 
In contrast to the TMDs, the different NBDs show, independent of prokaryotic 
or eukaryotic origin, in- or exporter, or the nature of the transported solute, a 
high sequence similarity; and this domain groups the different proteins in one 
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ABC super family (Higgins et al., 1986). Sequence motifs present in the ~ 200 
amino acids of the NBDs of ABC transporter include the WalkerA, WalkerB, 
A-, H- and Q-loop and the ABC signature motif (Figure 13). Walker A 
(GXXGXGKST, red) and the less conserved Walker B (grey) motif coordinate 
the nucleotide via hydrogen-bond interactions. The amino acid composition of 
Walker B is composed of a stretch of four hydrophobic residues followed by 
an aspartate, which makes the nucleophilic attack to the substrate 
(hhhhDEPT; (Orelle et al., 2003). In contrast to these motifs that are also 
present in other nucleotide utilizing enzymes, the ABC signature motif 
(LSGGQ, magenta) and the A-, H- and Q-loop (yellow, cyan, orange 
respectively) are unique to ABC transport proteins. They are involved in the 
active site formation and bind water molecules and the nucleotide. Although 
their precise function in the catalytic cycle is less clear, it is known that the 
ABC signature motif interacts with the nucleotide of the neighboring NBD 
(Locher et al., 2002). The ABC signature motif is located ~ 30 amino acids 
before and the conserved histidine in the H-loop (cyan) is approximately 30 to 
40 amino acids after the Walker B (grey) motif. The Q-loop (orange) 
determines the end of a β-sheet and is located around 40 amino acids after 
the Walker A (red) motif. 
 
 
Figure 13: Schematic representation of conserved regions in the NBD of ABC 
transporters. From left to the right from (N to C terminus) the conserved regions A-loop, Walker 
A, Q-loop, the signature motive, Walker B and the H-loop are shown. The lower row marks the 
corresponding conserved amino acids. Amino acids are denoted by their single amino acid 
code, where X stands for every amino acid, S/T stands for either S or T and hhhh represents the 
hydrophobic segment included in the Walker B motif. Walker A and B (red and grey) are found 
also in other ATP utilizing proteins whereas the signature (magenta) and the two loops Q and H 
(orange and cyan) are found exclusively in ABC transporter systems. 
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C.1.2 Domain Arrangement of ABC Transporters 
 
The classical ABC transporter consists of four domains; two α-helical 
hydrophobic transmembrane segments which generate the pathway for the 
substrate across the lipid bilayer; and two attached water-exposed cytosolic 
nucleotide binding domains (NBD) that mediate the conformational changes 
necessary during the transport process.  
In prokaryotic systems these four domains can be encoded on two to four 
different polypeptides. The different domains are found arranged in a variety 
of ways and schematic representations and examples of such transporters 
are shown in Figure 14. The individual proteins build up the functional 2+2 
units, either as homo- or heterodimers. An example of a transporter system 
containing four different proteins is the nickel uptake system Nik of E.coli that 
is formed by NikB, C, D and E. NikB and C are the two NBDs and NikD and E 
the hydrophobic pore forming membrane proteins. In addition, as with most of 
the uptake systems, this transport system contains an additional periplasmic 
protein NikA, which binds the substrate and locates it to the transporter 
(Figure 14A). The vitamin B12 uptake system from E.coli achieves the same 
transporter architecture with only two proteins. Two copies of the pore forming 
subunit BtuC and two copies of the NBD BtuD generate the functional 
transporter. BtuE, directing vitamin B12 to the transporter, is the 
corresponding periplasmic binding protein (PBP) of this uptake system. It 
binds the substrate after vitamin B12 is transported across the outer 
membrane (Figure 14B). 
Gene fusions between the individual subunits are found in various transporter 
systems such as the arabinose uptake system AraGFH, where both NBDs are 
encoded on the protein AraG, the E.coli lipid flipase MsbA that contains a 
NBD and a TMD on one polypeptide as well as ferrichrome transporter 
FhuBC, which consist of two copies of the NDB FhuC with the two membrane 
spanning domains fused on the gene FhuB (Figure 14 C to E, respectively). 
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In general, uptake systems contain an additional protein, a binding protein 
that binds the substrate in the periplasm and locates it to the related 
transporter before permeation through the inner membrane takes place. 
Export systems achieve transport without additional proteins and therefore, 
ABC transporters, which have no assigned function, are generally categorized 
as importers or exporters depending on the occurrence of a periplasmic 
binding protein. 
 
In contrast, eukaryotic ABC transporters generally consist of one polypeptide 
chain that encodes all four domains, but variations also occur here. A well 
studied example is the antigen presenting transport system Tap, where the 
formation of the active transporter is achieved by hetero dimerization of two 
different proteins, each of them containing one NBD and one TMD subunit 
(Figure 14F&G). The eukaryotic transporters, known to date, belong to the 
category of exporters, with no additional domains comparable to the bacterial 
PBP found within this class of proteins, although examples with additional 
domains at the intracellular side, for example the transporter CFTR, are 
described (Figure 14H). 
 
 
Figure 14: Different domain arrangements of ABC transporters. Gene fusion leading to 
multi domain proteins is a common feature in ABC transporter. Nucleotide binding domains 
are shown in circles and the transmembrane domains as elongated squares. Half circles with 
triangles represent additional binding proteins in the periplasm, which are present in the 
bacterial import systems. The domains are associated in various ways and examples of 
combinations that form the actual transporter are depicted in the scheme. A: four individual 
proteins, e.g. NikBCDE; B: two, but separated proteins, e.g. BtuCD; C: homodimeric 
assembly of fused TMD-NBD or NBD-TMD, e.g. MsbA; D: fused NBD-NBD and separated 
TMDs, e.g. AraG; E: fused TMD-TMD and separated NBDs, e.g. FhuB; F: all four domains in 
one chain, e.g. PGP; G: heterodimeric transporter with fused TMD-NBD, e.g. Tap system; H: 
full transporter with an additional domain in the cytoplasm, e.g. CFTR. 
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C.1.3 Structural Models 
 
Although the existence of ABC proteins has been known for over 20 years, 
they were not structurally characterized until 2001, when Chang and 
coworkers published the first ABC transporter MsbA of E.coli (Chang & Roth, 
2001). Until that point, structural characterization was based on electron 
microscopy data of PGP (Higgins et al., 1997) and structures of ABC proteins 
that consist of the NBD but lack the transmembrane segments. Since then 
two more structures of complete ABC transporters have been published 
including the homologue of MsbA from Vibrio cholare, which contrasts with 
the closed conformation of to the E.coli protein (Chang, 2003), and the 
Vitamin B12 uptake transporter BtuCD from E.coli (Locher et al., 2002). 
Although several groups reported biochemical studies of the cooperativity of 
the nucleotide binding domains (Karttunen et al., 2001, Benabdelhak et al., 
2005, Moody et al., 2002, Davidson et al., 1996), the arrangement of the two 
NBDs with respect to each other was debated because of the different dimer 
assemblies present in the various solved structures of NBD dimers (Locher & 
Borths, 2004). In general a monomeric NBD consists of two lobes. Lobe I 
contains the Walker A (red), Walker B (grey), H-loop (cyan) motifs as well as 
the tyrosine in the A-loop (yellow) while the ABC transporter signature motif 
(magenta) is found in lobe II or the helical region. The Q-loop (orange) 
present in the linker region between the two sub domains is also known as 
γ-Pi linker. 
 
Introduction - ABC Transporter 
 48 
 
Figure 15: Cartoon representation of one NBD of Mj0796. The α/β domain (Lobe I) is 
shown in dark green and the purely helical Lobe II in blue. The conserved motifs Walker A 
(red), Q-loop (orange), signature motif (magenta) and Walker B (grey) are highlighted. The 
ATP molecule, H-loop (cyan), the active site glutamate (located close to the Walker B motif) 
and the glutamine providing the name for the Q loop are shown in sticks. The signature motif 
is in close contact to the nucleotide of the second monomer that is shown as spheres. 
 
The dimer organization, first found in the ABC protein rad50, is now thought to 
be the biological arrangement of the NBDs and it is also observed in the 
BtuCD structure and in the dimer structure of MJ0796 E171Q mutant (Smith 
et al., 2002). Figure 16 shows the two protomers in a head to tail 
arrangement, building up the two binding sites of the nucleotides at the 
interface between the molecules. The two signature motifs (magenta) 
generate the active site; they cap the triphosphates of the nucleotide (stick 
representation) bound to the Walker A (red) in the related subunit. The H-loop 
(cyan) makes contacts with the nucleotide and the neighboring protein subunit 
whereas the interaction of the Q-loop (orange) is restricted to the nucleotide in 
the same subunit. The tyrosine of the A-loop (yellow) interacts with the 
aromatic ring of the nucleotide. These tight interactions between the two 
nucleotides and the two subunits in an intra- and intermolecular way explain 
the reported cooperativity of the nucleotide binding domains. In addition, the 
two ATP molecules contribute approximately half of the buried area in the 
dimer interface, suggesting that ATP has an essential role in the formation of 
the dimer. 
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Figure 16: Stereo cartoon representation of Dimer interface of MJ0796. The dimer 
interface of MJ0796 E171Q mutant is shown (PDB code: 1L2T;(Smith et al., 2002)). Mutation 
in the Walker B motif permitted binding but not the hydrolysis of ATP. The two NBD are 
shown in green and dark green and special sequence motifs are depicted as follows: red 
indicates the Walker A, grey color marks Walker B, magenta the signature motif for ABC 
transporter and A-, H- and Q- loop are shown in yellow, cyan and orange respectively. The 
two bound ATP molecules are shown in stick representation. See text for further 
explanations. 
 
A detailed interaction scheme, involving the residues that bind the nucleotide 
in the dimeric structure of MJ0796 (Smith et al., 2002), is shown in Figure 17. 
Each of the ATP molecules interacts with the Walker A (red) and B (grey) 
motifs, the A-, Q- and H- loop (yellow, orange and cyan respectively) of one 
NBD and with the signature motif (magenta) of the second NBD and therefore 
forming a sandwich like binding complex.  
 
Figure 17: Nucleotide Interactions in the dimer interface of the two NBD subunits 
Schematic representation of the amino acids that interact with the ATP molecule. For clarity 
only one ATP molecule is shown. The NBD containing the Walker A and B motifs is shown on 
the right whereas the second NBD that contains the signature motif is shown on the right 
side. Van der Waals contacts are shown as orange lines, the aromatic stacking interaction of 
the tyrosine of the A- loop and the adenine base is shown in black dashes and the polar 
interactions of the two NBDs to the nucleotide are shown in black lines. Interactions with the 
catalytic co-factor (Na+) or the active site water molecule are shown in green and grey. 
Adapted from Smith et al. (Smith et al., 2002). 
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The ATP is bound by several hydrophobic and polar interactions from both 
NBDs. The catalytic co-factor (here Na+) is bound to residues S45 of the 
Walker A and Q90 of the Q- loop of one NBD and to the β- and γ-phosphate 
of the nucleotide. The active site water is held in position by polar interactions 
of Q90 and E/Q171 of one NBD, the γ-phosphate of the ATP as well as of 
A175 of the second NBD. 
 
Although several structures of NBDs of ABC transporters are present in the 
literature (Lewis et al., 2004, Chen et al., 2003, Diederichs et al., 2000, Hung 
et al., 1998, Smith et al., 2002) the number of structurally characterized 
transporters including the membrane spanning parts is low. Up to now, 
structures of the Vitamin B12 uptake system BtuCD of E.coli, the multiple drug 
transport protein Sav1866 of Staphylococcus aureus, the putative metal-
chelate transporter HI1470/HI1471 of Haemophilus influenzae and the three 
structures of the lipid flipase MSBA of E.coli, Salmonella typhimurium and 
Vibrio cholerae are known (Locher et al., 2002, Dawson & Locher, 2006, 
Pinkett et al., 2007, Chang & Roth, 2001, Chang, 2003, Reyes & Chang, 
2005). The three structures of MSBA differ substantially from the other 
reported structures, particularly in the domain arrangement of the two NBDs, 
which is contradictory to the reported cooperativity. The observed MsbA 
structures rather reflect crystallographic artifacts and do not show the true and 
active arrangement of the transport system. In addition, the authors declared 
substantial errors during structure determination and therefore all structures of 
MsbA have been retracted and are under revision (Chang et al., 2006). 
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Figure 18: Structure of Vitamin B12 uptake system of E.coli. Cartoon representation of 
the BtuCD –BtuF-system. The structure was solved for the BtuCD complex that is comprised 
of two TMD subunits of BtuC (red and yellow) and two molecules of BtuD (green and blue). 
The periplasmatic protein BtuF-Vitamin B12 complex was placed manually in the complex 
and was not present in the structure (Taken from Locher; (Locher, 2004). 
 
The structures of solved ABC transporters containing both membrane and 
soluble domains (Locher et al., 2002, Dawson & Locher, 2006, Pinkett et al., 
2007) show similar features and have an arrangement supporting the 
biological findings. The structures show the two transmembrane domains 
surrounding the membrane translocation channel and the two attached 
energy proliferation domains. They are in close contact and share the widely 
accepted physiological interface that contains the conserved ATP-binding and 
ATP-hydrolysis motifs (Figure 18). In addition, the two structures of the BtuCD 
and HI1470/HI1471 show an alternating access to the inside or outside of the 
cell. A water filled cavity that is large enough to accommodate the substrates 
is accessible from the cytosol in the structure of HI1470/HI1471, whereas in 
the case of BtuCD the central cavity has access to the periplasm (Pinkett et 
al., 2007). The opening and closing of the translocation pathway of the 
substrates can be explained by small rearrangements of the transmembrane 
domain triggered by movements in the NBDs. 
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C.1.4 Transport Energy Proliferation and ATP-switch Model 
 
Up to now, it is still unknown when and how many nucleotides are hydrolyzed 
in one transport cycle and several models are proposed and discussed over 
the last decades to explain how ABC transporters achieve transport across 
the membrane (Higgins & Linton, 2004, Sauna et al., 2006, van Veen et al., 
2000, van der Does & Tampe, 2004). The processive clamp model favors the 
hydrolyzing event of both nucleotides followed by a dissociation of the NBD 
dimer before reloading with ATP (Smith et al., 2002, Janas et al., 2003). The 
actual power stroke that mediates the transport is either the binding of the two 
ATP molecules and the subsequent dimer formation or, upon ATP hydrolysis 
the electrostatic repulsion of bound ADP and Pi could generate the 
mechanical energy that is used to rearrange the connected TMD to their 
ground state. This model is supported by crystal structures, which always 
contain equally occupied nucleotide binding sites in the two subunits (Smith et 
al., 2002, Janas et al., 2003). 
 
However, studies of the vanadate trapped P-gp (Sauna et al., 2001, Sauna et 
al., 2006) and biochemical studies on the E.coli maltose uptake system 
MalFGK2 (Sharma & Davidson, 2000) showed asymmetric occupancy of the 
two NBDs. Only one ATP molecule was present and the ATPase activity of 
the second NBD was inhibited. Therefore a second model, the alternating 
access model was proposed. Here, one ATP molecule is hydrolyzed, the 
products ADP and Pi are released from one NBD and these events trigger the 
transport of the substrate. A second ATP is subsequently hydrolyzed to resets 
the transporter to its ground state (Ambudkar et al., 2006). However, it should 
be mentioned that in the state where one NBD is in an open and one in a 
closed state, the dimeric interface would be strongly destabilized and 
therefore such a form has not been observed in structures solved with 
detached NBD. It is possible that an attached TMD in a complete transporter 
could stabilize this state (van der Does & Tampe, 2004). 
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The ATP switch model proposes several communication events between the 
TMD and the NBD and changes in the NBD dimer interface (Higgins & Linton, 
2004). The model is based on two principal conformations for the NBDs: 
formation of a closed dimer upon binding of ATP at the dimer interface and 
dissociation to an open dimer after hydrolysis of ATP and release of ADP and 
Pi. Regulation of the transport and nonspecific ATP hydrolysis without 
transport of a substrate is regulated by signals of the TMD. The 
conformational changes also result in different affinities of the nucleotides and 
the substrate. Binding of the substrate to its high affinity site is the first step of 
the transport cycle, resulting in an increased affinity for ATP of the two 
nucleotide binding sites. In a second step ATP binds to each of the two the 
NBDs, which leads to a closed dimer between the two domains. This 
rearrangement of the NBD is communicated to the TMD enabling them to 
adopt a different conformation with a low affinity binding conformation for the 
substrate. The substrate then leaves the transporter and the hydrolysis of the 
two ATP molecules and the release of ADP and Pi finishes the transport 
cycle. 
 
The proposed models of transport are predominantly based on well 
characterized export proteins. Except for the maltose uptake system MalGFK, 
in general, the importers are not very well characterized biochemically (van 
der Does & Tampe, 2004). Nevertheless, the recent structures of ModB2C2A 
(Hollenstein et al., 2007), Sav1866 (Dawson & Locher, 2006) and 
HI1470/HI1471 (Pinkett et al., 2007) provided insight into a possible transport 
mechanism. Binding of two ATP molecules in the NBD dimer rearranges the 
attached coupled helices in the TMD, leading to a conformational shift of the 
inward-facing to the outward-facing conformation. Substrates bound to 
exporter could then be released to the outside of the cell. In contrast, in this 
conformation, the import proteins are accessible to their substrates opening a 
translocation pathway. Upon ATP hydrolysis, the NBDs and TMDs are 
rearranged to adopt their ground states and the opening of the transport 
channel releases the substrate to the cytoplasm (Hollenstein et al., 2007). 
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C.2 Results for ABC Transporters 
 
The aim of this work was the structural and biochemical characterization of an 
ABC transporter. To date three X-ray structures of complete transport 
systems from bacteria are known and published. In addition, there are low-
resolution EM images for example, of the human phospho-glycoprotein that 
allow a rough estimation of the architecture of these proteins. 
 
C.2.1 Eukaryotic ABC Transporter 
 
The mouse Bile salt export pump (mBsep) is a eukaryotic member of the ABC 
transporter superfamily. It is located at the canalicular (apical) membrane side 
of hepatocytes in the liver and is involved in the transcellular transport of bile 
acids. The uptake of bile acids in hepatocytes is mediated by various non 
ABC transporters, such as the sodium-taurocholate co-transporting 
polypeptide (Ntcp) and the sodium independent organic anion transporters 
(OATPs) (Stieger & Meier, 1998). The extrusion of the bile acids is mediated 
by the multi drug resistance proteins (MDR) and the bile salt export pump, 
which are all members of the ABC transporter family. 
 
MBsep or ABCB11 is a large protein of 1321 amino acids with a molecular 
weight of 147 kDa and belongs to the subfamily B of the ABC transporters 
(Dean et al., 2001); http://www.ncbi.nlm.nih.gov/books/). Analysis of the 
secondary structure predictions of the protein indicates the existence of 9 -11 
transmembrane helices, depending on the algorithm used (Figure 19). The 
protein contains two nucleotide binding domains (NBDs) located between and 
after the two transmembrane domains (TMDs); therefore it is thought that this 
gene is the product of a gene duplication of a former half transporter ancestor. 
Since both NBDs must be cytosolic, the number of transmembrane helices 
between the two NBDs must be even. The predicted helix in the region of 
residue number 900 (Figure 19) is likely to form two helices, and the helices at 
residues 1000 and 1030 are true helices. 12 transmembrane helices can 
therefore be assumed for the structure of mBsep. 
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Figure 19: Prediction of transmembrane helices of mBsep. The TMHMM server predicts 
9 helices, whereas helices 3 and helices 10 to 12 are not clearly defined 
(http://www.cbs.dtu.dk/services/TMHMM/). To locate both NBDs in the cytoplasm, the number 
of transmembrane segments in the second half of the molecule must be even. 
 
C.2.1.1 Protein Expression in Insect Cells 
MBsep was expressed in Sf9 insect cells in collaboration with B. Stieger of the 
University Hospital of Zurich. Infected Sf9 cells were harvested and 
resuspended in lysis buffer (50 mM Tris, 50 mM mannitol, 2 mM EGTA, pH 
7.0) containing 1 ug/ml antipain and leupeptin and 1 mM PMSF. The cells 
were homogenized and intact cells and nuclei removed by centrifugation (10 
min, 5000*g, 4°C). The membranes were collected (1 h, 100000*g, 4°C) and 
suspended in buffer (5 mM HEPES, 25 mM sucrose, 50 mM KNO3, 6.25 mM 
Mg(NO3)2, pH 7.4), homogenized and stored at -80°C. The amount of protein 
produced was estimated by silver stained SDS PAGE and Western blot 
(Figure 20). Expression of mBsep could be detected on the Western blot but 
the silver stained SDS-PAGE showed no difference in pattern and intensity of 
the protein bands upon infection. This indicated a very low expression level of 
mBsep. 
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Figure 20: Silver stained 7.5% SDS-PAGE and the corresponding Western blot. M: 
molecular weight marker; 1: Sf9 cells; 2: mBsep; 3: mBsep control expression; 4: Sf9 cells 
infected with wild type virus. Total amount of protein was 10 ug /lane on the silver stained 
SDS-PAGE and 100 ug /lane on the Western blot. The upper band in lane 2 and 3 on the 
Western blot shows the expressed mBsep band with to an apparent molecular weight of 130 
kDa. 
 
C.2.1.2 Solubilization of mBsep 
200 µl of membrane vesicles were incubated with 1 ml solubilization buffer 
(10 mM HEPES, 50 mM KNO3, 25 mM sucrose, 0.02 % (w/v) NaN3, 6 mM 
MgSO4, pH 7.4) containing N-octyl-β-D-glucoside, CHAPS or N-dodecyl-β-D-
maltoside at concentrations of 5, 5 or 5-100xCMC, respectively. The solution 
was stirred for 1 hour at 4°C. The samples were centrifuged and the protein 
concentration in the supernatant was determined (Advanced Protein Assay, 
Cytoskeleton). 900 µl of the supernatant was incubated at 4°C overnight with 
Ni-NTA material (Quiagen). The beads were collected and washed three 
times with solubilization buffer containing the detergent at a concentration of 
3x CMC. The protein was eluted with 250 mM imidazole in the detergent/ 
solubilization buffer. The elutate was applied to SDS-PAGE and analyzed by 
Coomassie staining or Western blot (Figure 21). 
 
None of the above detergents were suitable to achieve the solubilization and 
enrichment of mBsep from the Sf9 cell vesicles. Western blot analysis of the 
eluted fractions, visualizing the N-terminal His-tag of the protein and ATPase 
activity experiments showed similar results. 
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Figure 21: Solubilization of mBsep. Right: all lanes were loaded with 10 µg of total protein. 
M: molecular weight marker; 1: vesicles; 2: DDM extract; 3: DDM flow through; 4: DDM wash 
I; 5: DDM elution; 6: β-OG extract; 7: β-OG flow through; 8: β-OG wash I; 9: β-OG elution; 10: 
CHAPS extract; 11: CHAPS flow through; 12: CHAPS wash I; 13: CHAPS elution; 14: 
external marker. Left: 1: 10 µg vesicles; 2: pellet after solubilization; 3: supernatant after 
solubilization; 4: flow through; 5: wash I; 6: wash II; 7 elution I; 8: elution II; 9: 100 µg vesicles; 
M: molecular weight marker. 
 
C.2.1.3 Cloning and Expression of mBsep in Escherichia Coli 
The expression yield in Sf9 cells was far too low to conduct biochemical or 
structural studies of mBsep. Therefore, the following constructs were 
generated to facilitate the expression of mBsep in E.coli. Constructs of the full 
transporter with an additional cleavable N-terminal 6xHis-tag as well as 
constructs containing half of the transporter were generated. Full length and 
half transporters were PCR amplified using the appropriate primers and the 
mBsep pFASTBac HTb DNA as template. The PCR products were purified 
and ligated into the bacterial expression vectors pET20ch and pET20NHT. 
The two half transporter constructs comprised amino acids 1-755 or 756-1320 
of the cDNA of mBsep. The cleavage site was chosen according to the start of 
the first transmembrane helix of the second transmembrane domain. The 
bacterial expression of mBsep constructs was carried out in E.coli 
BL21 (DE3), E.coli BL21(DE3) CodonPlus RIL and E.coli BL21 (DE3) plysS. 
The different E.coli strains were transformed with the plasmid of interest and 
plated on a LB agar plates containing the appropriate antibiotic. A single 
colony was used to inoculate a 3 ml preculture that was subsequently grown 
at 37 °C over night. 100 ml LB media was incubated with 1 ml of preculture 
and grown at 37°C to an OD600 of 0.6. Protein expression was started using 
0.2 mM IPTG and the cells were grown at 18, 25 or 37 °C. The cells were 
harvested 1-8 hours after induction and a 1 ml sample was loaded on an 
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SDS-PAGE. The expression tests were repeated with 2YT media. Various 
expression tests with different strains, temperatures, media and IPTG 
concentrations showed no expression of the full or half transporters. 
 
C.2.1.4 Cloning and Expression of mBsep in Mammalian Cells 
Full-length mBsep was PCR amplified using the plasmid mBsep pFASTBac 
HTb as template. The resulting PCR product, containing the full-length 
mBsep, the N-terminal hexa His tag and the rTEV cleavage site, was cloned 
into the pEAK8 vector digested with Hind III and Eco RI. 
 
The vector pEAK8-mBsepEGFP was produced by PCR amplification of full-
length mBsep from the mBsep-peak8 vector including the N-terminal addition 
of the 6xHis-tag and cleavage site but lacking the 3` stop codon. The DNA of 
the enhanced green fluorescence protein was PCR amplified using the vector 
pEGFP-N1 as template. Both PCR products were sequentially cloned into the 
pEAK8 vector using Hind III and Eco RI or Eco RI and NotI, respectively.  0.5 
x 106 293T cells were transformed with 10 µg of the appropriate vectors. After 
7 h of incubation the cells were washed with 5 mL PBS buffer and grown in 
8 ml media for an additional 20 h. The rate of transfection was checked by 
fluorescent microscopy with the control vector EGFP. The cells were 
harvested and loaded on an SDS Gel and the proteins were visualized with an 
anti-HIS antibody (Figure 22, left). 
No signal was detected at a molecular mass around 120 kDa. Therefore the 
amount of DNA used for transfection was varied in the range 1-20 µg and the 
time of expression was varied from 1 to three days. A total amount of 150 µg 
of protein was applied to an SDS-PAGE and subsequently transferred to a 
cellulose membrane. The proteins were visualized with the primary antibody 
against mBsep and a secondary antibody, which was coupled to the enzyme 
horse radish peroxidase (Figure 22, right). Small amounts of mBsep could be 
detected upon transfection of the cells with 10 – 20 µg vector and an 
incubation time of 48 hours. Nevertheless the control of the mBsep expressed 
in Sf9 cells showed higher expression levels. 
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Figure 22: Expression tests of mBsep in mammalian cells. Left image: 293T cells 
transfected with 0,1,2,5 and 9 µg of mBsep-peak8 are shown in lanes 1-5, respectively. As a 
positive control, a vector containing PYD was used. The protein was detected using an 
antibody recognizing His-tagged proteins. Right image: 293T cells transfected for 24 h with 
1,5,10 and 20 µg of mBsep-peak8 are shown in lanes 2-5. A GFP control plasmid was loaded 
on lane 1 and the cell without transfection in lane 6. Lanes 7-12 and 13-19 are the same 
experiment, except, with expression time of 48 and 72 h. 
 
Although sufficient protein was produced to perform activity tests in 
membrane vesicles (Stieger et al., 2000), the amount of the eukaryotic ABC 
transporter mBsep produced in all tested heterologous expression systems 
was barely detectable. Having available only small amounts of protein, for 
purification, structural studies, and biochemical characterization become 
impractical and, therefore, the work with mBsep was discontinued and the 
focus was shifted towards ABC transporters originating from different bacterial 
strains. 
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C.2.2 Prokaryotic ABC Transporters 
 
The following section on prokaryotic ABC transporters describes the work and 
progress of the selection process, expression, purification and biochemical 
analysis of successfully selected prokaryotic ABC transporters. 
 
C.2.2.1 Strategy 
The main bottleneck to obtaining structural and functional information about 
membrane proteins is the availability of large amounts of the desired proteins. 
The heterologous expression and preparation large amounts of functional 
membrane proteins is influenced by various parameters, including protein 
stability, posttranslational modifications for example glycosylation or 
phosphorylation, lipid composition of the host, membrane thickness, toxicity 
and protease stability (Wagner et al., 2006). Furthermore, the solubilization of 
the expressed proteins in an appropriate detergent is critical. Removal of the 
proteins from their natural lipid environment decreases the stability of the 
polypeptides during solubilization. This often results in nonhomogenity or 
precipitation of the sample mainly due to unfolding of the protein, depending 
on the detergent selected. However, in addition, to the mentioned problems 
during production and purification of the membrane protein, a further 
complication arises during crystallization. The dynamic nature of many 
transport proteins leads to multiple conformations, which, if present in the 
sample are unfavorable for the formation of well ordered crystals. 
 
Working simultaneously with homologues of the protein of interest from 
different organisms is one strategy to overcome these problems. For example, 
instead working with a highly complex and unstable eukaryotic or human 
protein a bacterial homologue might be chosen. In cases where homologues 
an identical function are not present or accessible, homologues with different 
functions, but inheriting for example a conserved reaction mechanism, are an 
alternative to understand the protein of interest. 
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To gain insights into the general function and architecture we started with a 
selected set of 28 ABC transporters, including importers and exporters, 
transporters consisting of two or four polypeptide chains and proteins that 
originate in different bacteria. This should enhance the chances to obtain a 
transporter suitable for structure determination. 
 
 
Figure 23: General strategy applied in the work on ABC transporters. The proteins of 
interest were selected and cloned into bacterial expression vectors. Different E.coli strains 
were transformed with these vectors and expression of the proteins was examined. Proteins 
with highest expression yields were subjected to purification, characterization and 
crystallization. 
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C.2.2.2 Selection 
Since ABC transporters are occurring in all kingdoms of life and transport a 
wide range of different substrates, it is not surprising that the number 
sequences found in the ABC transporter superfamily is over 2000. Conserved 
sequence features that are located in the cytosolic domain of the transporters, 
harboring the ATP binding site, identify sequences of ABC transporters. In 
contrast, the membrane associated regions of the transporters are less 
conserved. These domains are responsible for the recognition of the substrate 
and therefore may show variations that allow transport of the different 
compounds across the membrane. 
 
Starting with the protein sequence of mBsep, a blast search was performed to 
find possible homologues of this transporter in bacteria, but the enormous 
numbers of different ABC transporters and the high sequence identity present 
in the NBDs, resulted in too many diverse candidates. The annotated 
SwissProt database (Bairoch2004) was therefore used to identify possible 
targets for the project. A subset of the ABC transporters was selected 
according to two criteria: 
 
1. Proteins should originate from thermophilic organisms. 
These bacteria or archeabacteria live in an environment that reaches 
temperatures up to 100°C. Normally functioning at these high temperatures, it 
is clear that these proteins should exhibit higher stability and lower flexibility at 
room temperature. In particular, the potential increase in the chance of 
trapping the transporter in a distinct state of its catalytic cycle makes these 
proteins attractive targets for crystallographic studies. 
 
2. Simplified cloning and expression  
Simplified cloning and expression procedures could be achieved using those 
transporters that contain a fusion of TMD and NBD. This restriction reduces 
the number of different clones that have to be produced from each individual 
gene. In addition such constructs enhance the chance of obtaining a protein 
sample that contains the full transporter complex. 
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Despite these ideal’s, however, other considerations influenced the selection 
of the target and various genes were chosen that do not fulfill the above 
mentioned criteria. For example it was argued to be advantageous to choose 
proteins originating from E.coli as they might express better in E.coli than 
proteins from other organisms. It was also decided to choose transport 
systems with known function so that material obtained could be characterized 
biochemically and functionally. Unfortunately, the annotated sequences 
mostly originate from E.coli and the majority of E.coli ABC transporters consist 
of an NDB and TMD on separate polypeptide chains. Nevertheless six of 
these transport systems were included in the pool of targets. 
 
Bacteria were selected and their genomes scanned for the presence of NBD 
domains containing the signature motif of the ABC transporter family. Hits 
were analyzed with TMHMM (http://cbs.dtu.dk/services/TMHMM) to verify the 
presence of transmembrane helices. In the case of proteins that did not 
contain transmembrane helices, the two neighboring ORFs situated directly 
up and downstream on the genome were analyzed for the presence of 
transmembrane helices, and, if helices were detected, included in the work. 
The proteins and the corresponding open reading frames that were selected 
and used in this work are summarized in Table 2. 
 
Figure 24 shows the alignment of a subset of the selected transporters and 
the similarity of the NBDs; especially highly conserved are the two motifs 
walker A and B. These two features are also present in other nucleotide 
binding proteins, however, the ABC transporters contain an additional, so 
called, signature motif, that distinguish them from other classes of nucleotide 
binding protein. 
 
 
 
 
 
 
 
Results - Prokaryotic ABC Transporters 
 64 
Table 2: Selected Proteins 
Name Species Domain 
arrangement1 
Substrate Accession 
number2 
TM0043 Thermotoga 
maritima 
h Unknown Q9WXQ0 
TM0287 Thermotoga 
maritima 
h/m Unknown Q9WYC3 
TM0288 Thermotoga 
maritima 
h/m Unknown Q9WYC4 
TM1256 Thermotoga 
maritima 
h Unknown Q9X0Y3 
TM1310 Thermotoga 
maritima 
h Unknown Q9X136 
TM1319 Thermotoga 
maritima 
h Unknown Q9X144 
TM1328 Thermotoga 
maritima 
h Unknown Q9X151 
HP0600 Helicobacter 
pylori 
h Multi drug 
resistance 
O25322 
HP1082 Helicobacter 
pylori 
h Lipids O25714 
PH1735 Pyrococcus 
horikoshii 
h/m Unknown O59382 
PH 1736 Pyrococcus 
horikoshii 
h/m Unknown O59381 
YFIB Bacillus subtilis h/m Unknown P54718 
YFIC Bacillus subtilis h/m Unknown P54719 
YHEH Bacillus subtilis h/m Unknown O07549 
YHEI Bacillus subtilis h/m Unknown O07550 
YKNU Bacillus subtilis h/m Unknown O31707 
YKNV Bacillus subtilis h/m Unknown O3170 
YDDA Escherichia coli h Unknown P31826 
YOJI Escherichia coli h  P33941 
YWJA Bacillus subtilis h Unknown P45861 
MacB Escherichia coli h macroliden P75831 
YBIZ Escherichia coli h Unknown Q8XED0 
araG/H Escherichia coli m L-arabinose P0AAF3* 
P0AE26 
glnP/Q Escherichia coli m L-glutamate P0AEQ6 
P10346* 
mglA/C Escherichia coli m Methyl-
galactoside 
P0AAG8* 
P23200 
tauB/C Escherichia coli m taurine Q47538* 
Q47539 
xylG/H Escherichia coli m xylose P37388* 
P0AGI4 
znuB/C Escherichia coli m zinc P39832 
P52648* 
mBsep Mus musculus f Bile acids Q9QY30 
1 f: full transporter, h: half transporter, m: two different polypeptides assemble the transporter, 
h/m two transporters neighbored on the genome that might form a heterodimer. 2: (Bairoch et 
al., 2005) UniProtKB/TrEMBL database, * denotes the ATP binding subunits of the transport 
systems.  
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Figure 24: Alignment of NBD of 4 different ABC transporters. Sequences of BTUD, 
mBsep, TM0288 and MJ0769 are shown. Walker A and B motifs, Q-, D-, and H-loops and the 
signature motif are shown in red, gold, green, magenta, cyan and blue, The alignment was 
created with T-Coffee (Notredame et al., 2000) and edited with JalView (Clamp et al., 2004). 
 
C.2.2.3 Cloning of Prokaryotic ABC Transporters 
DNA of the selected ABC transporters was amplified by PCR using genomic 
DNA as the template and the product was subsequently cloned into an E.coli 
expression vector. The primer pairs were designed to match their theoretical 
melting temperature. According to the restriction enzyme used, 5-7 bases 
were added at the 5` end of each primer to enhance the digest activity. The 
PCR product obtained was purified on an agarose gel (Figure 25), digested 
and ligated into an expression vector, which was subsequently amplified and 
analyzed by restriction enzyme analysis and sequencing. 
 
To reduce the number of PCR steps and to allow a fast transfer of the 
different constructs to different vectors, the following expression vectors were 
generated before the first cloning steps. Starting with the commercially 
available vectors pET20, pET21/28, pET28, and pTFT, three vector series 
were created containing an identical multiple cloning site (Table 3 to  
Table 5). 
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The majority of the vectors encode additional tags, which add the 6xHis-tag 
either at the N- or C- terminal end of the protein of interest. This tag enables 
the detection by His-tag specific antibodies and, furthermore, allows 
purification of the tagged protein by metal chelate chromatography; a robust 
and fast method to isolate the protein of interest. 
 
Table 3: Modified pET20 Vectors  
pET20-series, Ampicillin resistance Properties 
pET20b(+) N-terminal pelB signal sequence, 
optional C-terminal 6xHis-tag, T7 
promoter 
pET20-no-Tag-no-pel - 
pET20-no-Tag-pel pelB signal sequence for export to 
the periplasm 
pET20-GST N terminal fusion of the GST protein 
pET20-GST-c-6xHis N terminal fusion of the GST protein 
C-terminal 6xHis-tag  
pET20-c-6xHis C-terminal 6xHis-tag 
pET20-c-6xHis-pel pelB signal sequence for export to 
the periplasm, C-terminal 6xHis-tag 
 
pET20-n-6xHis N-terminal 6xHis-tag 
pET20-c-6xHis-n-6xHis C-terminal 6xHis-tag 
N-terminal 6xHis-tag 
 
Table 4: Vectors used for co-expression of 2 proteins 
pET21, pET28-series Properties 
pET21-c-6xHis C-terminal 6xHis-tag 
Ampicillin resistance 
pET28-c-6xHis C-terminal 6xHis-tag 
Ampicillin resistance 
pET21-n-6xHis N-terminal 6xHis-tag 
Kanamycin resistance  
pET28-n-6xHis N-terminal 6xHis-tag 
Kanamycin resistance 
 
Table 5: High and low copy plasmids 
pET28/TFT-series Properties 
pET28-c-6xHis-new C-terminal 6xHis-tag 
Kanamycin resistance 
pET28-n-6xHis-new N-terminal 6xHis-tag 
Kanamycin resistance 
TFT-c-6xHis 
Low copy plasmid 
N-terminal 6xHis-tag 
Ampicillin resistance 
TFT-n-6xHis 
Low copy plasmid 
N-terminal 6xHis-tag 
Ampicillin resistance 
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Figure 25: Resulting PCR products. 10 µg genomic DNA was amplified with the appropriate 
primer pairs. Lane 1: Marker DNA; lanes 2-4: TM0043; lanes 5-7: TM0287; lanes 8-10: 
TM0288; lanes 11-13:TM1256, lane 14: marker DNA; lanes 15-17:TM1310; lanes 18-20: 
TM1328; lanes 21-23: PH1736. Nearly all PCR showed additional band at molecular weights, 
which were smaller than the actual transporters ~1.5 kbp. 
 
C.2.2.4 Expression of Prokaryotic ABC Transporters 
The next section describes a general protocol that was used for the 
expression, purification and characterization of the selected ABC transporters 
mentioned in Table 2. More detailed protocols of individual transporters are 
given in the following chapter. A summary of all the expression tests with the 
various constructs and different expression cells can be found in the appendix 
in Table 8. 
 
The plasmids encoding for the selected and successfully cloned ABC 
transporters were subjected to expression analysis in E.coli. Freshly 
transformed cells were grown over night in 2 ml pre-cultures, transferred to 
100 ml liquid media and grown to an OD600 of ~ 0.5. After induction with IPTG 
samples were taken after 1, 3, 5 and 18 hours and subjected to SDS-Page 
analysis. In general, different types of media, different concentrations of IPTG 
and two induction temperatures were tested to obtain the highest expression 
levels for each transporter. Overexpression of the transporters could not be 
visualized on Coomassie stained gels, therefore, all expression tests were 
analyzed by Western blot. The protein was visualized using an antibody that 
recognizes N- or C-terminal His-tags (Quiagen) or an antibody specific to a 
C-terminal 6xHis-tag (Kaufmann et al., 2002). 
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In general, it was observed that all transporters expressed poorly using the 
pET20b vectors. Transformation of the E.coli strains BL21(DE3), CD41 or 
CD43 (Miroux & Walker, 1996) with the generated plasmids lead to no or only 
very few colonies on a normal LB-Agar plate. After a supplement of 1% 
glucose to the LB-agar media more colonies were observed on the plates 
directly indicating toxicity in the cells upon induction of the heterologously 
expressed transport proteins. Therefore, all transporters were recloned into 
vectors based on the pET21 and pET28 series which have much greater 
control of the basal protein production. These vectors allow a stricter control 
of the expression levels before induction and are therefore more suitable for 
the production of proteins that are toxic to the host cell. In addition to the 
above-mentioned variations of the culture conditions, experiments with 
controlled pH during growth of the cells and nutrient feeding were carried out 
in a parallel fermenter.  
 
C.2.2.5 Purification 
The transporters that showed the highest expression levels in E.coli were 
further examined. The expression of each of the transporters was maximized 
by slight variations of protocols used during the expression tests. After 
determining the optimal expression parameters for each transporter, the 
protein was subjected to the purification process. After expression, the cells 
were pelleted by centrifugation and opened using a FrenchPress. The 
membrane fraction was collected and analyzed by SDS-PAGE and Western-
blot. This allowed to find out whether the protein of interest had been correctly 
inserted in the membrane of E.coli or was disposed of in inclusion bodies. The 
membranes were subsequently solubilized using different buffers and 
detergents at various concentrations. The solubilized material was subjected 
to an ultracentrifugation step to remove the non-solubilized material and 
subsequently loaded onto metal chelate resin that had been previously 
equilibrated with nickel ions (chelating agarose Pharmacia; Ni-NTA Quiagen). 
After washing the column with increasing amounts of imidazole, the bound 
protein was eluted with a high concentration of imidazole. The eluted protein 
solution was analyzed by SDS-PAGE and size exclusion chromatography.  
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Size exclusion chromatography experiments were useful and necessary to 
determine the oligomeric state of the transporters after purification. Most of 
the transporters which showed high expression levels could be solubilized 
and purified by Ni-chelate chromatography. Unfortunately, however, the 
majority failed the size exclusion chromatography analysis either showing 
high amounts of aggregated protein or eluting with an estimated molecular 
weight that reflected rather a monomer than the proposed multimeric 
functional complex. In particular, the transporters that consist of two 
polypeptide chains, for example araG/H or tauB/C, were shown to be prone to 
fall apart with the two different polypeptide chains eluting at different volumes 
during the size exclusion chromatography run. In the cases mentioned above, 
where the transport proteins behaved unexpectedly during the size exclusion 
chromatography analysis, different pH values, salt concentrations and 
detergents were chosen and applied to the previous purifications steps to try 
to enhance the mono dispersity of the protein sample and increase the 
fraction of correctly formed complex. 
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C.2.3 Protocols for Specific Prokaryotic ABC Transporters  
 
C.2.3.1 Proteins Originating from Thermotoga maritima 
 
TM0287 and TM0288 
 
The two ABC transporters TM0287 and TM0288 originate from the bacterium 
Thermotoga maritima strain MSB8. Both proteins contain a fusion of a 
transmembrane and a nucleotide-binding domain and belong to the so-called 
half transporters. TM0287 contains 577 amino acids with a molecular weight 
of 64360 Da. Prediction of the transmembrane helices indicated six clearly 
defined helices located between amino acids 7 and 297 and the cytosolic C-
terminal NBD. Between helices one and two and helices five and six two 
shorter loops with a length of 30 and 14 amino acids respectively, are 
predicted to be located at the extracellular side of the membrane (Figure 26). 
 
Figure 26: Prediction of the transmembrane helices in the ABC transporter TM0287. 
The red bars describe the localization of the transmembrane helices in the protein sequence. 
Two shorter loops outside of the cell are found between helices one and two or between 
helices five and six. (http://www.cbs.dtu.dk/services/TMHMM/). 
 
Results - Prokaryotic ABC Transporters 
 71 
TM0288 consist of 598 amino acids with a molecular weight of 67708 Da. The 
prediction of the transmembrane helices suggested 4 clearly defined 
transmembrane segments and one less well defined helix 5 (Figure 27). The 
prediction suggests the N-terminus is in the cytosol, but the 5 predicted 
helices place the C-terminal NBD domain incorrectly. It is obvious, therefore, 
that the broad peak in the prediction for helix 5 reflects two transmembrane 
helices rather than the one indicated by the algorithms. Splitting helix 5 into 
helices 5 and 6 would result in the correct cytosolic localization of the NBD. 
The protein contains a short external loop between helices 1 and 2 with a 
length of 23 amino acids. 
 
Figure 27: Prediction of the transmembrane helices in the ABC transporter TM0288. 
The red bars describe the localization of the transmembrane helices in the protein sequence. 
The broad red around amino acids 270-310 rather reflects two transmembrane helices, 
resulting in a total number of six helices and a correct localization of the C-terminal 
nucleotide-binding domain. Between helices one and two, a short external loop with a length 
of 23 amino acids is predicted. (http://www.cbs.dtu.dk/services/TMHMM/). 
 
On the genome of T. maritima TM0287 is located between base pairs 
303150-304883, whereas TM0288 is encoded by the base pairs 304876-
306672. The two proteins share 8 bases encoding for the C-terminal 
aspartate, alanine and the stop codon of TM0287 or the starting methionine, 
proline and glutamate of TM0288 (Figure 28). Because of this close proximity 
it is not clear, if both genes encode for one hetero-dimeric transporter or if 
both proteins form homodimers, resulting in two individual ABC transporters. 
To address this question, the two proteins were expressed either alone or 
together in one host. 
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Figure 28: Gene organization of TM0287 and TM0288. The red bar in all three panels is the 
transcript of the DNA sequence. Upper panel shows the 5`end of TM0287, located at base 
pair 303150. The center panel shows the overlapping region of the two ABC transporters 
TM0287 and TM0288. Both genes make use of base pairs 304876 to 304883 either as the C-
terminal end of TM0278 that is translated in frame 3 or as the N-terminal starting sequence in 
frame 2 used by TM0288. The lower panel shows the end of TM0288 encoding the stop 
codon at base pairs 306669-72. 
 
Expression and Purification of TM0287 or TM0288 
 
Expression levels of the transporters TM0287 and TM0288 were rather poor 
during the normal procedure for expression in shaker flasks. Therefore, a pH-
controlled experiment in a parallel fermenter was carried out. The pH could be 
controlled externally with acid and bases (HCl and NaOH) or by the 
metabolites glucose and ammonia (acid/base). The latter allowed additional 
nutrient feeding during growth of the bacteria, but initial experiments showed 
that this method was prone to instability of the pH values due to the different 
growth behaviors of the bacteria. Therefore, all experiments were carried out 
with the HCl-NaOH combination to keep the pH at a constant value of 7.4. 
 
A shaker flask containing 250 ml of 2YT media (16g/l bacto tryptone, 10g/l 
yeast extract, 5 g/l NaCl) and the appropriate antibiotic was inoculated with an 
overnight culture of BL21(DE3) containing the pET28-CH construct of 
TM0288, to give a starting OD600 of 0.1-0-15. The cells were grown at 37°C to 
an OD600 of 0.6-0.7, supplemented with 1% (w/v) glucose, induced with 0.2 
mM IPTG and protein expression was carried out at 30°C for 3 h. The cells 
were harvested by centrifugation (30 min, 4000xg 4°C), flash frozen in liquid 
nitrogen and stored at -20°C.  
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Cells of a 3L culture were suspended in 60 ml buffer A (20 mM Tris, 20 mM 
NaCl, pH 7.5) containing 20 µl Dnase (30 mg/ml), 20 µl RNase (5 mg/ml), 
1 mM PMSF and complete protease inhibitor cocktail (Roche). The cells were 
lyzed by 3 passes in the FrechPress, were centrifuged to remove soluble 
proteins and the resulting pellet was incubated for 1h at 4° with 110 ml buffer 
A containing 1 mM PMSF, complete Protease inhibitor cocktail (Roche) and 
1% (w/v) DDM. Non-solubilized material was removed by ultra-centrifugation 
(100000 x g 4°C) and the supernatant was loaded on a 2 ml Chelating 
Sepharose column loaded with nickel (Pharmacia) that had been equilibrated 
in buffer A containing 0.03% DDM. Prior to elution with buffer A containing 
250 mM imidazole and 0.03% DDM, unbound sample and impurities were 
removed by washing the column with 100 ml buffer A containing 0.03 % DDM 
and 50 ml buffer A containing 50 mM imidazole and 0.03 % DDM. The 
purification process is summarized in Figure 29. The protein TM0288 
migrated with an apparent molecular weight of 65 kDa. 
 
Elution 1-3 ml was concentrated to 180 µl and analyzed by size exclusion 
chromatography (Superdex 200 23 ml, Pharmacia) using an isocratic elution 
in buffer A supplemented with 0.03 % DDM. The protein eluted in a single 
peak at 10.6 ml corresponding to a size of ~130 kDa (Figure 30). Fractions 
containing pure protein were concentrated and stored at 4°C. Analysis of the 
sample after two weeks showed that the protein was stable at 4°C. No 
degradation or different elution properties of the size exclusion 
chromatography column fractions were observed. 
 
 
Figure 29: Purification of TM0288. The SDS-PAGE shows the enrichment of the transporter 
during purification. Lane 1+10: Marker proteins; lane 2: 2 µl of the membrane fraction; lane 3: 
2 µl of the flowthrough of the Ni-column; lane 4: 5 µl of the wash without imidazole; lane 5: 30 
µl of the wash with 50 mM imidazole, lane 6: 30 µl of elution 0-1 ml; lane 7: 10 µl of elution 1-
3 ml; lane 8: 30 µl of elution 3-5 ml; lane 9: 30 µl of elution 5-7. 
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Figure 30: Size exclusion chromatography and corresponding SDS-PAGE of TM0288. 
The protein eluted in a sharp peak at an elution volume of 10.6 ml corresponding to a 
molecular weight of 130 kDa. In addition a small amount of aggregate is visible at 7.8 ml. 
SDS-PAGE: lane 1 +7: Marker proteins; lane 2: 2µl of the concentrated sample prior to size 
exclusion chromatography; lane 3-6: 10 µl of the fractions 9-12; lane 8: 2 µl of pooled and 
concentrated fractions; lane 9-10: 30 µl of the flowthrough from both concentrations steps. 
The arrow indicates TM0288. 
 
To verify the presence of folded material, an ATP-agarose binding assay was 
carried out using the purified protein. 24 µg purified TM0288 were incubated 
for 1h at 4°C with 25 µl ATP-agarose (02065, Sigma), previously equilibrated 
with 100 µl buffer A. The suspension was applied to a small column, washed 
twice with 30 µl of buffer A and the protein was eluted by addition of 30 µl 
buffer A containing 10 mM ATP. The last step was repeated 2 times. In 
addition, the experiment was carried out in the presence of 5 mM MgCl2. The 
samples were analyzed by SDS-PAGE (Figure 31). The SDS-PAGE shows 
that the protein had bound to the ATP-agarose and that the addition of ATP 
released the transporter of the beads as seen in rows 5-7 and 7-9 of Figure 
31. As expected, the addition of Mg2+ ions slightly enhanced the binding of the 
transporter to the beads as concluded by comparing the band intensities of 
the flowthrough fractions (lane 2 and 9). 
 
Expression and purification of TM0287 was carried out as described for 
TM0288, except that buffer A contained more salt (500 mM NaCl). Figure 32 
shows the purity of the sample after the Ni-column, whereas Figure 33 shows 
the elution profile during size exclusion chromatography (Superdex 200 
HILOAD, 320ml, Pharmacia) and the corresponding fractions, which were 
analyzed by SDS PAGE. The sample was not as pure as the protein obtained 
from TM0288 and multiple impurities were visible on the SDS-PAGE. 
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Further purification with cationic or anionic exchange materials did not 
improve the protein purity and further analysis was carried out with samples 
containing these impurities.  
 
 
Figure 31: ATP-agarose binding of TM0288. The binding and elution of TM0288 to the 
ATP-agarose is shown. Lane 1: Marker proteins; lane 2: unbound protein; lane 3-4 wash 
steps; 5-7: samples after addition of ATP; lane 8: beads after elution. Lanes 9-15: loaded as 
lanes 2-8 but without the addition of MgCl2. 
 
 
Figure 32: Purification of TM0287. Lane 1: Marker proteins; lane 2: 2 µl of the soluble 
fraction after cell lysis; lane 3: pellet after solubilization; lane 4: 5 µl of the flowthrough of the 
Ni-column; lane 5: 250 µl of the wash without imidazole; lane 6: 125 µl of the wash with 10 
mM imidazole, lane 7: 25 µl of elution with 50 mM imidazole; lane 8: 25 µl of elution with 100 
mM imidazole; lane 9: 25 µl of elution with 250 mM imidazole; lane 10: column material after 
elution. The small arrow indicates TM0287. 
 
  
Figure 33: Size exclusion chromatography and SDS-PAGE analysis of TM0287. Size 
exclusion chromatography (Superdex 200 HILOAD, 320 ml, Pharmacia) indicated higher 
amounts of aggregates, which eluted in the void volume of the column (~110 ml). Right 
image: SDS PAGE of the fractions corresponding to those marked with green triangles on the 
size exclusion chromatography profile. Lane 1: Marker proteins; lanes 2-10: 500 µl of the 
individual fractions were precipitated and loaded on the gel. Multiple impurities at lower and 
higher molecular weight were found over the full range of the peak. The arrow indicates 
TM0287. 
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The transporter TM0287 showed less stability than TM0288 and precipitated 
after 2-3 day even at low concentration. Adding 20% (v/v) glycerol or 200 mM 
sucrose during purification did not improve the stability of the transporter as 
indicated in Figure 34, which shows the elution of the Ni-column after 2 days 
incubation at 4°C. The high amount of aggregates that do not enter the gel 
and the degradation products at lower molecular weight indicate a lower 
stability compared to TM0288. The addition of sucrose promoted the 
aggregation and after 2 days of incubation a white precipitate of protein could 
be observed.  
 
    
Figure 34: Stability test of TM0287. SDS-PAGE analysis of the fractions of the Ni-column 
after 2 day storage at 4°C. Lane 1: Marker proteins; lane2: TM0287 purified in 500 mM NaCl; 
lane 3: TM0287 purified in the presence of 20 % glycerol; lane 4: precipitate of TM0287 
purified in presence of 200 mM sucrose. The right image shows the corresponding Anti-His 
Western blot. 
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Biochemical Analysis of TM0287 and TM0288 
 
To address the question if the two half transporters TM0288 and TM0287 
form a heterodimeric complex, which would be a bacterial analogue of the 
human TAP1/2 system, or instead form two individual ABC transport systems, 
a series of experiments were carried out. These experiments examined the 
full length and truncated constructs of both transporters. The first indication of 
a possible heterodimer was found upon measuring ATP hydrolysis (see page 
169) of the individual transporter and a mixture of both. Individual transporters 
showed no activity, whereas the activity was increase 10 fold upon mixing of 
the two transporters (Figure 35). But, since TM0287 could not be purified to 
homogeneity and the substrate of the transport process is unknown, further 
experiments to analyze the transport process in more detail could not be 
carried out. 
 
Figure 35: ATPase activity of the transporters TM0287 and TM0288. Both transporters 
were measured separately and as mixture of both. The mixture showed a higher release of 
PO43- than the individual transporters. The blue bars correspond to twice the amount of 
protein compared to the measurement that is displayed in red. 
 
However, further investigations on the formation of the heterodimer were 
carried out. To verify the presence of this complex, the two proteins were 
separately expressed and purified and subsequently analyzed by size 
exclusion chromatography either alone or as mixture. Although different 
detergents and salt concentrations were used, no condition was found in 
which a clear shift of the elution volume would indicate the presence of the 
dimeric complex. On the other hand, the formation of the dimeric complex 
might be prevented, because both the membrane spanning domains were 
expressed separately and were therefore surrounded by detergent. This 
question was addressed using constructs without the TMD or the 
simultaneous expression of both full length proteins in one host. 
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The NBD of TM0287 (starting at bp 958) and the NBD of TM0288 (starting at 
bp 1071) were cloned in the vector pat222 which contains an N-terminal 
6xHis-tag and a maltose binding protein. An avidin tag was introduced at the 
C-terminal end of TM0287 and TM0288, resulting in a protein mass of 75 kDa 
of TM02878 and 70 kDa of TM0288. Proteins were co-expressed in XL1-blue 
at 18°C and purified by IMAC. The elution of the IMAC was analyzed by size 
exclusion chromatography (Figure 36). Both proteins eluted at ~ 9.2 ml 
(Superdex 75, 23 ml, Pharmacia) corresponding to a molecular weight of ~60 
kDa. In addition, a 1:1 mixture of both proteins was incubated for 1h and 
analyzed by size exclusion chromatography. The mixture eluted at the same 
volume as did the individual proteins, and therefore complex formation of the 
NBDs of TM0287 and TM0288 could not be observed. The addition of ATP 
and Mg2+, which should bind in the interface, had no effect upon dimer 
formation, as shown in Figure 36. The elution profile of TM0288 in presence 
or absence of ATP of 1 mM ATP and 5 mM MgCl2 was the same. 
 
Figure 36: Size exclusion chromatography of the NBDs of TM0287 and TM0288. The 
picture shows the elution profiles of the NBDs of TM0287, TM0288 and the 1:1 mixture of 
both proteins in red, blue and green, respectively. Upon mixing of the two individual 
expressed proteins no experimental evidence was found for the presence of a heterodimer. 
The elution profile of the NBD of TM0288 in the presence of ATP and Mg2+ is shown in black. 
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The contradicting results on complex formation were further addressed by co-
expression of TM0288 and TM0287 in the same host. To ensure that both 
plasmids were inside the cell, TM0288 was cloned in pET21 vector providing 
a resistance against ampicillin and TM0287 was used as a pET28-ch 
construct harboring the gene for the resistance against kanamycin. The 
construct of TM0288 contained an additional avidin tag to enable detection of 
both proteins separately. To further ensure that only hetero complexes could 
be purified, the 6xHisTag at the C-terminal end of TM0288 was removed. 
Both plasmids were simultaneously transformed into BL21(DE3) E.coli cells. 
The proteins were expressed as described for the transporter TM0288, in the 
presence of both antibiotics using a controlled pH environment. The fractions 
from the Ni column were analyzed by Western-Blot and both proteins were 
visualized by Anti-His or Streptavidin antibodies. Although the presence of 
TM0288 was verified by crude extract analysis, the inspection of both Western 
blots indicated that the two transporters did not form a hetero complex. 
TM0287 was present in the samples of the Ni-column whereas the blot 
stained with streptavidin showed no band in the corresponding fractions that 
could be related to TM0288. Overall the results indicated that the two 
transporters TM0287 and TM0288 do not form a heterodimer, but are rather 
compounds of two individual ABC transport systems. 
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C.2.3.2 Proteins Originating from Escherichia Coli  
 
ZnuBC 
 
The high affinity zinc uptake system ZnuABC of E.coli is used as a second 
transport mechanism when the environmental concentration of the substrate 
is reduced. The complete transporter system consists of the periplasmic 
binding protein ZnuA, the membrane-spanning domain ZnuB and the ATP 
binding protein ZnuC. Metal loaded ZnuA binds to the TMD of ZnuB in the 
periplasm of E.coli. The two proteins ZnuB and ZnuC then facilitate the 
transfer of the zinc ions across the membrane into the cytosol of the bacteria. 
The three proteins are located in close proximity on the genome of E.coli, 
where ZnuC and B are enconded on the forward DNA strand and ZnuA 
resides on the reverse strand on the genome. An additional protein Zur, which 
binds to the bidirectional promoter region of ZnuA and ZnuBC, regulates the 
expression of the zinc transporter in vivo (Patzer & Hantke, 1998). 
 
Analysis of ZnuB suggested the presence of seven transmembrane helices 
with the C-terminal end of the protein located in the cytosol (Figure 38) (Daley 
et al., 2005). Two loops residing in the periplasm are present between helices 
2 and 3 and between helix 4 and helix 5. Three longer loops between helices 
1 and 2, 3 and 4 or 5 and 6 with a length of 22, 19 and 20 amino acids 
respectively, are located on the inner side of the membrane. 
 
 
Figure 37: Gene organization of the ZnuABC zinc transport system. The three genes of 
the zinc uptake system are encoded by base pairs 1939675 to19490607 for ZnuA, 1940686 
to 1941441 for ZnuC and 1941438-1942223 for ZnuB. ZnuA is transcribed from the reverse 
strand whereas ZnuB and ZnuC are located on the forward strand of the DNA. Note that 
ZnuC and ZnuB have 4 base pairs in common, encoding for the stop codon of ZnuC in frame 
1 and the start methionine of ZnuB in frame 2 of the DNA sequence. 
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Figure 38: Prediction of the transmembrane helices in the ZnuB. The red bars describe 
the localization of the transmembrane helices defined by the sequence of ZnuB. The N- and 
C-termini reside in the periplasm and in the cytosol, respectively. Two loops, located between 
helices 2 and 3 or helices 4 and 5 are located in the periplasm. Large loops in the cytosol are 
found between helices 1 and 2, 3 and 4 of between helices 5 and 6. 
(http://www.cbs.dtu.dk/services/TMHMM/) 
 
The two proteins ZnuB and ZnuC were cloned into the vectors pET21 and 
pET28 (Table 4) with the 6xHis-tag either at the N- or at the C-terminus of 
each polypeptide. The two tags generate 4 different combinations depending 
on which tag position is chosen for each polypeptide. Western blot analysis 
(Figure 39) of test expressions in E.coli BL21(DE3) with all four combinations, 
showed that the expression of the membrane protein ZnuB was highly 
affected by the position of the tag. Both proteins were detectable and 
available in reasonable amounts if the membrane protein was tagged at the 
C-terminus. An N-terminal tag of the membrane protein resulted in a 10 fold 
lower expression level. The NBD ZnuB was less affected by the location of 
the tag and therefore having both proteins tagged at the C-terminal end of the 
polypeptide resulted in the best expression. Nearly no expression could be 
detected if both proteins carried their tags at the N-termini of the proteins. 
Western blot analysis also showed that the expression of the membrane 
protein ZnuB was much lower than the expression level of the soluble protein 
ZnuC. 
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Figure 39: Expression test of the ZnuB-CH and ZnuC-NH. Samples were taken at different 
time points during growth of the bacteria. To distinguish between both proteins N- and C-
terminal were stained separately. The black sharp lines mark the expressed membrane 
proteins ZnuB whereas the grey dots show the NBD ZnuC. M: marker proteins; lane 1-5: 
induction with 0.2 mM IPTG, samples are taken after 15`, 30`, 1h, 2h or 3h respectively; lane 
6-9: induction with 1 mM IPTG, samples after 15`, 30`, 1h or 2h are shown. 
 
The cells were resuspended (20 mM Tris pH 7.5, 50 mM NaCl, DNAse and 
protease inhibitors) and opened by FrenchPress. The suspension was 
centrifuged and the pellet was transferred to a high or low salt solubilization 
buffer containing 500 mM NaCl or 50 mM NaCl with or without 20% glycerol 
and 20 mM Tris pH 7.5. To start solubilization, DDM was added to a final 
concentration of 1% (w/v) and the suspension was gently shaken 1 hour at 
4°C. Centrifugation (45000xg, 4°C, 1h) removed non-solubilized material and 
the supernatant was applied to an IMAC column. The column was washed 
with 10 column volumes of the buffer, reducing the detergent concentration to 
0.03% DDM. A second wash with 50 mM Imidazole was used to remove 
bound impurities and finally the protein was eluted with 250 mM imidazole. 
The elutate was concentrated and applied to a size exclusion chromatography 
column. Analysis of the fractions of the different solubilization procedures 
revealed that the transporter Znu was not formed correctly. Only one band 
could be identified, which was related to the ZnuC while the membrane-
spanning domain ZnuB was missing in all experiments. Although both 
proteins could be overexpressed in the cells (Figure 39), the complex could 
not be purified by the above mentioned protocols. One explanation could be 
that ZnuB had been inserted incorrectly into the membrane or that the two 
proteins could not form the correct assembly of the complex when not 
expressed physically adjacent to each other. Therefore a further construct 
using the original gene assembly, as it is present in the E.coli genome, was 
generated. 
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Expression of ZnuC/B as a Single Construct 
 
The two proteins ZnuBC are encoded in the same direction in the genome of 
E.coli sharing 4 base pairs (Figure 37). A single PCR construct (named 
ZnuC/B) harboring both proteins was generated using the genomic DNA of 
E.coli XL1-blue strain, the 5` primer of ZnuC and the 3` primer of ZnuB. The 
resulting PCR product was cloned into the modified pET vectors pET28-CH-
neu and pET28-NH-neu. 
 
Figure 40: Cloning of ZnuC/B. Double digest of the plasmid DNA obtained after the ligation 
of the single construct of ZnuC/B with pET28-NH-neu. The plasmids were digested with 
BamHI and XhoI. The image shows the backbone at 5.5 kbp and the insert at 1.5 kbp, 
corresponding to the mass of ZnuC/B. Lane 1-6 : plasmid of the colonies 1-6; lane 7: Marker 
DNA.  
 
Expression of ZnuC/B was carried out as follows. 500 ml 2YT media were 
inoculated with cells harboring the plasmid ZnuC/B pET 28-CH-neu. The cells 
were grown to an OD600 = 0.5, induced with 0.2 mM IPTG, and protein 
expression was carried out at 30°C for 4 h. Cells were cracked by 
FrenchPress in 12.5 ml buffer containing 20 mM Tris pH 7.5, 50 mM NaCl, 
PMSF, DNAse, RNAse and complete Protease inhibitors (Roche). After 
centrifugation the pellet was solubilized using 30 ml of 20 mM Tris pH 7.5, 150 
mM NaCl and a final DDM concentration of 1%. After incubation at 4°C for 1 h 
the solution was centrifuged (45000xg, 4°C, 1h) and the remaining 
supernatant was applied to Chelating Agarose, which was previously loaded 
with Ni and equilibrated in buffer Z (20 mM Tris, 150 mM NaCl, 0.03%DDM, 
pH 7.5). The column was washed with 30 ml buffer Z, followed by 20 ml buffer 
Z containing 50 mM Imidazole. Elution was carried out with 250 mM Imidazole 
in buffer Z. The eluate was concentrated and analyzed by size exclusion 
chromatography (Superdex 200, 23 ml, Pharmacia; 20 mM Tris pH 7.5,150 
mM NaCl, 0.03% DDM) and SDS-PAGE (Figure 41). The protein had 
aggregated and eluted after the void volume of the column at ~7.8 ml. But 
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nevertheless, two major bands were visible in the peak and analyzed by 
tryptic digest and mass spectrometry. The two bands were identified to be 
ZnuC (lower band) and ZnuB (upper band). In contrast to the experiments 
with two plasmids, this was the first time that both proteins were found in the 
same fraction of the elution after size exclusion chromatography. However, 
the complex was not stable in solution and precipitated after a short period of 
time. Therefore, the detergent DDM was replaced by Fos-choline-12 or LDAO 
and the resulting elution profiles and SDS-PAGEs are shown in Figure 42 and 
Figure 43. With these detergents, the aggregation peak was smaller and two 
additional peaks at 10.9 ml and 13.0 ml or 11.1 ml and 12.7 ml were found in 
the presence of Fos-choline-12 or LDAO, respectively. SDS-PAGE analysis of 
these peaks revealed that only the peak at 11.1 ml contained both proteins 
whereas the peak at 12.7 ml mainly consists of ZnuB (Figure 43). In contrast, 
the first peak obtained in the presence of Fos-choline-12 contained neither of 
the two proteins, but both proteins were found in the peak eluting at 13.0 ml. 
The proposed complex, formed from two molecules of ZnuB and two 
molecules of ZnuC would have a molecular weight of ~120 kDa. The elution 
volume of 13 ml corresponded to an apparent molecular weight of ~50 kDa 
and therefore, the presence of a correctly formed ABC transport system could 
not be established. In contrast, in the presence of LDAO, both proteins could 
be found at an elution volume of 11.2 ml corresponding to a molecular weight 
of ~110 kDa. This detergent looked, therefore, to be more promising than 
DDM or Fos-choline-12, however, most of the protein was still found in the 
fractions equivalent to the void volume of the column. Although numerous 
variations of buffer compositions and additional detergents were carried out, 
the aggregation of the proteins could not be sufficiently prevented and 
therefore the protein could not be subjected to crystallization experiments. 
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Figure 41: Size exclusion chromatography and SDS-PAGE analysis of ZnuC/B. The 
elution profile of the size exclusion chromatography column of ZnuC/B in DDM is shown. The 
fractions of the elution, analyzed by SDS-PAGE are marked with triangles. In DDM the 
transporter ZnuCB was aggregated and it is found mainly in the void volume of the column. 
Cut bands were analyzed by tryptic digest and Maldi-Toff to verify the presence of both 
proteins. ZnuB and ZnuC are indicated. Lane 1: Marker proteins; lane2: elution of Ni-column; 
3: precipitate after concentration; 4: supernatant after concentration; lanes 5-10: size 
exclusion chromatography fractions corresponding to the blue triangles. 
 
  
Figure 42: Size exclusion chromatography and SDS-PAGE of ZnuC/B in Fos-choline-12. 
The elution profile of ZnuC/B in Fos-choline-12 and the purification are shown. SDS-PAGE: 
lane 1: Marker proteins; lane 2: wash with 50 mM imidazole; lane 3-4: elution with 250 mM 
imidazole; lane 5: concentrated sample before size exclusion chromatography; lane 6-10: size 
exclusion chromatography fractions corresponding to the red triangles.  
 
  
Figure 43: Size exclusion chromatography and SDS-PAGE of ZnuC/B in LDAO. The 
elution profile of ZnuC/B in LDAO and the purification are shown. SDS-PAGE: lane 1: wash 
with 50 mM imidazole; lane 2: Marker proteins; lane 3-4: elution with 250 mM imidazole; lane 
5: concentrated sample before size exclusion chromatography; lane 6-10: size exclusion 
chromatography fractions corresponding to the green triangles.  
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YDDA 
 
The protein YDDA from E.coli consists of 561 amino acids with a molecular 
weight of 64985 Da. This protein, as yet, belongs to the class of ABC 
transporters with unknown function. The membrane spanning domain and 
ATP binding domain are fused together, and YDDA, therefore, belongs to the 
so called half-transporters. Analysis of the topology of YDDA reveals five 
transmembrane helices with the C-terminal end of the protein located in the 
periplasm (Figure 44). Since the ATP binding C-terminal region of the 
polypeptide must reside in the cytosol to maintain its function, this prediction 
is false. Daley et al (Daley et al., 2005) fixed the C-terminus to the cytosol and 
the prediction changed to 4 transmembrane helices. 
 
 
Figure 44: False predicted transmembrane helices of YDDA. The prediction results in 5 
transmembrane helices with the C-terminus of the protein located in the periplasm of the cell. 
Since the C-terminus must reside inside of cell to maintain its function as an NBD, this 
prediction is false. Fixing the C-terminus to the cytosol, Daley et al (Daley et al., 2005) 
reported four membrane-spanning helices for the protein YDDA. 
 
Amplifying the gene of YDDA using genomic DNA of E.coli XL1-blue as the 
template, generated a PCR construct, which was cloned into the two vectors 
pET28-CH and pET28-NH using BamHI and XhoI as restriction enzymes. 
Bl21(DE3) cells were grown to an OD600 = 0.7 at 37° in 2YT media and 
protein production was started with 0.2 mM IPTG and carried out at 18°C over 
night. The cells were harvested, resuspended in lysis buffer (20 mM Tris pH 
7.5, 150 mm NaCl, 1 ug/ml DNAse, 1 mM PMSF and protease inhibitors 
containing EDTA (Roche)) and opened by FrenchPress. 
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The solution was centrifuged (1 h, 40000xg, 4°C) and the remaining pellet 
was solubilized for 1.5 h at 4°C in lysis buffer containing 1% (w/v) DDM. To 
avoid interference with the metal chelate column, EDTA was not added to the 
solubilization buffer. Insoluble material was removed by centrifugation (1 h, 4°, 
100000 x g) and the supernatant was loaded on 1 ml Protino Ni-IDA 
(Machery-Nagel) beads. The column was washed with 40 column volumes 
(CV) of buffer YA (20 mM Tris pH 7.5, 150 mM NaCl, 0.03% DDM), 20 CV of 
buffer YB (20 mM Tris pH 7.5, 300 mM NaCl, 0.03% DDM) and 20 CV of 
buffer YC (20 mM Tris pH 7.5, 150 mM NaCl, 0.03% DDM, 2.5 mM 
Imidazole). Protein was eluted with 1 x 0.5 ml and 4 x 2 ml of buffer YE (20 
mM Tris pH 7.5, 150 mM NaCl, 0.03% DDM, 150 mM Imidazole). SDS-PAGE 
analysis of the purification process is shown in Figure 45. Fractions 2-5 of the 
elution were concentrated and applied to a size exclusion chromatography 
column (Superdex200, 23 ml, Pharmacia) equilibrated with 20 mM Tris pH 
7.5, 150 mM NaCl, 0.03% DDM. The main fraction of the protein eluted after 
10.5 ml corresponding to a molecular weight of 200 kDa (Figure 46). 
 
 
Figure 45: IMAC purification of YDDA. The gel shows 
the enrichment of the protein during purification. Lane 1: 
marker proteins, lanes 2-4: 1 ml of the corresponding 
wash steps are loaded; lanes 5-9: 10 µl of the elution 1-5, 
lane 10: resin.  
 
Fractions containing YDDA were concentrated and crystallization trial set up 
in the 96-well plate format. Although the protein concentration varied from 5-
20 mg/ml, the major observation was a heavy precipitation of the protein 
immediately after the initial set up of the crystallization experiment, and 
therefore further detergents were tested to improve the stability of the protein. 
Two strategies were applied during these experiments. 
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Figure 46: Size exclusion chromatography and SDS-PAGE analysis of YDDA. Elution 
fractions from the Ni-column were concentrated and applied to a size exclusion 
chromatography column. The main protein peak eluted at 10.5 ml corresponding to an 
apparent molecular weight of 200 kDa. The fractions corresponding to the two peaks were 
loaded on a SDS-PAGE. Lane 1 and 8: Marker; lane 2-7 and 9 correspond to elution 
volume 8.7 to 12.3 ml in steps of 0.5 ml (black line). 
 
Detergents with high CMC values were not able to solubilize the transporter 
from the membrane, and, therefore, these detergents were introduced at the 
stage of the IMAC column whilst the protein was initially solubilized with DDM. 
In contrast, detergents with low CMC values were able to extract the protein 
from the membrane and therefore detergents like Fos-choline 14 or Fos-
choline 16 were used during the initial steps of the purification. Size exclusion 
chromatography analysis of YDDA in the different detergents is shown in 
Figure 47. In the presence of DDM and Fos-14, the protein eluted as a sharp 
peak whereas the elution profiles in Fos-12 and DM showed a broader peak. 
In contrast, the detergents Fos-16 and Fos-9-iso destabilized YDDA and 
higher amounts of aggregates were observed. 
 
Figure 47: Behavior of YDDA in different detergents during 
size exclusion chromatography analysis. See text for details. 
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Biochemical Characterization of YDDA 
 
Reconstitution of the YDDA into liposomes followed by an activity assay of the 
transport process could not be exploited since the substrate of YDDA is still 
unknown. Therefore, activity of the protein was measured upon ATP binding. 
10 µg protein, which had been solubilized in DDM, were incubated for one 
hour at 4° with 5 mg ATP-agarose (Sigma Aldrich). The beads were 
transferred to a small column and washed twice with 20 µl buffer AB (20 mM 
Tris, 150 mM NaCl, 0.03% DDM, pH 7.5). Elution of the protein was carried 
out with 3 x 20 µl buffer AB containing 10 mM ATP. Samples were analyzed 
by SDS-PAGE (Figure 48). As shown in Figure 48, the protein did not bind to 
the ATP-agarose and all protein was found in the flowthrough of the column. 
Although the experiment was repeated several times, including the 
solubilization of YDDA in the mild detergent digitonin, variations of the ATP 
anchor point to the agarose and the spacer length, no ATP binding of the 
protein could be observed. 
 
         
Figure 48: ATP-binding assay of YDDA. The SDS-
PAGE analysis of the binding experiment with ATP 
agarose (attached at C8, 9 atoms spacer) is shown. Lane 
1: flowthrough; lane 2-3 wash 1+2; lane 4: marker 
proteins; lanes 5-7: elution 1-3; lane 8: resin after elution, 
lane 9: YDDA positive control.  
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Since correct folding of the protein by binding to ATP could not be established 
it was tried to verify the presence of folded material in the detergent 
environment by an FT-IR experiment. YDDA was purified in the presence of 
DDM and concentrated to 22 mg/ml. 20 µl of the sample were applied and an 
attenuated total reflectance (ATR) experiment was carried out (Tensor 27 FT-
IR; Bruker). The spectrum obtained in the region of the amide I band is shown 
in Figure 49. Comparison of the spectrum with a set of spectra obtained from 
proteins with known 3D structures resulted in a prediction of 47% α-helices 
and 11% β-sheets, which is in excellent agreement with the prediction of the 
ABC transporter BtuCD that has 45% α-helices and 17% β-sheets. 
 
 
Figure 49: FT-IR spectra of YDDA. The image shows the amide I region (1700 -
1600 cm-1) that is mainly influenced by the C=O stretching vibration of the 
peptide bond. Comparison with a set of known structures is shown and revealed 
47% of α-helices and 11% β-sheet content of YDDA. 
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To determine the absolute mass and the oligomeric state of the transporter in 
solution, a static light scattering experiment was carried out (miniDAWN, 
Wyatt). The protein was purified according to the general purification protocol 
and applied to a size exclusion chromatography column (Superose 6, 23 ml, 
Pharmacia) coupled to the miniDAWN (triangular light scattering detector, 
Wyatt) and OPTILAB (interferomertric Refractometer, Wyatt) instruments. An 
internal calibration run with 100 µl of 2.5 mg/ml BSA was used to detect the 
correct settings of the dead volume and delay of the system. The major peak 
of the elution profile contained protein with a polydispersity (Mw/Mn) of 1.000 ± 
0.005 and a molecular weight of 250 kDa which is in good agreement to a 
homodimeric protein (2x 65 kDa) plus the attached micelle of DDM with a 
mass of 70 -100 kDa. In summary, the biochemical investigations on YDDA 
showed that the protein is folded and forms a homodimeric complex.  
 
 
Figure 50: Static light scattering of YDDA. The UV280 signal (solid line) and 
the distribution of the molar mass (dotted line) vs. the elution volume are shown 
of YDDA and BSA in blue and red, respectively. The main peak of YDDA 
consists of a monodispers 250kDa species. 
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AraG 
 
The L-arabinose transport system of E.coli consists of three proteins named 
AraF, AraG and AraH. The periplasmatic protein AraF, which binds the solute 
in the periplasm, targets the sugar to the transporter. The membrane 
spanning domain AraH, which forms 10 helices across the membrane, builds 
up the pore where the sugar crosses the lipid bilayer. The ATP binding protein 
AraG provides the energy used by the transport process. This protein is 
special among the selected ABC transporters, since it contains a fusion of two 
NBDs. The special arrangement of the two domains on one polypeptide might 
reveal answers to the question of how the two nucleotide binding domains are 
arranged in an active transporter. Therefore, the purification and 
crystallization of the NBD AraG of the L-arabinose transport system was 
pursued. 
 
Expression and Purification of AraG 
 
Freshly transformed E.coli BL21(DE3) cells, harboring the full length cDNA of 
AraG in a pET21-CH vector, were used to inoculate 2 ml LB media. The pre-
culture was transferred after 4h to a second pre-culture with a volume of 25 ml 
LB media. This second pre-culture was used to inoculate 2 x 500 ml LB-media 
containing the antibiotic ampicillin. Cells were grown to an OD600=0.7 at 37° 
and protein expression was induced by the addition of 0.2 mM IPTG and the 
cells were left at 18°C o/n. Cells were harvested by centrifugation and stored 
at -20°C. 
 
The cells were suspended in 25 ml of buffer PA (50 mM Tris, 50 mM NaCl, pH 
8.0) containing 1 mM PMSF and DNAse and finally opened by FrechPress. 
Cell debris was removed by centrifugation (40000 x g, 4°C, 1h) and the 
supernatant was applied to a 4 ml Ni-NTA IMAC column. The column was 
washed with 50 ml PA followed by 30 ml PA containing 50 mM imidazole. The 
protein was eluted with 7 mL PA containing 250 mM imidazole. The elution 
was applied to a size exclusion chromatography column (Superdex 75 26/60, 
320 ml, Pharmacia) and isocratic elution was carried out in buffer PA    
(Figure 51).  
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The main fraction of the protein eluted at ~150 ml corresponding to a 
molecular weight of 50 kDa, which is in good agreement with the theoretical 
mass of 56 kDa. SDS-PAGE analysis showed that the two purification steps 
produced protein still containing minor impurities. 
     
Figure 51: Size exclusion chromatography and SDS-PAGE analysis of AraG. The main 
peak corresponds to a molecular weight of 50 kDa, which is in good agreement with the 
theoretical mass of 56 kDa. Lanes 1-2: 2 µl of the elution of IMAC column (not boiled and 
boiled); lane 3: marker proteins; lanes 4-5: elution 1 and 2 corresponding to the first peak 
showing aggreagated protein; lane 6: elution 3 corresponding to the middle peak; lanes 7-10: 
elution 4, 4 (boiled), 5 and 6 corresponding to the main peak in the size exclusion 
chromatography. 30 µl of the individual samples were loaded. 
 
Therefore, the protein was further purified using a MonoQ column (8 ml, 
Pharmacia). Fractions of the elution corresponding to the main peak of the 
size exclusion chromatography were diluted 1:1 with 50 mM NaCl and applied 
to the column. Protein was eluted using a 50 to 150 mM NaCl gradient in 10 
CV.  
 
Figure 52: IEX and corresponding SDS-PAGE analysis of AraG. The 
chromatogram of the MonoQ run is shown. AraG elutes in two peaks that contain 
pure protein. Lane 1: marker proteins, lane 2 combined fractions of the size 
exclusion chromatography run, lanes 3-15: elution corresponding to the two main 
peaks.  
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SDS-PAGE analysis of the samples showed that the protein was pure and no 
other contaminations were present in the samples (Figure 52). Interestingly, 
the elution profile of AraG showed two peaks, which both contained pure 
protein; analytical IEX chromatography in the presence of 5 mM ATP and 5 
mM MgCl2 revealed a difference in their ability to bind the supplemented 
nucleotide. The absorption at 260 nm is dominant within the second peak, 
whereas the first peak showed no additional signal at 260 nm, indicating that 
the protein that eluted in peak 2 was able to bind the nucleotide and ATP, 
whilst the protein in peak 1 was not. It was therefore, concluded, that peak 1 
either contained misfolded protein or protein in a conformation unable to bind 
ATP (Figure 53). The protein corresponding to the active fractions of AraG 
was concentrated up to 5 mg/ml and crystallization trials were set up. The 
crystallization process was complicated by the fact that the protein AraG was 
prone to aggregation. Reducing the protein concentration or adding inhibitors, 
e.g. AMP-PNP, ADP-VO43-, could not resolve the problem and no suitable 
initial crystallization conditions have been found so far. 
 
 
Figure 53: Binding of ATP to AraG. Analytical IEX in 
the presence of ATP and MgCl2 revealed that the protein 
under peak 2 was able to bind ATP whereas peak 1 
contains an inactive form of AraG. 
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C.2.3.3 Crystallization of ABC transporters 
 
The purified protein samples of TM0288, TM0287 or YDDA were 
concentrated to perform crystallization experiments. Various screens including 
wide ranges of polyethylene glycol, buffer and salt conditions were performed. 
ATP, ADP, ADP and vanadate (VO43-) or AMP-PNP were used to enhance 
the homogeneity of the sample and enforce the dimerization of the NBD. No 
suitable conditions for crystal growth of one of the full transporters have been 
found so far for the selected proteins. 
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C.3 Discussion and Conclusion 
The results described in this part of the thesis demonstrate the successful 
selection, purification, and partial characterization of ABC transporters 
originating from different species. 
 
The initial work on ABC transporters included the work on mBsep, a 
mammalian bile salt export pump. Although, the protein could be functionally 
expressed in insect cells, the total yield of expressed transporter was low. 
Expression tests, in combination with silver stained SDS-PAGE and Western 
blot analysis using an Anti-his antibody, showed no differences in the band 
intensities. Structural and biochemical characterization of a protein demands 
milligrams of pure and homogenous sample, and therefore the solubilization 
and purification of the protein was not carried out since the quantities of 
protein required for the experiments could not be produced. Therefore, we 
focused our work on prokaryotic ABC transporters. 
 
The large number of different ABC transporter sequences available in the 
databases complicated the selection process. Thus, additional criteria were 
applied to enable a selection of a subset of transporters, with the focus on half 
transporters and transporters where the function is known. Cloning of the 
transporters was straightforward but although various PCR protocols were 
employed, it was not possible to amplify the DNA of the genome of B. subtilis. 
The problem, therefore, is most likely the high GC content of the DNA in these 
bacteria. However, all other selected transporters were cloned and expression 
tests were carried out. The expression test showed that, in general, the 
pET20 constructs were not very successful and the cells often died at early 
stages during the expression tests. In contrast, using pET21 and pET28 
constructs, all cloned transporters produced viable cells. The difference 
between the two systems pET20 and pET21/pET28 is a different in the 
regulation of the transcription of the plasmid. Transcription in the vectors 
pET21/pET28 is better regulated than in pET20 and, therefore, the intrinsic 
expression of the ABC transporter is reduced, which leads to lower mortality 
of the E.coli cells. Overall, the expression tests revealed that there is no 
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expression strain that is ideal for all ABC transporters and that optimal 
expression for each protein needed slightly different culture conditions. In 
contrast, there was a preference for the position of the His-tags. Expression of 
half transporters was increased, or even only detectable, if the His-tag was 
placed at the C-terminus of the protein. Although, the individual TMDs of 
E.coli were less affected by the position of the His-tag, again these proteins 
showed a higher expression yield with a C-terminal His-tag. A single 
exception was found, the TMD of the Xylose transporter of E.coli could only 
be expressed with an N-terminal His-tag. Membrane proteins are synthesized 
by membrane associated ribosomes that interact with the translocon 
machinery of the cell (Hessa et al., 2005, Mackinnon, 2005, Mitra et al., 2005, 
Van den Berg et al., 2004). The properties of N-terminal nascent chain of the 
protein determines further processes and thus the additional N-terminal His-
tag might interfere with the correct insertion of the transporter into the cell 
membrane and might explain why the position of the His-tag at the C-terminus 
of the protein is favored. 
 
Solubilization and purification could be achieved for most transporters using 
one of the following detergents: DDM, LDAO or Fos-cholines. None of the 
expressed transporters were resistant to solubilization, however the stability of 
the proteins in the different detergents varied and therefore had to be 
explored for each transporter individually. Shorter, and therefore harsher, 
detergents were prone to induce aggregation of the proteins. Although all 
transporters could be solubilized and partially purified with IMAC, most of 
them could not be recovered after size exclusion chromatography analysis. 
Exceptions were the transporters of T. maritima TM0288 and TM0287, the 
E. coli transporters YDDA, YOJI and ZnuC/B. In this respect, giving 
preferences to half-transporters was worthwhile since 4 out of 5 of the purified 
transporters belong to this class. On the other hand, it is hard to judge if a 
protein, which elutes at 130 kDa of a size exclusion chromatography column 
e.g. TM0288, has formed the correct dimer assembly, or if the protein is 
eluting as a non-physiological monomer. 
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The formation of a hetero dimer of the two proteins of T. maritima TM0288 
and TM0287 is still ambiguous. As it was shown, a mixture of both proteins 
hydrolyzed ATP at higher rates than each individual protein. However, the 
presence of the heterodimer could not be established by other biochemical 
investigations and this issue could not be resolved. Furthermore, hydrolysis of 
the nucleotides is not correlated with transport process. Low rates of intrinsic 
ATPase activity have been reported for solubilized NBDs of ABC transporters 
(Benabdelhak et al., 2005, Greller et al., 2001). Once the nature of the 
transported substrate is known, the question of the dimer assemblies of 
TM0287 and TM0288 could be solved, since transport experiments with 
reconstituted proteins in liposomes and the appropriate substrates could be 
carried out. 
 
In contrast to TM0288 and TM0287, the protein YDDA of E.coli eluted at the 
approximate calculated elution volume and the presence of the dimer was 
verified by static light scattering. However, although the presence of folded 
material was established by FT-IR, the protein was unable to bind the 
substrate ATP, which is in contrast to TM0288 that did bind to ATP-agarose. 
In addition, it was not possible to determine the intrinsic ATPase activity of the 
protein in detergent micelles. A complete or partial inhibition has been 
described for the multi drug resistance protein PGP (Callaghan et al., 1997, 
Orlowski et al., 1998). Here it was shown, that the detergent, which was 
present in the experiment below the CMC concentration, had not only an 
inhibitory effect on ATPase activity but also reduced the binding of the 
substrate vinblastine. Interestingly, the effect could be partially reversed by 
the addition of lipids to the protein, indicating that lipids are essential for the 
function of this ABC transporter. Although no functional assay of YDDA could 
be performed, the protein was subjected to crystallization trials. 
 
The purification of the transporter ZnuC/B showed the importance of the 
construct design. Although both proteins were overexpressed from two 
plasmids, the transporter did not form correctly in the expression host E. coli. 
The situation changed when both proteins were incorporated on one plasmid. 
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The full transporter could be partly purified with IMAC but failed subsequently 
in size exclusion chromatography experiments. Nevertheless, only one of the 
two proteins carried the His-tag and therefore it can be concluded that a 
correct assembly of the two proteins was at least present during the first 
purification steps. This information is important for future work on this 
particular transport system. 
 
In summary, 28 ABC transporters were selected for our work, resulting in 120 
constructs that were analyzed for expression. 15 transporters (54%) could be 
expressed in sufficient amounts. Of these, we were able to solubilize 5 
transporters (18%) in different detergents. 2 transporters (7%) TM0288 and 
YDDA showed the expected molecular weight during size exclusion 
chromatography analysis, and were therefore, subjected to crystallization 
trials. However, up to now, no initial crystallization conditions for these 2 
transporters could be determined. 
 
The low abundance of eukaryotic ABC transporter in natural sources, the 
problems during production of these proteins, (Linton & Higgins, 2002) led us 
to the here presented strategy of using prokaryotic homologues. However, 
although two prokaryotic ABC transporters could be purified and obtained in 
sufficient amounts, the high number of sequences that failed during screening 
raised concerns and several improvements might be advantageous: 
 
(i) Selection. Although our experience showed that it was more 
straightforward to use half transporters, most of the published high resolution 
structures are derived from transporter consisting of multiple proteins 
(Hollenstein et al., 2007, Locher et al., 2002, Pinkett et al., 2007). Exceptions 
are Sav1866 (Dawson & Locher, 2006) and the low resolution structures of 
Pgp and ABCG2 (McDevitt et al., 2006, Rosenberg et al., 2005) obtained by 
cryo electron microscopy. Since bacterial genomes contain many transporters 
that are made of multiple proteins, it is obvious that the restriction to half 
transporter leads to a limit variability of sequences available for analysis. 
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(ii) Construct design. As seen for the zinc transporter ZnuC/B, the expression 
of the transporter originating from one plasmid is advantageous. Therefore, all 
transporters that consist of two or more proteins should be cloned as a single 
construct.  
 
(iii) New sequences. Although the E.coli proteins are annotated and their 
functions mostly known, their expression and purification yields were not 
superior to other proteins originating from other bacteria. Therefore, there 
should be no restriction of the origin of an ABC transporter during selection 
process and all available genomes should be analyzed for the presence of 
these transporters. 
 
(iv) Mutations. Studies with single site mutations showed effects on binding of 
the nucleotide, dimerization of the NBDs and transport processes 
(Benabdelhak et al., 2005, Chen et al., 2003, Davidson & Sharma, 1997, 
Smith et al., 2002, Yuan et al., 2001). The stabilization of the NBD dimer is of 
special interest, since it stabilizes the protein in presence of ATP (Smith et al., 
2002). The tremendous effects of these mutations will be exploited in the near 
future for the NBD of the L-arabinose transporter from E.coli, which shares 
two NBDs on the single gene araG. This structure would represent a close 
homologue of the mammalian ABC transporters. 
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Chapter D - CitS 
 
D.1 Introduction to the Sodium Citrate Symporter CitS 
 
In contrast to the ABC transporters, which utilize ATP to create an active 
transport process across the membrane, the family of the 2-
hydroxycarboxylate transporter (2HCT) uses the electrochemical salt or 
proton gradients to transport the solutes across the membrane. 
 
The secondary transporters belonging to the 2HCT family are found 
exclusively in bacteria and transport substrates such as citrate, malate, and 
lactate (Sobczak & Lolkema, 2005c), which are all 2-hydroxy derivatives of 
tri-, di-, and monocarboxylates (Figure 54). 
 
 
Figure 54: Substrates of the 2HCT transporter family. The tri-, di-, and mono- 
carboxylates citrate, malate and lactate are show from the left to the right, respectively. The 
2-hydroxy carboxylate group, providing the name of this transporter family is shown in bold. 
 
The family members are further subdivided according to their transport 
properties into exchanger and symporter. Well-studied symporters are the 
Na+/citrate symporter CitS of K. pneumoniae or Na+/malate MaeN symporter 
of B. subtilis. Known exchangers are CitP of Leuconostoc mesenteroides or 
MleP of Lactococcus lactis, which transport citrate or malate into the cytosol 
and thereby export lactate. The substrates citrate and malate are precursors 
in the citrolactic and malolactic fermentation pathways where they are 
degraded to lactate. The exchange of divalent citrate or malate to monovalent 
lactate generates a membrane potential that is used by the bacteria as 
secondary metabolic energy. 
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D.1.1 Anaerobic Citrate Metabolism: Citrate Fermentation  
 
Several species of enterobacteria are capable of using citrate as a carbon and 
energy source, whereas most E.coli strains are not able to utilize this 
carbohydrate. Under aerobic conditions E.coli lacks an appropriate transport 
system to facilitate the uptake of the solute citrate into the cell. E.coli is 
however, able to ferment citrate under anaerobic conditions, but the 
fermentation of citrate to succinate requires an oxidizable co-substrate such 
as glucose or glycerol and the citrate succinate antiporter CitT (Pos et al., 
1998). In contrast, the closely related enterobacterium Klebsiella pneumoniae, 
one of the best-studied organisms with respect to citric fermentation (Bott et 
al., 1995), is able to grow on citrate under both aerobic and anaerobic 
conditions. 
 
Three different transport proteins involved in citrate transport have been 
identified in K. pneumoniae. The citrate/proton symporter CitH is expressed 
during aerobic growth and transports citrate (H-citrate2-) in co-transport with 
three protons (van der Rest et al., 1992). The CitS and CitW transporters are 
both expressed under anoxic conditions and play a major role in the citrate 
fermentation of K. pneumoniae. CitW was recently identified as a 
citrate/acetate antiporter (Kästner et al., 2002). The protein CitS, on the other 
hand, is the transporter that facilitates citrate uptake coupled to the transport 
of sodium ions. Figure 55 shows a summary of the citrate fermentation of K. 
pneumoniae during anaerobic growth. Imported citrate is degraded to 
oxaloacetate and acetate by the enzyme citrate lyase. This 550 kDa complex 
consists of six copies of each of the α, β and   subunit (Schneider et al., 
2000). The membrane bound enzyme oxaloacetate decarboxylase sodium 
pump (OAD) further converts the resulting product oxaloacetate. This enzyme 
is a multi subunit protein consisting of three subunits α, β and   in a 1:1:1 
stoichiometry. The α subunit catalyzes the carboxyl transfer from the 
substrate oxaloacetate to generate pyruvate and thereby modifies the 
prosthetic biotin group to carboxybiotin. Decarboxylation of carboxybiotin is 
facilitated by the β-subunit of OAD in a sodium dependend reaction and two 
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sodium ions are consequently translocated from the cytosol into the periplasm 
(Dimroth & Thomer, 1990). The enzyme pyruvate formate lyase (PFL) 
catalyzes the conversion of pyruvate and CoA to acetyl-CoA and formate. 
Interestingly this homo-dimeric protein uses a glycine radical in the enzymatic 
reaction (Becker et al., 1999). Formate is decarboxylated by the enzyme 
formate hydrogen lyase to produce carbon dioxide and hydrogen. The 
hydrogen is used by a membrane bound hydrogenase to convert NAD(P)+ to 
NAD(P)H and therefore provides reducing equivalents to the metabolism 
(Steuber et al., 1999, Kästner et al., 2002).  
 
Figure 55: Citrate Fermentation in Klebsiella pneumoniae. Citrate is imported into the cell 
by the protein CitS in a sodium dependent transport process. The 2-hydroxycarboxylate is 
degraded by citrate lyase (CL) to acetate and oxalacetate that is further decarboxylated to 
formate and pyruvate by the oxalacetate decarboxylase Na+ pump (OAD). The enzyme 
pyruvate formate lyase (PFL) metabolizes pyruvate to formate and Acetyl-CoA. Formate is 
decarboxylated and the resulting hydrogen is used by a membrane-bound hydrogenase (HG) 
to reduce NAD(P)+. The acetyl group is transferred to phosphate by the enzyme 
phosphotransacetylase (PTA). The resulting product acetylphosphate is converted by the 
acetate kinase (AK) to acetate and ATP. The citrate/acetate antiporter CitW releases the 
generated acetates to the surrounding environment and simultaneously imports the nutrient 
citrate (Kästner et al., 2002). 
 
The enzyme phosphotransacetylase (PTA) converts Acetyl-CoA and inorganic 
phosphate to free CoA and acetylphosphate. The latter is dephosphorylated 
by acetate kinase (AK) to form the two products acetate and ATP (Buss et al., 
2001, Iyer et al., 2004). AK and PTA are present in aerobic or anaerobic 
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microbes of the bacteria or archea kingdoms. They play a major role in the 
decomposition of organic material to methane. Under anaerobic conditions 
the overall reaction in bacteria generates energy in the form of ATP whereas 
archea use AK to activate acetate to acetylphosphate and decompose it to 
methane and carbon dioxide (Buss et al., 2001). The overall process of citrate 
fermentation by K. pneumoniae produces 1 mol of ATP per mol of citrate. 
 
D.1.2 The Sodium Citrate Symporter CitS of Klebsiella Pneumoniae 
 
The citrate sodium symport protein CitS of K. pneumoniae (P31602, TC 
2.A.24) consists of 446 amino acids with a molecular weight of 47588 Da. 
Analysis of the N- and C-terminal part of the transporter shows a sequence 
similarity between the two domains which are separated by a long loop 
between helix VI and VII. This generates an inverted membrane topology, 
which is present in other transport systems (Lolkema et al., 2005). The 
number of predicted transmembrane helices depends on the algorithm used 
and varies between 9 and 12. Analysis by single site mutagenesis, alkaline 
phosphatase (PhoA) and biotin acceptor domain (BAD) fusion experiments, 
and labeling with cysteine specific reagents all revealed 11 transmembrane 
helices with two additional peptide segments, the so called pore-loops, which 
enter the membrane without crossing it (van Geest & Lolkema, 2000, 1999, 
Sobczak & Lolkema, 2005a).  
 
The two loops Vb and Xa that penetrate the membrane are found between 
helices V and VI or X and XI. They play an autonomous role in the 
translocation mechanism and are important for functionality and specificity of 
the transporter (Figure 56). The mutation of N186V in the conserved region 
Vb affects the binding affinity of citrate to the transporter therefore indicating 
the involvement of that residue in the transport cycle (Kästner et al., 2000). 
Fluorescence spectroscopy experiments of single site labeled C398 showed 
different accessibility to the solvent upon incubation with citrate (Kästner et 
al., 2003) and, in addition, the loop Xa contains two cysteine residues which 
show a different accessibility depending on the catalytic state of the 
transporter (Sobczak & Lolkema, 2003).  
Introduction - CitS 
 105 
Evidence for the presence of the pore loops in the class of secondary 
transporters is also found in the closely related glutamate transporter family 
(Sobczak & Lolkema, 2005b). Recent work on the sodium-coupled aspartate 
transporter GltPH of Pyroccocus horikoshii defines the importance of the two 
re-entrant hairpins: both are involved in substrate and ion binding (Yernool et 
al., 2004, Boudker et al., 2007). 
 
 
Figure 56: Topology of CitS. The eleven transmembrane segments and the loops 
penetrating the lipid bilayer (Vb and Xa) are shown. Transmembrane helices VIII and IX are 
connected by the amphipathic helix AH (shaded turquoise) that faces the protein with its 
hydrophobic side and contacts the water phase with its hydrophilic part. Amino acids marked 
in orange letters share > 80% identity with other Na+-citrate or Na+-malate transporters. A 
mutation N185V (shaded red) affected citrate transport whereas E196Q (shaded blue) did not 
change transport behavior (Kästner et al., 2000). Cysteine mutants of the green shaded 
residues reduced the citrate uptake <20 % in membranes. The magenta shaded cysteines 
398 and 414 are accessible from the periplasm (Sobczak & Lolkema, 2003). Transmembrane 
domains were predicted with HMMTOP (Tusnady & Simon, 2001). 
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Recently it was shown that the loop connecting helix VIII and IX resides in the 
cytosol and forms an amphipathic helix. The hydrophobic side of this helix 
faces the protein whilst the other face is hydrophilic and exposed to the water 
(Sobczak & Lolkema, 2005a). Since the accessibility depends on the catalytic 
state of the transporter, an alternating access transport model, comparable to 
the transport mechanism described for the glycerol-3-phosphate transporter of 
E.coli and the lactose permease of E.coli, can be assumed (Locher et al., 
2003, Abramson et al., 2003, Huang et al., 2003, Sobczak & Lolkema, 
2005b). 
 
As shown in Figure 55 the protein CitS of K. pneumoniae transports citrate 
across the membrane. Transport studies with whole cells or membranes 
showed that the transport process is Na+ and ∆pH dependent and 
electroneutral (Dimroth & Thomer, 1990, Pos & Dimroth, 1996). The 
transported species are Na+ and Hcit2- (Van der Rest et al., 1991). Since the 
transport is also pH gradient dependent it was suggested that one Na+ ion 
and a proton might be the counter ions during transport (van der Rest et al., 
1992). The cooperative effect of Na+ ions during transport, however, 
suggested that two sodium ions are transported with one Hcit2- molecule 
(Lolkema et al., 1994) and therefore the overall transport reaction was 
assumed to be: 
 
Hcit2-out + 2Na+out + Na+in OH-in  Hcit2-in + 2Na+in + Na+out + OH-out 
 
with a net transport of Hcit2-, one Na+ ion and one proton into the cell or, 
instead of the proton, a OH-, which is transported out of the cell during the 
transport cycle. In addition, Pos & Dimroth (Pos & Dimroth, 1996) showed that 
the transporter contains a high and a low affinity binding site. The high affinity 
site of the external site is Km = 140 µM whereas the internal low affinity site 
binds the substrate citrate with a Km = 14 mM. 
 
Results - CitS 
 107 
D.2 Results of the Sodium Citrate Symporter CitS 
 
The aim of this project is the crystallization and structure determination of the 
first member of the 2HCT family that belongs to the class of secondary 
transporters. Protein production, construct design and purification strategies 
were carried out in a close and fruitful collaboration with Thomas Huber of the 
group of Andreas Plückthun, Institute of Biochemistry, University of Zürich. 
 
Expression and purification of CitS was carried out as described in material 
and methods. The purification yielded ~ 2 mg purified protein per liter of cell 
culture. The protein was concentrated to 10-30 mg/l and initial screen of 
crystallization conditions were carried out according to the protocol described 
in material and methods. Improvement of the initial crystals obtained is 
described in the following chapters. 
D.2.1 Improvement of Crystal Growth 
The initial crystals that were obtained by the screening on a nano liter scale 
were tested by diffraction to prove the presence of protein. Although protein 
crystals were detected, their size was too small and their quality too poor for 
structural studies. Therefore the initial conditions had to be improved. 
 
 
Figure 57: Initial crystals of CitS: The size of the 
black bar is 40 µm. 
 
The initial conditions that were identified during screening (100 mM KCl and 
15-25% PEG 400 or 50 mM Magnesium acetate and 15-25% PEG 400 both in 
a pH range of 6.5-8.4) were further examined and refined in 1+1 µl drops, 
using 24 sitting drop well plates. Crystals appeared after 1-3 days and grew to 
full size in 20-30 days. Rod like shapes, plates and triangles were observed 
and the biggest crystals reached dimensions of about 50x50x50 µm. 
Refinement included variations of different salts and their concentration (KBr, 
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KI, NaCl, NaBr, CsCl, RbCl, Mg(Acetate)2, KCl; 50-300 mM), the PEG 
concentration and composition (15-35%, PEG 200-400), as well as the 
different buffer systems: ADA, Tris or HEPES within their appropriate pH 
values. This fine tuning of the original conditions led to an increase in the 
diffraction power from 15 to about 8 Å. 
 
To further improve the crystal quality, an additive screen including salts (mono 
or divalent), small organic molecules, sugars, amino acids, detergents, dyes 
or cryopreservatives, was performed in a 96-well plate format using 100 nl 
protein solution and 100 nl of reservoir solution containing 10 % of additive. 
Although the experiments were repeated with different starting conditions, 
none of the additives improved the crystal quality. Crystallization with 100 µM 
citrate in the reservoir solution prevented the formation of crystals. 
Additionally, several additives were manually added during crystallization in 
the µl format. These included bi- or tri-alcohols, lipid extracts from E.coli and 
different detergents to affect the original DDM detergent micelles and 
therefore potentially enable better crystal growth. A major improvement in the 
crystals was achieved by supplementing the reservoir solution with 3 µl of 
10 % (w/v) of the detergent Cymal-7. Although the crystal shape and size 
were not tremendously affected, it improved the crystal handling since the 
crystals were less prone to stick to the bottom of the well. As with other 
additives used such as heptantriol, heptandiol or MPD, detergents such as 
glycosides, LDAO, DDAO, Mega-8 or Cymal-5 had no effect on crystal growth 
or crystal behavior. 
 
Under the assumption, that the N-terminus of CitS is flexible which potentially 
prevents crystal contacts, new constructs with truncations at the N-terminus 
were made. The construct SD had a deletion of the first 15 amino acids from 
the original CitS sequence, whereas the construct GF started just before the 
first predicted α-helix. Additional truncations were introduced in the linker 
region between the N-terminal His-tag and the protein to generate the 
construct SH. The constructs were screened for initial crystallization 
conditions in the 96-well format and refined using the 24-well sitting drop 
plates. 
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Figure 58: N-terminal truncations of CitS: The first 15 or 19 N-terminal residues were 
truncated generating the constructs SD or GF, respectively, both containing a 10xHis-tag 
attached to the N-terminus. 
 
The construct SD crystallized under similar conditions as the original 
construct. Although the protein is shorter, the observed crystals did not diffract 
as well as those from the full length and the maximum resolution that could be 
obtained was 18 Å. In contrast, the construct GF crystallized in different 
conditions (10 mM sodium cacodylate, 100-200 mM NaCl, 8-13% PEG 4000, 
pH 5.5) and the shape of the crystals changed to a cubic form. Crystallization 
in these conditions was associated with a strong precipitation of the protein, 
but nevertheless small crystals could be obtained. However, the properties of 
these crystals were, compared to the original conditions, worse. Although 
multiple attempts were carried out, including seeding and buffer, salt and 
detergent exchange, the crystals size remained small, about 10 x 10 x 10 µm. 
Since the crystals diffracted only to 12 Å and cell parameters and space group 
were equal to the original crystal form, this construct and crystallization 
conditions were not considered for further experiments. 
 
Deleting amino acids at the N-terminal end of the protein did not improve the 
quality of the crystals. However, an improvement was observed after the 
further deletion of residues in the linker region between the protein and the N-
terminus. Diffraction quality was slightly enhanced compared with the original 
construct and all subsequent expression and crystallization trials were carried 
out with the construct SH that lacks the protease cleavage site between the 
His-tag and the protein. 
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Changing the detergent often enhances the properties of membrane protein 
crystals since the detergent belt around the protein favors or disturbs the 
intermolecular contacts. Therefore, the detergent DDM was exchanged, in 
turn, to various other detergents during purification. Maltoside detergents 
were superior with respect to aggregation compared to glucosides, Fos-
cholines or LDAO, as deduced from initial experiments and size exclusion 
chromatography analysis. In these detergents, the protein eluted mainly as a 
single peak, while the “extremes” tridecyl- and nonyl- maltoside showed 
additional peaks  (Figure 59). 
 
Figure 59: Behavior of CitS in the presence of different 
detergents. Elution diagrams of size exclusion chromatography 
experiments of CitS in the presence of different maltosides are 
shown. For comparison, the elution profile in presence of DDM is 
shown in red. Incompatible detergents, e.g. octyl-glycoside promoted 
aggregation and the protein eluted directly after the void volume of 
the column (Superose6 10/300 Pharmacia). 
 
DDM was therefore exchanged to tridecyl β-D-maltopyranoside (TDM), 
undecyl β-D-maltopyranoside (UDM), decyl β-D-maltopyranoside (DM), nonyl 
β-D-maltopyranoside (NM) or cyclohexyl-heptyl β-D-maltopyranoside 
(CYMAL-7). Crystallization trials of CitS preparations in different detergent 
were set up using the 96-well and the 24-well plates. Crystals could be 
obtained from the preparations containing the detergents UDM, DM and TDM, 
but the diffraction quality of these crystals was not as good as of crystals in 
DDM. 
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To further improve the crystal quality, seeding experiments, including micro 
and macro seeding, were carried out. In macro seeding, a single crystal from 
a previous experiment is transferred to a new crystallization drop that already 
contains the protein and reservoir solution. Micro seeding is similar, although 
the seeds are much smaller and the crystals from a previous experiment are 
transferred differently into the new drop. Two transfer techniques are widely 
used: diluting the seeds in reservoir solution and subsequently adding this 
solution to the new experiment; or transfer using a cat whisker. For the latter, 
a the cat whisker is pulled through the original drop containing small crystals, 
and is then passed through the new drop, which contains the protein and 
reservoir solution. 
 
Macro seeding was carried out by transferring crystals that had grown at the 
same pH, with a crystal mounting loop, to the new drop containing the 
reservoir and protein solution. Trials with higher precipitant concentration 
failed due to heavy precipitation of the protein and therefore the standard 
concentration of precipitants was used. Although the seeds started to dissolve 
initially, the final crystal size and shape was greatly enhanced by this 
technique. Similarly, micro seeding experiments led to a higher probability of 
crystal growth, resulting in a larger number of smaller crystals. 
 
These modifications of the crystallization protocol in combination with post 
crystallization refinement eventually resulted in crystals with dimensions of ~ 
300 x 100 x 100 µm (Figure 60) that diffracted in the best case to 3.6 Å. 
 
 
Figure 60: Crystals of CitS. 
Refined crystals viewed through 
polarized light. The field of view is 
500 µm. 
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D.2.2 Post Crystallization Improvement of CitS Crystals 
All crystallization experiments with CitS had to be done at 4°C and the 
crystals were sensitive to temperature changes. Crystals, therefore, required 
stabilization to enable data collection and flash freezing was mandatory since 
diffraction data of CitS can only be obtained using synchrotron radiation. 
Freezing is standard today, especially for delicate crystals that suffer 
dramatically from radiation damage. The disadvantage of freezing the crystal 
is the additional manipulation step of cryo soaking and the freezing process 
itself. Both can introduce disorder in the crystal that leads to a higher 
mosaicity and potentially lower the diffraction quality of the crystal. To freeze 
crystals, suitable cryo-preservative conditions must be found and the freezing 
protocol itself considered. Cryo protection agents, for example glycerol, 
ethylene glycol or low molecular weight PEGs, prevent the water molecules 
from forming ice during cooling, leading to two positive effects: first, the 
formation of ice could destroy the crystal lattice, especially if the protein 
crystals, as in the case of membrane proteins, have high solvent content. 
Secondly, the formation of ice generates strong background diffraction during 
data collection. 
 
An ideal situation occurs if the condition in which the crystals have grown 
already promotes the formation of vitreous water and prevents the formation 
of ice. Therefore, the identified crystallization conditions of CitS were adjusted 
to contain enough glycerol or ethylene glycol, two well known cryoprotectants, 
to enable the glass formation during freezing. Unfortunately, the substitution 
of 15% water by glycerol or ethylene glycol in the reservoir solution prevented 
the formation of crystals and, since at least 24% of either glycerol or ethylene 
glycol are required, this technique could not be used. The crystals were 
therefore transferred to solutions containing the original reservoir solution in 
which glycerol, ethylene glycol or PEG 400 replaced the water at a 
concentration of 24, 24 or 32.5% respectively. When using glycerol or 
ethylene glycol as a cryoprotectant, the crystals were sequentially dipped into 
solutions containing 5, 10, 15, 20 or 24% of the cryo preservative, to avoid 
dramatic changes in the environment of the crystal. When using PEG 400 as 
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a cryoprotectant, the concentration was slowly increased in steps of 2%. The 
diffraction data analysis clearly indicated that ethylene glycol was better than 
glycerol, and equally good as PEG 400, although, with the latter, it was 
necessary to increase the soaking time from ~5 to a minimum of 20 seconds. 
Crystals soaked with PEG 400 as the cryoprotectant showed the lowest 
mosaicity, but the resolution limit of the diffraction data was slightly better with 
ethylene glycol and therefore ethylene glycol was mainly used as the cryo 
preservative. 
 
Liquid nitrogen, liquid propane and gaseous nitrogen at 100° K promote 
different velocities in which the crystals reach the glass transition temperature 
of 136°K for pure water and therefore the three possibilities were examined. 
All three could be used to obtain ice-free crystals of CitS, although the cryo 
buffers for liquid propane had to contain 5% more ethylene glycol. In addition, 
the crystals that were frozen in liquid propane showed a higher background 
during measurement since the propane was prone to stick to the crystals. 
Freezing of the crystals in the gaseous nitrogen stream was possible, but the 
direct freezing in liquid nitrogen at 4°C was more reliable and reproducible. 
Therefore, this method was used to freeze the CitS crystals. 
 
No other post crystallization treatments of the crystals, including several steps 
of dehydration and rehydration with different concentrations of PEG or 
humidified gaseous streams improved the crystal quality. Similarly, cross-
linking experiments of the crystals with glutaraldehyde, performed according 
to Lusty et al (Lusty, 1999), did not improve handling or diffraction properties 
of the crystals. 
 
A summary of the improvement of the crystallization process, including all of 
the above mentioned steps, is illustrated in Figure 61. The image shows the 
diffraction produced by various crystals at different stages during the 
crystallization refinement process. Figure 61 A shows a diffraction pattern with 
spots to a resolution of 12 Å of crystals that were obtained during initial 
screening. Crystallization in 24-well plates, combined adjustment of the 
precipitant PEG 400 resulted in the first complete data set collected with a 
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resolution of 8 Å (Figure 61 B). Macro seeding and post crystallization 
refinement improved crystal size and quality, and a diffraction pattern, of 
routinely obtained crystals, with spots up to 4 Å is illustrated in Figure 61 C. 
Nevertheless, the individual crystals have tremendous variations in their 
diffraction quality and more than 100 crystals had to be screened to obtain a 
complete data set to 3.6 Å (Figure 61 D). 
 
 
Figure 61: Diffraction images at different stages of 
crystallization refinement: A: diffraction of crystals obtained in the 
initial crystallization trials ~12 Å; B: after refinement of the precipitant 
PEG 400 the first complete data set to a resolution of ~8 Å was 
recorded; C: diffraction pattern routinely obtained of the refined CitS 
crystals, ~4 Å; D: Diffraction image of a crystal of CitS obtained after 
screening more than 100 crystals resulted in a resolution of 3.6 Å. 
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D.2.3 Crystallographic Analysis 
To obtain the highest quality data and resolution, data sets were measured at 
cryogenic temperatures of 100° K at the Swiss Light Source, Villigen, 
Switzerland.  
 
The CitS crystals diffracted to a resolution > 4 Å using a synchrotron light 
source, but the diffraction power of the crystals was dependent upon the 
orientation of the crystal. All measured crystals were highly anisotropic with 
the highest resolution of ~4 Å in one direction but only 5-6 Å ~90° away. 
Anisotropic diffraction is common in membrane protein crystals and is mainly 
due to the packing properties of the molecules. In addition to their anisotropic 
behavior, the crystals of CitS were sensitive to the strong radiation of the 
synchrotron beamlines. In general, protein crystals are sensitive to the X-ray 
beam, since the high energy produces radicals which diffuse through the 
crystal and thus destroying the uniformity of the crystal lattice. Figure 62 
shows an example of the diffraction quality of a crystal and the loss of 
diffraction power during data collection. In Figure 62A, the last image of the 
data set, which diffracts to 7 Å, is shown. The same φ angle after translation is 
shown in Figure 62B in which spots to 4 Å are visible by eye on the image. To 
overcome the radiation damage, the crystals were therefore translated during 
the data collection and the multiple data sets obtained were scaled together 
after individual integration. Since radiation damage mainly depends on the 
total dose a crystal absorbs (Murray et al., 2005, Ravelli & Garman, 2006), it 
was also possible to obtain complete data sets with an attenuated beam. The 
beam intensity was reduced by 50 or 70% by inserting aluminum filters into 
the pathway of the incident X-ray beam. The attenuation of the beam had no 
effect on the resolution of the measured crystals. 
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Figure 62: Radiation damage of CitS crystals: A: diffraction image of a 
crystal after exposure of 180 frames. B: Diffraction image of the same 
oscillation range after translation. Arrows indicate visual diffraction spots at 
7 respectively 4 Å. 
 
The homodimer CitS consists of two molecules of the protein CitS with a total 
molecular weight of 95.2 kDa. With a cell volume of 1957693 Å3, the most 
probable number of homodimers in the asymmetric unit is 2 or 3, with a 
solvent content of 76.1 or 64.2 %, respectively (Table 6). The most frequently 
observed values of the Matthew parameter are in the range of VM = 2.0 to 2.6, 
but these numbers are determined for soluble proteins. In the case of 
membrane proteins, where the detergent around the molecule must be taken 
into account, the values of VM are higher and solvent contents of 70 % 
(VM = 4.7) are common. Static light scattering analysis of the CitS protein in a 
detergent buffer containing DDM suggested that CitS is a homodimer in 
solution. The protein was surrounded by detergent molecules with a weight of 
~100 kDa and the entire complex showed a molecular weight of ~200 kDa (T. 
Huber, personal communication). According to this molecular weight, the most 
probable number of complexes in the asymmetric unit is 2, with a VM of 2.45 
and a solvent content of 49.8%. Note, that these numbers are calculated with 
a molecular weight of the complex of 200 kDa, and the correct value of VM 
assuming 100 kDa of protein is 5.15 with a solvent content of 76%. 
Table 6: Cell Content Analysis P2 
Homodimers in the 
asymmetric unit 
Matthews coefficient 
VM 
Solvent content 
(%) 
1 10.29 88.06 
2 5.15 76.11 
3 3.43 64.17 
4 2.57 52.22 
5 2.06 40.28 
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To further characterize the cell content of the crystals, a self-rotation function 
and native Patterson map were calculated (Collaborative Computational 
Project  Number 4, 1994). A section of the native Patterson map where 
additional peaks would indicate the presence of molecules related by a 
translation is shown in Figure 63. The map was calculated using data in range 
of 15-4 Å and a peak threshold > 4 σ. Apart from at the origin, no peaks were 
observed in the different sections of the map. Therefore a pure translational 
symmetry between the molecules can be ruled out. A plot of the self-rotation 
function, which detects the relative orientation of the molecules independent 
of their position in the asymmetric unit, is shown in Figure 64. Beside the two 
peaks at ω =90° and φ = ±90°, which are generated by the two-fold screw axis 
present in space group P21, four additional peaks (I - IV in Figure 64) at 
ω=14° φ =0°, ω= 45° φ = 104°, ω=67° φ =94° and ω= 28° φ = 118° are found in 
the κ =180° section with a height of 74%, 66%, 55% and 45% of the origin 
peaks, respectively. Peak I, which is located close to the pole, is also present 
in the κ= 90° section at ω = 76° and φ = 0° indicating a tetrameric (dimer of a 
dimer) CitS in the crystal. The four-fold axis of this tetramer would be nearly 
parallel to the a-axis of the crystal. Peak II could therefore be explained as the 
diagonal through the tetramer. The weaker peaks III and IV might correspond 
to a second tetramer in the asymmetric unit, which is again parallel to the a-
axis but slightly tilted ~20°, compared to the first tetramer. Reducing the 
integration radius to a value of 20 Å resulted in less defined peaks and the 
peaks III and IV were not appearing at all. This might result from the similarity 
of the rotation angle of the two protomers comprising the homodimer, thus 
indicating the approximate size of the monomer to be approximately 20 Å. 
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Figure 63: Native Patterson map. No peaks were 
detected above 4σ, indicating the absence of 
translational symmetry. 
 
 
Figure 64: Self-rotation function. The plot was generated using the program POLARRFN of 
the CCP4 program suite (Collaborative Computational Project  Number 4, 1994). Data was 
used in the range of 20-7 Å with an integration radius of 25 Å; a smoothing factor of 6 Å and 
sharpening was applied by setting the B-value to -20. Peaks were contoured at >30% of the 
origin peak in steps of 5%. The κ = 180° and the κ = 90° sections are shown on the left and 
right, respectively. Note that changing the value of the integration radius between 25-40 Å 
had no effect on the appearance of the plot. 
 
D.2.4 Heavy Atom Derivative Preparation of CitS Crystals 
Since the calculation of an electron density map depends on the availability of 
the intensities and the corresponding phase angles of each reflection 
(F(hkl)=|F|exp[iα]) and since structures of homologues of CitS are not known, 
molecular replacement could not be used to calculate initial phases. 
Therefore, SAD, MAD, MIR, SIR and SIRAS techniques have to be 
considered to solve the protein structure. These methods require that crystals 
contain either heavy atoms or selenomethionine. The anomalous signal from 
the sulfur atoms present in methionines and cysteines in the protein can also 
be used to phase the protein structure but the diffraction quality of the CitS 
crystals is far too low to exploit this weak signal for structure determination. 
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D.2.4.1 Isomorphous Derivatives using Heavy Metals  
Isomorphous derivatives can be prepared by adding the heavy metals during 
crystallization or, by soaking preformed crystals in solutions containing the 
heavy metals. The first procedure is more gentle and thus preferred, although 
the addition of an extra compound to the reservoir solution can prevent 
crystallization completely. Two initial incomplete factorial screens in the 96-
well format were set up by adding 16 different heavy metal solutions with a 
final concentration of 100 µM to the crystallization conditions of CitS (50 mM 
Tris pH 7.0-8.5, 100 mM KCl and 20-21.5% PEG400, Figure 65). In 10 of the 
16 conditions tested, nice crystals were obtained and in an additional 4 
conditions crystalline material appeared. The two mercury derivatives 
thiomersal and methyl mercury (I) chloride prevented crystal growth. 
Successful heavy metal compounds were then applied to further 
crystallization experiments using 24-well plates. Trials with the two mercury 
compounds that failed in the first round of screening were set up at a ten 
times lower concentration and crystals were obtained. 
In addition to the co-crystallization experiments, various soaking experiments 
with pre-existing crystals were carried out. Heavy metals (100 µM stock 
solution in water) were diluted to a final concentration of 0.1-2 mM in the 
appropriate reservoir solution and CitS crystals were added. The crystals 
were harvested at different time points (30 s, 2 min, 15 min, 30 min, 1h, 2h or 
12 hours), cryo protected and frozen in liquid nitrogen. Possible derivatives 
were analyzed by diffraction and a fluorescence spectrum. Properties of 
derivatives that provided complete data sets are summarized in the appendix 
in Table 9. 
 
Data sets of possible derivatives were recorded at appropriate wavelengths 
keeping Friedel`s pairs separate to detect a possible anomalous signal 
present in the data. The mean  value assuming Friedel`s law as true, divided 
by the mean σ value assuming Friedel`s law as false gives an estimation of 
the presence of anomalous scatterers in the crystal. Values > 1.00 indicate 
the contribution of anomalous scattering to the intensities and these data sets 
were further analyzed to find the positions of possible heavy atom sites. 
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Figure 65: Incomplete Factorial Screen. 16 different heavy metal solutions (potassium 
platinate (II) cyanate, dichloro (2,2,6`,2``-terpyridine)platinium (II), osmium (III)chloride, lead 
(II) nitrate, uranylacetate, potassium di-cyanoaurate (I), holmium (III) chloride, mercury 
(II)acetate, thaliumbromide, di-ammonium tetrathiotungstate (VI), potassium hexachloro 
platinate (IV), potassium tetra-chloro aurate (III), methyl mercury (I)chloride, thalium (I) 
chloride) were added to a final concentration of 100 µM to the crystallization buffer. A1-H12 
indicates the number of the wells and colors green, yellow and red correspondent to observed 
and nice crystals, crystals or no crystals at all, respectively. 
 
Positions of the heavy atoms were searched individually with the programs 
SHELX97, CNS and phenix.hyss (Schneider & Sheldrick, 2002, Brünger et al., 
1998, Adams et al., 2004). The resulting positions of the heavy metals were 
used to calculate a Patterson map that was compared to the anomalous 
Patterson map obtained from the data. In addition, data sets that showed 
equal cell parameters to the native data were analyzed by difference Patterson 
maps to obtain the positions of the heavy metals. Unfortunately, no heavy 
metal positions could be deduced from the various data sets collected. 
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D.2.4.2 Derivatization with L-selenomethionine 
An alternative to soaking crystals with heavy atoms is the incorporation of 
heavy scatterers to the protein at the stage of transcription. The amino acid 
L-methionine is replaced by L-selenomethionines, which contain a selenium 
atom at the position of the sulfur. The presence of these modified residues in 
the protein sequence, and thus in the crystal, allows the selenium atoms to be 
used to determine initial phases of the reflections. 
 
Selenomethionine derivatized CitS was prepared and purified according to the 
above-mentioned protocol, except that the cells were grown in minimal media, 
supplied with all amino acids and selenomethionine (per liter media: 5.4 g 
K2HPO4, 1.6 g KH2PO4, 0.8 g (NH4)2SO4, 0.2 g Na-citrate, 80 mg 
MgSO4•7 H2O, 32 mg thiamine, 32 mg thymine, 100 mg of each amino acid 
including selenomethionine and 16 ml 40% (w/v) glucose. The incorporation 
of selenomethionines was verified by MALDI-MS spectra. Crystals were 
obtained but they were much smaller and grew to a final size of ~20 x 20 x 20 
µm3. Further screening of the crystallization condition with the SeMet 
derivatives showed that further addition of 1 mM holmium (III) chloride 
promoted larger crystals of approximately ~50 x 30 x 30 µm3. These crystals 
diffracted about to 6 Å and a complete data set to 7 Å could be obtained. 
Although the anomalous signal was present and complete MAD data sets 
were recorded, the low resolution and the high number of selenomethionines 
in the unit cell (assuming 4 CitS monomers in the AU: 4 x 17 x 2= 136) 
prevented structure determination of the transporter. 
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D.3 Crystallization of CitS - Complexes 
The crystallization of the membrane protein CitS with two types of 
proteinaceous binding partners was carried out. The aim was to grow crystals 
diffracting to higher resolution than crystals of CitS alone. First attempts 
involved the crystallization of CitS in complex with Fab fragments while the 
second trials used the recently developed DARPin molecules as binding 
partners. 
D.3.1 Complex Crystallization of CitS with Fab Fragments 
Four Fab fragments were selected from the HuCAL GOLD® library (Knappik 
et al., 2000) and all four showed high binding affinities in the nano molar 
range (Röthlisberger et al., 2004). Individual complexes for each of the 
fragments with CitS were prepared and crystallized. The preparation included 
the following steps: separate expression and purification of both proteins, 
mixing in a molar ration of CitS : Fab =1 : 3 and subsequently, a size 
exclusion chromatography purification step to separate the complex and the 
unbound antibody fragment. As yet, no crystals of the complexes have been 
obtained. Nevertheless, the control experiment with the Fab f3p4 alone 
produced crystals that diffracted to 1.9 Å. Structure determination and 
refinement of this structure are described in Chapter E. 
D.3.2 Complexes of CitS with selected DARPin Proteins 
To further increase the probability to obtain better diffracting crystals, 
designed ankyrin repeat proteins (DARPins) as binders were created. The 
molecules were selected from an existing library (Binz et al., 2004) by 
ribosome display and phage display against the native CitS protein (Huber et 
al., 2007). DARPin molecules that showed positive binding signals in ELISA 
experiments were further analyzed by size exclusion chromatography. A 
typical size exclusion chromatography experiment (Superose6, 10/300, 
Pharmacia) is shown in Figure 66. The dashed lines show CitS, which elutes 
at ~12.2 ml and a DARPin, which elutes at ~16 ml. The solid line shows the 
chromatogram of the complex which shows a shift of ~0.5 ml towards higher 
molecular mass, indicating the presence of a CitS DARPin complex. Excess 
DARPin could be separated from the complex, which eluted at ~16 ml. 
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Figure 66: Size exclusion chromatography of the CitS-DARPin 
complex. Size exclusion chromatography analysis of both proteins alone 
and the CitS DARPin complex are shown as dashed and solid lines, 
respectively. The insertion shows the SDS-PAGE analysis of the 
individual peaks. 
 
D.3.2.1 Crystallization of the CitS-DARPin Complexes 
Proteins for co-crystallization experiments were purified separately and mixed 
with an excess of DARPin. CitS was purified using the mentioned protocol. 
DARPins were purified according to the established protocol (T.Huber, 
personal communication). Excess of DARPin was removed by size exclusion 
chromatography chromatography. 
 
Crystallization trials were set up with selected DARPins that showed a clear 
shift in size exclusion chromatography analysis. The complex was 
concentrated to ~25 mg/ml (Amicon Ultra, 50 kDa cutoff, Millipore) and initial 
crystallization conditions were screened in the 96-well plate format. Initial 
conditions were refined using the 24-well format resulting in the final 
conditions containing 1 µl protein solution mixed at 4°C with 1 µl of 50 mM 
MES (pH 6.0-6.7) or 50 mM HEPES (pH 6.8-7.2), 150 -250 mM CaCl2 and 25-
28% PEG400. Crystals appeared after 3-5 days and grew to full size in ~2 
weeks (Figure 67). Two types of crystals could be observed: rhombohedral 
like plates that were surrounded by a protein skin were located at the surface 
of the drop and rod like crystals, predominantly at the bottom of the drop, 
those were mostly attached to the plastic surface.  
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The presence of the complex in the crystals was verified by SDS-PAGE 
analysis of dissolved crystals. Therefore, crystals were washed 6 times in 
reservoir solution, dissolved in pure water and applied to the SDS-PAGE 
(Figure 68). Both proteins were visible and showed the expected apparent 
molecular weights of 35 kDa for CitS and 17 kDa for cp34h_15. 
 
   
Figure 67: CitS-cp34h_15 complex crystals. Crystals obtained from a co-crystallization 
experiment of CitS and the DARPin cp34h_15. The right image shows a zoomed view of 
the rectangle in the left image. The lower left crystal has an approximately size of 280 x 
140 x 30 µm3. 
 
 
Figure 68: SDS-PAGE analysis of complex crystals. Different 
amounts of washed and dissolved crystals were applied to lanes 1-
3. Lane 3 contained the most extensively washed crystals. Both, 
CitS and the DARPin cp34h_15 at apparent molecular masses of 
35 kDa and 17 kDa, respectively, were visible, verifying the 
presence of the complex in the crystals. 
 
As with with the non-complexed CitS, additional experiments to improve the 
crystals were set up. These included detergent exchange during protein 
purification and stabilization procedures of the crystals formed as well as 
testing freezing and cryo-conditions. Detergent exchange with shorter alkyl 
maltoside chains led to a similar crystallization condition, although the optimal 
pH of crystal growth slightly decreased to pH 6.5 for UDM and pH 6.0 for NM. 
However, both the size and the appearance of the crystals were worse than 
those obtained from the crystals grown in DDM. The optimal cryo solution 
contained the original reservoir components with the water changed to 35 % 
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PEG 400 or 22% glycerol. To prevent sudden changes in the crystal 
environment, the concentration of the cryoprotectant was slowly increased by 
2 or 5% for PEG 400 or glycerol, respectively. Cryo-protected crystals were 
frozen in liquid nitrogen. 
D.3.2.2 Crystallographic Analysis of CitS-DARPin Complexes 
Two data sets of the complex crystals were collected and both inherited a 
high anisotropy in the data as seen in Figure 69. Similar to the native CitS 
crystals, a high resolution area of ~4 Å in one direction could be recorded but 
only 5-6 Å ~90° away. 
 
  
Figure 69: Anisotropic behavior of CitS-DARPin complex crystals. Diffraction images of 
complex crystals at 0 and 90° are shown. The left image shows the high resolution area with 
spots visible up to 4 Å. The right image illustrates the diffraction 90° away. In contrast to 0° 
the resolution of the crystal is decreased to 6 Å. 
 
The data obtained from the crystal grown in DDM showed a resolution limit of 
4.5 Å and a full data set could be obtained to 5 Å. In contrast, crystals grown 
in UDM diffracted to 4 Å and a complete data set could be obtained to 4.5 Å. 
Both data sets were in the same triclinic space group but had different cell 
parameters of a = 91.16 Å, b= 103.13 Å, c = 126.78 Å, α = 111.46°, β = 
95.07° and γ = 94.01° and a = 86.62 Å, b = 98.64 Å, c = 121.34 Å, α = 70.95°, 
β = 81.30° and γ = 90.34°, respectively. The κ = 90° section (not shown) 
shows no peaks above the threshold, indicating that the DARPin molecules 
bound disable the formation of the tetramer, which was observed in the 
crystals of CitS alone (Figure 64). Two additional twofold axis were detected 
along φ = 127° and ω = 65° and φ = 47° and ω = 118°. 
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Figure 70: Self-rotation function of complex 
crystals. The plot of the k=180° section was 
generated using the program GLRF (Tong & 
Rossmann, 1997) with data in the range of 15-5 
Å. Peaks are countered > 45 % of the origin peak 
height in steps of 5%. Two additional two fold 
axes are located at φ = 127° and ω = 65° and 
φ = 47° ω = 118°. 
 
In contrast to the data obtained from non-complex crystals, the Patterson map 
of the data collected from the CitS-DARPin crystals showed an additional 
peak. The peak had a height of ~11% of the origin, and was located at the 
fractional positions u= 0.8843, v= 0.7384 and w= 0.4164 (equal to u= 0.1157, 
v= 0.2616 and w= 0.5836), indicating a possible pseudo translational 
symmetry between the molecules (Figure 71). 
 
 
 
Figure 71: Plot of the Patterson map of the complex crystals. Section of u, v 
and w are shown from the left to the right. The map was calculated in CCP4 
(Collaborative Computational Project  Number 4, 1994)using data in the range of 
30-4Å. Peaks are contoured < 3 σ in intervals of 0.5 σ. 
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The cell content analysis of the P1 crystal form, assuming a pure protein 
content of a homodimeric CitS and 2 bound DARPins with a molecular mass 
of the complex of ~130 kDa, indicates the presence of 2 complex molecules in 
the asymmetric unit (Table 7) with a VM of 3.72 and a solvent content of 67 %. 
The results of the self rotation analysis and the cell content analysis indicate 
the presence of two distinct molecules in the cell that are related by a two fold 
symmetry. Each complex molecule itself contains a two fold symmetry 
between each of the protomers. 
 
Table 7: Cell Content Analysis P1 
Complexes in the 
asymmetric unit 
Matthews coefficient 
VM 
Solvent content 
(%) 
1 7.44 83.47 
2 3.72 66.95 
3 2.48 50.42 
4 1.86 33.90 
 
 
Discussion and Conclusion - CitS 
 128 
D.4 Discussion and Conclusion 
 
This chapter has described the successful purification, crystallization and 
preliminary crystallographic analysis of the first member of the 2HCT family of 
membrane proteins. The protein CitS was expressed in a functional form and 
sufficient protein of high quality and homogeneity was obtained. The amount 
of purified protein was in the range of 1.5 – 2 mg purified CitS per liter of 
culture and, therefore, the significant hurdle in structural studies of membrane 
proteins, the low expression and purification yields, was overcome. Size 
exclusion chromatography analysis in several detergents revealed a single 
protein species with a molecular mass of ~ 200 kDa (Figure 59). The mass 
corresponded to the dimer assembly of the transporter reported by Pos (Pos 
& Dimroth, 1996). The amount of detergent around the transporter dimer is 
high and was estimated to account for half of the mass of the analyzed 
species. 
 
Crystals of the protein were obtained and their diffraction properties improved 
to obtain data to 3.6 Å. The main improvement was achieved by seeding the 
crystals. The crystals grew to a larger size and the reproducibility was 
enhanced, thus enabling the search for derivatives for phasing. The 
transporter crystallized in the monoclinic Laue class P2 with apparently 4 or 8 
molecules in the asymmetric unit, generating a Matthews Parameter of 5.2 
and 2.6 and a solvent content of 76 and 52 %, respectively. In contrast to 
soluble proteins, for which the Matthews parameter allows a good 
approximation of the number of protein molecules in the unit cell, the number 
of molecules of membrane proteins is less predictable, since both protein and 
detergent molecules are present in the unit cell. Assuming a detergent to 
protein ratio of 1 : 1, as concluded from static light scattering analysis, the 
most favorable number of molecules in the asymmetric unit would be 4. Since 
the number of detergent molecules in the crystallized material is unknown, the 
corresponding number of protein subunits cannot be estimated correctly and a 
number of up to 8 molecules would be feasible. The tetramer, present in the 
self-rotation function and the Matthews coefficient analysis, would therefore 
correspond to 4 or 8 molecules in the asymmetric unit cell of the crystals. 
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A high number of molecules in the cell has advantages and disadvantages. At 
the resolution obtained for these crystals, non crystallographic symmetry and 
averaging of the individual chains often leads to improved electron density 
maps and therefore would help in model building. On the other hand, the high 
copy number of protein chains in the cell disabled the structure solution with 
selenomethionine derivative crystals. The crystals obtained from protein that 
was expressed in the presence of selenomethionine, were smaller and did not 
diffract as well, but nevertheless, data to 7 Å were obtained. Positioning of the 
selenium sites could not be achieved since the high numbers of molecules in 
the unit cell, as mentioned above, would generate ~ 130 selenium sites. Even 
at a higher resolution of ~ 2 Å or better, this enormous number of scattering 
atoms is unfavorable for solving the structure of any protein. Unfortunately no 
experiments including truncation of the protein, detergent and buffer 
exchange resulted in a different crystal form and with the high copy number of 
molecules structure determination was hindered. The resolution of the crystals 
soaked or co-crystallized with heavy atoms was low, ranging between 5 and 
8 Å. Therefore, it was not possible to determine the positions of the heavy 
atoms. It was expected, that the soaks in particular with mercury compounds, 
provide some phasing information, since at least two of the 5 cysteines have 
been reported to be chemically accessible (Kästner et al., 2003, Sobczak & 
Lolkema, 2003, 2004), and could react with mercury compounds. However, 
despite testing several mercury compounds, a clear signal in a Patterson map 
could not be observed. 
As an alternative to the derivatization of crystals, other techniques were 
considered to enable structure determination. Crystal of the complex of CitS 
with antibody fragments could not be produced by co-crystallization 
experiments. There are two possible explanations for the lack of crystals (i) 
the low solubility of the Fab f3p4, insoluble above 12 mg/ml; (ii) the presence 
of the membrane protein in the complex in a different conformation rendering 
it unsuitable for crystallization. The latter was observed during crystallization 
experiments in the presence of citrate. If the transporter substrate was 
present in crystallization experiments, no crystals appeared and, significantly, 
crystals grown in the absence of citrate dissolved rapidly after incubation with 
the substrate. 
Discussion and Conclusion - CitS 
 130 
In contrast to the co-crystallization experiments with the antibody fragments, 
the ankyrin-CitS complexes could be crystallized. Although the crystals 
belonged to the triclinic Laue class and diffracted to only 4.5 Å, the 
crystallization did provide a second crystal form and also reduced the time 
between obtaining initial crystals and crystals suitable for data collection. The 
improvement of crystals of the free form of CitS took more than 1½ years, 
whereas the complex crystals were refined in less than 3 months. 
Unfortunately, this process was to no avail, since, neither crystal form could 
be used to solve the structure. However, the great reduction in time between 
identification of initial and final crystallization conditions and the numerous 
additional ankyrin complexes available for testing in the near future could 
enable structure determination of the first member of the 2-HCT transporter 
family. 
 
Several other strategies will also be employed to increase the chance of 
structure determination. Initial experiments with the class of poly oxyethylene 
ether detergents were promising. The detergent polyoxythylene(8)dodecyl 
ether (C12E8) promoted a possible different oligomeric assembly in solution. 
Size exclusion chromatography analysis revealed that the peak was shifted to 
higher molecular mass and the transporter could be concentrated with a 100-
kDa cut-off membrane. This could not be achieved with the detergent DDM, 
where most of the protein was present in the flow through. This provides an 
advantage since concentration with a 100-kDa cut-off membrane will allow 
concentration of the protein-micelle particles but not of empty micelles 
potentially increasing the reproducibility of the crystallization process. The 
presence of a higher oligomeric assembly in solution might also result in a 
different crystal form or, since a tetramer is present in the crystals obtained so 
far, might improve the quality of those crystals. This has been reported for 
phage T4 lysozyme, where the synthetic dimerization yielded in numerous 
novel crystal forms that were not obtainable using the monomeric form of the 
protein (Banatao et al., 2006, Heinz & Matthews, 1994). 
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The second strategy is to work with homologous proteins from different 
species. Similar to the work presented on the ABC transporters, several 
homologous proteins of CitS will be selected, expressed, purified and 
crystallized. This strategy is often applied in the field of membrane protein 
structure determination.  
 
Mutating the desired protein sequence to enhance the crystallization behavior 
of a membrane protein can be successful, as illustrated with the protein LacY 
(Abramson et al., 2003). A single site mutation of C154G trapped the 
transporter in one conformation and enabled the structure determination of a 
member of the major facilitator superfamily of transporters. A further example 
where mutations in the protein sequence enhanced the crystallization and 
diffraction quality is the outer membrane protein OmpA of E.coli. Several 
mutations had to be introduced in the sequence to produce crystals that were 
suitable for structure determination (Pautsch & Schulz, 1998). In contrast to 
LacY, where the mutation in helix V induced a stronger binding interface in the 
crystals, the residues mutated in OmpA are located in the loop regions of the 
protein and are not assigned to secondary structural elements. Nevertheless, 
the mutation of Leu154 to Tyr stabilized a crystallographic contact and led to 
the formation of crystals with improved diffraction quality. Furthermore, 
potentially flexible regions in the protein could be stabilized by additional 
mutations. These sites can be predicted with the entropy server 
(http://nihserver.mbi.ucla.edu/SER/), but the effect of a specific mutation to 
the general protein behavior or, more particularly, to the effect on 
crystallization and diffraction, is, in general, not predictable and all mutations 
must be tested for expression, folding and crystallization. Nevertheless, 
homologous proteins or the mutational studies could lead to crystals that are 
more suitable for determining the structure of the citrate transporter CitS. 
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Chapter E - Structure of the Fab Fragment f3p4 
E.1 Unusual twinning in crystals of the CitS binding antibody 
Fab fragment f3p4 
Daniel Frey, Thomas Huber, Andreas Plückthun and Markus G. Grütter 
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Chapter F - Appendices 
F.1 Crystallographic Methods 
 
Data Collection 
 
Collection of data at home or at the synchrotron was always carried out in a 
similar manner: a couple of images were first taken to determine a suitable 
oscillation angle, exposure time and distance between crystal and detector 
before collecting a full data set from the crystal.  
 
Protein crystals contain an inherent amount of disorder which limits diffraction 
quality. Data processing of the resulting spots on the diffraction images 
requires that each spot can be separated from its neighbors. It is not possible 
to correctly measure the intensity of spots that overlap with neighboring 
reflections on consecutive images. The oscillation angle selected for data 
collection must be chosen to reduce the number of overlapping spots. The 
separation of the spots on individual images can be achieved by varying the 
detector to crystal distance. An increase in distance generates greater spot 
separation but decreases the maximum resolution obtained. A good balance 
between spot separation and resolution must therefore be found. 
 
The high intensity of synchrotron radiation generally allows diffraction to 
higher resolution, but it also increases the radiation damage of the crystal. 
Several kinds of radiation damage are known, including reduction of disulfide 
bonds, decarboxylation or radical formation (Burmeister, 2000, Garman, 2003, 
Ravelli & McSweeney, 2000). Reducing the beam intensity, decreasing the 
time of exposure, or translation of the crystal after several frames can be 
employed to counteract the radiation problem and ensure a continuous data 
quality during the measurement. 
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Data Processing 
 
Data were processed using one of two programs; XDS (Kabsch, 1993) or the 
HKL suite (Otwinoswki & Minor, 1997). To determine the correct unit cell and 
crystal orientation, parameters such as the wavelength of the radiation, the 
angle over which the crystal was oscillated per frame, the direct beam 
position, detector characteristics and detector to crystal distance must be 
provided. 
 
Processing using the Program Suite HKL 
 
Strong reflections from a single image were used to determine the crystal 
orientation and the correct unit cell. The resulting predicted pattern was 
compared to the diffraction pattern of the indexed frame. The following 
variables were adjusted before processing the first frame: direct beam 
position, detector to crystal distance, mosaicity, spot and box sizes. The 
parameters obtained from the first image were used to process the remaining 
images. 
 
The scaling and merging of the data, as well as the global refinement of the 
crystal parameters, were performed by Scalepack (Otwinoswki & Minor, 
1997). In the first run, the program rejects spots from the images and stores 
them in a separate file. After adjusting the error model, the program was rerun 
several times excluding the rejected spots. Once no more reflections were 
rejected and the goodness of fit (Chi2) was around 1, the scaling was stopped. 
The Rsym and the signal to noise ratio I/  indicate the quality of the data. Rsym 
compares intensities of reflections that have been measured more than once 
(multiplicity) or of their symmetry equivalents.  
 
 
Rsym(I) =
Ii(hkl) ! I (hkl)
i
"
hkl
"
Ii(hkl)
i
"
hkl
"
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Ii(hkl)  defines the observed intensity of a measured reflection and 
 
I (hkl) the 
mean intensity of the observation i. A low Rsym value indicates that there is a 
good agreement between symmetry related reflections, whereas high Rsym 
values occur if the data was incorrectly indexed or the measurement of the 
intensities was inaccurate. A high multiplicity with a low Rsym value indicates 
that the reflection intensities have been reliably measured. Other indicators of 
data quality are the signal to noise ratio I/  and the completeness of the data. 
In general data were truncated at I/ < 2, Rsym >50% or if the completeness 
dropped below 80%. 
 
Data Processing with XDS 
 
The program package XDS (Kabsch, 1993) refines the crystal and 
experimental parameters and integrates the intensities (subprogram XDS), 
calculates statistics for the data (subprogram XSCALE) and converts the 
output file to formats suitable for crystallographic refinement programs 
(subprogram XDSCONV). The parameters used for data collection were input 
to XDS. Initially strong reflections from the first 5 to 10° were analyzed to 
determine the space group and cell parameters. These cell parameters are 
then provided for subsequent examination of the entire data set. The resulting 
reflection file is merged and scaled with XSCALE and the data is evaluated 
according to the values mentioned in the previous section (Processing using 
the program suite HKL). 
 
Structure Determination 
 
Calculation of an electron density map requires structure factors Fhkl.  Fhkl is a 
periodic function, and therefore can be described by its amplitude, frequency 
and phase. The frequency corresponds to the frequency of the X-ray source 
and the amplitude is proportional to the square root of the measured intensity, 
Ihkl, of the reflection. The phase angle can not be directly measured in a single 
experiment. The phasing information can be obtained in several ways, often 
requiring the presence of additional heavy atoms in the unit cell. Single or 
multiple isomorphous replacement (SIR or MIR) use data that have been 
colleted in the presence and absence of heavy metals. Combining the native 
and derivatized data sets, the heavy metals can be placed in the unit cell and 
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their positions are used to calculate initial phases. The methods single- and 
multi- wavelength anomalous dispersion (SAD, MAD) take advantage of the 
signal from anomalous scatterers at particular wavelengths. These techniques 
depend on a small difference in anomalous signal that leads to disruption of 
Friedel`s law. In MAD two or more wavelengths are collected and phases can 
be obtained by measuring differences in the intensities due to the changes in 
anomalous behavior at the different wavelengths. 
 
A further method to obtain phase information can be used if a similar protein 
structure is available and identified. This method, called molecular 
replacement technique is explained in detail in the next chapter. 
 
The structure factor Fhkl is the sum of all scattering atoms in the unit cell of a 
crystal.  
 
Fhkl = fi
N
! exp 2" i hxi+ kyi+ lzi( )[ ]exp #Bisin2$ /%2[ ] 
The atomic scattering factor fi of each atom depends on the number of 
electrons of an atom. The last term in the equation, the B or temperature 
factor, represents the thermal and statistic disorder of the crystal lattice. fi and 
the B-factor decrease with higher resolution and thereby limit the intensity of 
the structure factor Fhkl. The electron density map can be calculated by 
performing a Fourier transform of the individual structure factors: 
 
 
! (x,y,z) =
1
V
F(hkl)exp("2# i(hx+ ky+ lz))
l
$
k
$
h
$  
where V is the volume of the unit cell and   the corresponding electron 
density at the grid point x, y and z. F (hkl), the structure factor of the reflection 
(hkl), is the product of the amplitudes |F| obtained from the measured 
intensities I(hkl) where I equals |F|2 and the corresponding phase angle α 
(F(hkl)=|F|exp[iα]). α is determined by molecular replacement, single or 
multiple isomorphous replacement or anomalous dispersion methods (SAD, 
MAD). 
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Structure Determination by Molecular Replacement 
 
A method to overcome the “phase problem“ is: retrieve the phases from the 
structure factors of a known protein structure and use these phases as initial 
estimates for the new structure to be determined. This method is called 
molecular replacement and as the number of structures deposited in the 
protein data bank is growing rapidly, it is becoming more and more important. 
 
To apply the phases of the known structure to the unknown molecule, both 
models have to be superimposed. Therefore the known structure (trial model) 
has to be positioned in the unit cell of the unknown structure using a rotation 
and translation function. The superposition is carried out using the Patterson 
function P(  
 
r 
u ), which is a Fourier summation of intensities with all phase 
angles equal to zero. Patterson functions are calculated for both the known 
and unknown molecule. The obtained Patterson map contains two types of 
vectors: self vectors, which are vectors between atoms in an individual 
molecule; and cross vectors, which are vectors between atoms in one 
molecule in the crystal and atoms in an other molecule. Self vectors are used 
to define the correct rotational orientation of the trial model whereas cross 
vectors are used to translate the previously rotated trial model in the unit cell 
of the unknown protein. A schematic representation is show in Figure 72. 
 
 
Figure 72: Molecular replacement. A graphic representation of the main principle of the 
molecular replacement method is shown. The phasing molecule (probe) must be rotated and 
translated to fit the unknown molecule (target molecule) in the asymmetric unit of the crystal. 
R is the rotation matrix and T the translation vector. 
(http://daffy.bioc.cam.ac.uk/~dima/whitepapers/mr-in-action/node4.html) 
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The software package AMoRe (Navaza, 1994) was applied to solve the 
structure of DDAH-1. 1H70, a close homologue of DDAH-1, was used as the 
search model (Murray-Rust et al., 2001). The cross-rotation function, defined 
as the overlap of the Patterson functions of the unknown structure and the 
phasing model, was calculated using a sphere radius for the model of 25 Å 
and a resolution range of 10.0-4.0 Å. The search model had previously been 
reduced to a poly serine model with the program MOLEMAN (G.J. Kleywegt; 
1992-2004, Uppsala University, Uppsala, Sweden, unpublished program). 
The poly serine model is useful since it provides more information than a poly 
alanine would. The best 99 solutions from the rotational search were then 
applied to the translational search function. The top solutions of the 
translational search were minimized using the rigid body refinement function 
implemented in the AMoRe program package. 
 
 
Model Building and Refinement 
 
Refinement of a crystal structure is an iterative process of adjusting the model 
to find a better agreement between the calculated and the observed structure 
factors. The quality of the model depends upon the target function used for 
the refinement. The two target functions, least-square (LSQ) and maximum 
likelihood (ML), are used in macromolecular structure determination. The 
programs minimize a residual value E, which is the weighted sum of squared 
deviations between the observed 
 
Fo( )  and the calculated 
 
Fc( )  structure-
factor amplitudes, including a relative scaling factor k and wa, which is a 
weight between experimental and geometric restraints: 
 
ELSQ = Erestraints + wa
 
Fo ! k Fc( )
2
hkl
" . 
Erestraints are geometric (bond length, bond angle, planarity and atomic 
repulsion) restraints included in the refinement. Although the atomic model is 
improved, problems arise because such a least square residual is poorly 
justified, especially in the early stage of refinement. The value that is 
minimized is the root mean square deviation between the model electron 
density and the electron density computed from Fourier coefficients 
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|Fo|exp(iαc), where the phases αc are obtained from the model and |Fo| are 
derived from the measured intensities. This deviation can be minimized either 
by improving the model or by introducing systematic errors that erase 
differences in the electron density. Due to the unfavorable parameter-to-
observation ratio, the data are typically overfitted, which means that 
systematic errors are introduced (Pannu & Read, 1996). 
A more general approach, which also applies to incomplete or error containing 
models, uses maximum likelihood (ML) functions. The principle of ML is that 
the quality of the model is judged by its consistency with the measured 
observations. Consistency means that a correct model would reproduce the 
observed data points with a high probability. The effects of model errors 
(misplaced or missing atoms) on the calculated structure factors are 
quantified with σa values, which correspond roughly to the fraction of each 
structure factor that is expected to be correct. A random test set of reflections 
(5-10%), which is excluded from the refinement process, is used to calculate 
σa. These cross-validated values are used to compute 
 
Fo
cv
 and the 
corresponding variance (σ2MLcv). The target function that is minimized is given 
by: 
EML = Erestraints + wa 
 
1
! 2MLcv
" 
# 
$ 
% 
& 
' Fo ( Fo
cv
( )
hkl)workingset
*
2
. 
 
The advantages of ML are that the false minima are less pronounced, the 
radius of convergence is larger and overfitting compared to LSQ refinements 
is reduced (Adams et al., 1997). 
 
The fit of the calculated and experimentally observed structure factors is 
described by the R-factor: 
 
 
R =
Fobs ! kFcalc
hkl
"
Fobs
hkl
"
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The temperature Factor (B-factor) 
 
The temperature or B-factor represents the thermal and statistic disorder of 
the crystal. The intensity of a reflection is reduced according to: 
 
I = Io exp [-B (sin2θ/ λ2)] 
where B equals 8π2u2. u is the root-mean-square displacement of the atom 
around the ideal position at 0 Kelvin. This factor only reduces the intensity of 
the observation and does not change the sharpness or shape of the spot in 
the diffraction experiment. The overall B-factor can be estimated in early 
stages during structure determination. The intensities determined from 
diffraction images are divided into a series of shells according to the 
resolution (d = λ/2sinθ) and the mean intensity 
 
I  is calculated in each shell. A 
graph ln (
 
I 
f 
2 ) where f are the individual atomic scattering factors against 
(sinθλ)2  assuming a random distribution of the atoms results ideally in a 
straight line with a slope of –B and is called a Wilson plot (Wilson, 1949). The 
Wilson plot for a real protein structure at a resolution higher than 3 Å 
resolution deviates from the theoretical straight line because of secondary 
structural elements, which disturb the statistical intensity distribution due to 
the regular arrangements of atoms.  
In refinement, the positions and the B factor of each individual atom are 
determined. However, the low observation to parameter ratio only allows the 
determination of B of each atom for resolutions better than ~ 2.5 Å. At lower 
resolution the B factor is therefore calculated either separately for side and 
main chains or only one B is calculated for each amino acid. At high resolution 
the motions of the atoms can be described in more detail. Here, the distortion 
of the atomic electron density might not be spherical (isotropic), but could vary 
depending on the direction. Therefore the anisotropic B-factor is introduced, 
which is displayed as an ellipsoid around the central atom position. In total, 
the number of parameters to be defined therefore increases to 9; three 
parameters locate the individual atom in space (x, y, z) and six parameters 
define the ellipsoid of the anisotropic B-factor U11, U22, U33, U12, U13 and U23. 
 
Appendix – Biochemical methods 
 169 
F.2 Biochemical Methods 
 
Protein and DNA Markers 
 
             
Figure 73: Protein and DNA Marker used in this work. Protein ladder was purchased from 
Fermentas and 1kb DNA ladder was obtained from Promega. 
 
 
ATP Hydrolysis Assay 
 
1-12 µl of the sample was inoculated with 100 µl ATPase buffer (50 mM 
Hepes, 2 mM EGTA, 2 mM DTT, 5 mM NaN3, 1 mM Ouabain, MgCl2, pH 7.4) 
and ATP was added to a final concentration of 5 mM. Care had to be taken 
that the ATP solution was buffered to ~pH 6-7 with NaOH. The hydrolysis of 
ATP was stoped after 20 min at 37°C by adding 112 µl of a 5% SDS solution. 
The solution was diluted by adding 1 ml water and 400 µl ammonium 
molybdate solution (1.25% NH4) MoO4 in 1.25 M H2SO4). After vigorous 
mixing the color development was started by adding a 1% solution of the 
Fiske-Subbarow reducer. After 10 min the samples were measured at 660 
nm. Linearity of the activity assay was checked with a 10 mM phosphate 
solution. In the case of mBsep, the ATPase activity was enlarged by the 
addition of the substrate taurochendeoxycholate in a final concentration of 
30 – 50 µM. 
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F.3 ABC Transporters 
 
mBsep - Constructs 
 
mBsep pFASTBac HTb: full cDNA of mBsep cloned in pFASTBac HTb (Ehe 
I/ Not I). Expression vector used to infect insect Sf9 cells with baculovirus. 
The N-terminal extension of MSYYHHHHHHDYDIPTTENLYFQG contained 
the His-tag as well as the protease cleavage site for the TEV protease. The 
vector was obtained from B. Stieger of the University of Zurich.  
 
mBsep pET20NHT: full length cDNA of mBsep in the bacterial expression 
vector pET20 NHT. 
Sense primer: 
5`-GCTGAATTCATGTCTGACTCAGTGATTCTTCGCAGTG-3` 
Antisense primer: 
5`-GCTATCAGCGGCCGCTTCAACTGATGGGGGCTCCAG-3` 
 
mBsep pET28NH: full length cDNA of mBsep in bacterial expression vector 
pET28 NH. 
Sense primer: 
5`-GCTGAATTCATGTCTGACTCAGTGATTCTTCGCAGTG-3` 
Antisense primer: 
5`-GCTATCAGCGGCCGCTTCAACTGATGGGGGCTCCAG-3` 
 
mBsep pET28ch: full length cDNA of mBsep in bacterial expression vector 
pET28 ch. 
Sense primer: 
5`-GCTGAATTCATGTCTGACTCAGTGATTCTTCGCAGTG-3` 
Antisense primer: 
5`-GCTATCAGCGGCCGCTTCAACTGATGGGGGCTCCAG-3` 
 
mBsep I pET 20ch: amino acids 1-755 of mBsep in pET20ch vector. 
Sense primer: 
5`-GCTGAATTCATGTCTGACTCAGTGATTCTTCGCAGTG-3` 
Antisense primer: 
5`-GCTACTGCGGCCGCTTATGTAGGGCCATTCTGAG-3` 
 
mBsep I pET20NHT: amino acids 1-755 of mBsep in pET20 NHT vector. 
Sense primer: 
5`-GCTGAATTCATGTCTGACTCAGTGATTCTTCGCAGTG-3` 
Antisense primer: 
5`-GCTACTGCGGCCGCTTATGTAGGGCCATTCTGAG-3` 
 
mBsep II pET 20ch: amino acids 756-1320 of mBsep in pET20ch vector. 
Sense primer:  
5`-GCTGAATTCCTGGTAGGGGCTTTGTGTGC-3` 
Antisense primer: 
5`-GCTACCTCGAGACTGATGGGGGCTCCAGTGATG-3` 
 
mBsep II pET20NHT: amino acids 756-1320 of mBsep in pET20 NHT vector. 
Sense primer:  
5`-GCTGAATTCCTGGTAGGGGCTTTGTGTGC-3` 
Antisense primer: 
5`-GCTACCTCGAGACTGATGGGGGCTCCAGTGATG-3` 
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pEAK8 mBsep: full length mBsep in the vector pEAK8 designed for 
expression in mammalian cells. The construct contained an additional N-
terminal 6xHis-tag plus TEV recognition site. 
Sense primer:  
5`-GCTACAAGCTTACCATGGCGTACTACCATCACCATCACC-3` 
Antisense primer: 
5`-GCTACGAATTCTCAACTGATGGGGGCTCCAG-3` 
 
pEAK8-mBsepEGFP: identical to pEAK8 mBsep vector but with an C-
terminal fusion of enhanced green fluorescent protein to locate the protein. 
mBsep:  
Sense primer: 
5`-GCTACAAGCTTACCATGGCGTACTACCATCACCATCACC-3` 
Antisense primer: 
5`-GCTACGAATTCACTGATGGGGGCTCCAG-3` 
 
EGFP: 
Sense primer: 
5`-GCTACGAATTCATGGTGAGCAAGGGCGAGG-3` 
Antisense primer: 
5`-GCATTAGCGGCCGCTTACTTGTAACAGCTCGTCCA-3` 
 
Sequencing primer for the mBsep constructs: 
bs1: 5`-GCTGATGTTTATGGGAAGTG-3` 
bs2: 5`-AGGTTGTGGGTAATCACTGG-3` 
bs3: 5`-TGAGTGTGGCCAAGTTCACG-3` 
bs4: 5`-GATTTTCCTCTGTGTCATAA-3` 
bs5: 5`-AGCACAGCACTACAGCTCAT-3` 
bs6: 5`-GACAGAAGCAAAGGGTAGCC-3` 
bs7: 5`-TACTCACAAAGAAACAGGCA-3` 
bs8: 5`-TTTGTGTGCAGCCATTAATG-3` 
bs9: 5`-CAGATGCTTCCCAAGTTCAA-3` 
bs10: 5`-TGAGGTTGAGCTGGAGAAGT-3` 
bs11: 5`-GTACAGTGGAGCAGGTGAAA-3` 
 
 
 
Constructs of prokaryotic ABC Transporter 
 
Thermotoga maritima 
 
TM0043: 
Sense primer: 
5`-GGTGGATCCGTGATTTTGAGTCCGGAGAAGTTTCTGC-3` 
Antisense primer: 
5`-GGCTACTCGAGCGCATTTTCGAACTGTATCTTGTAAAGG-3` 
 
TM0287: 
Sense primer: 
5`-GCTCAGAGCTCATGAAAACACTCGCCAGATATTTAAAGCC-3` 
Antisense primer: 
5`-GCTCACAGCGGCCGCTGGCATCGTTCATCACCCCG-3` 
Antisense primer with no tag: 
5`-GCTCACAGCGGCCGCTCAGGCATCGTTCATCACCCCGT-3` 
Nucelotide Binding domain: 
Sequencing primer (start at 600) 
5`-GGTGTCAGGGTAGTGAGGGC-3` 
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TM0288: 
Sense primer: 
5`-GCTGGATCCATGCCTGAGATCAGAAGAAGGCC-3` 
Antisense primer: 
5`-GCTACCTCGAGTTCTTTTTCTACAACGAGACCGTATTGGC-3` 
Antisense primer without tag: 
5`-GCTACCTCGAGtcaTTCTTTTTCTACAACGAGAC-3` 
antisense primer: only avi-tag: 
5`-GCTGACTCGAGTCACTCGACTTCGTGCCATTCGATTTTCTG-3` 
Sequencing primer (start at base 596) 
5`-GCCAAACCAGAAAATACTTCTACG-3` 
 
TM1256: 
Sense primer: 
5`-GCTGGATCCTTGAAGACTTCCTCAATTCTCGTTGATTTC-3` 
Antisense primer: 
5`-GCGACTGAAGCGGCCGCTTCCCTCCTCGATGAGCTGTTTTCTG-3` 
 
TM1310: 
Sense primer: 
5`-GCTGGATCCATGAATCTCAGGAGTATCCAG-3` 
Antisense primer: 
5`-GCTCACTCGAGGACATCTTTATCAGCGATCC-3` 
 
TM1319: 
Sense primer: 
5`-GCTGGATCCATGAAAACTGGAAAGTTTCGGCTCTTGAG-3` 
Antisense primer: 
5`-GCGACTGGCGGCCGCTTACCTCCAATTGACTCCTTACAATCTC-3` 
 
TM1328: 
Sense primer: 
5`-GCTGGATCCATGAAATTTTTCTCAGCAAGTAACGTCAGAG-3` 
Antisense primer: 
5`-GCTCACTCGAGTCTCATCAGCTGGCTCTTCA-3` 
 
 
Escherichia coli: 
 
D-galactose transporter MglC/A: 
Mgla: 
Sense primer: 
5`-GCTAGGGATCCATGGTCAGCTCAACGACTCC-3` 
Antisense primer: 
5`-GCTACGTGCGGCCGCAGGTGCAAAGACGCAAGACG-3` 
 
MglC: 
Sense primer: 
5`-GCTAGGGATCCATGAGTGCGTTAAATAAGAA-3` 
Antisense primer: 
5`-GCTACCTCGAGTTTCTTACGCGCGTATTTCA-3` 
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CVAB 
1: 
Sense primer: 
5`-GATCCATGACTAACAGGAATTTCAGACAAATTATA-3` 
Antisense primer: 
5`-TCGAGAATAGAAATAACTCTATCAACAGTTCTCAA-3` 
 
2: 
Sense primer: 
5`-CATGACTAACAGGAATTTCAGACAAATTATA-3` 
Antisense primer: 
5`-GAATAGAAATAACTCTATCAACAGTTCTCAA-3` 
 
 
HLYB 
1: 
Sense primer: 
5`-GATCCATGGATTCTTGTCATAAAATTGATTATGGG-3` 
Antisense primer: 
5`-TCGAGGTCTGACTGTAACTGATATAAGTAACTGTA-3` 
 
2: 
Sense primer: 
5`-CATGGATTCTTGTCATAAAATTGATTATGGG-3` 
Antisense primer: 
5`-GGTCTGACTGTAACTGATATAAGTAACTGTA-3` 
 
Sense primer: 
5`-ATGGATTCTTGTCATAAAATTGATTATGGG-3` 
Antisense primer: 
5`-GTCTGACTGTAACTGATATAAGTAACTGTA-3` 
 
MACB 
1: 
Sense primer: 
5`-GATCCATGACGCCTTTGCTCGAATTAAAGGATATT-3` 
Antisense primer: 
5`-TCGAGCTCTCGTGCCAGAGCATCTACTGGATCCAG-3` 
 
2: 
Sense primer: 
5`-CATGACGCCTTTGCTCGAATTAAAGGATATT-3` 
Antisense primer: 
5`-GCTCTCGTGCCAGAGCATCTACTGGATCCAG-3` 
 
YBIZ 
1: 
Sense primer: 
5`-GATCCATGACGCCTTTGCTCGAATTAAAGGATATT-3` 
Antisense primer: 
5`-TCGAGCTCTCGTGCCAGAGCATCTACTGGATCCAG-3` 
 
2: 
Sense primer: 
5`-CATGACGCCTTTGCTCGAATTAAAGGATATT-3` 
Antisense primer: 
5`-GCTCTCGTGCCAGAGCATCTACTGGATCCAG-3` 
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YDDA: 
1: Sense primer: 
5`-GATCCATGCATAACGACAAAGATCTCTCTACGTGG-3` 
Antisense primer: 
5`-TCGAGTTGGCCAAACTGCATTTTGTGAAGTTGC-3` 
 
2:  
Sense primer: 
5`-C ATGCATAACGACAAAGATCTCTCTACGTGG-3` 
Antisense primer: 
5`-GTTGGCCAAACTGCATTTTGTGAAGTTGC-3` 
ydda_pET_28_ch_neu_primer 
Sense primer: 
5`-GCTCAGGATCCATGAAATCGCGCCAG-3` 
Antisense primer: 
5`-GCTATCTCGAGTAAAACCGCGCTAAT-3` 
 
Yoji: 
1: 
Sense primer: 
5`-GATCCATGGAACTTCTTGTACTTGTCTGGCGGCAG-3` 
Antisense primer: 
5`-TCGAGTGCCGTCCGGGCAACGGCATCACGCGAAGC-3` 
 
2: 
Sense primer: 
5`-CATGGAACTTCTTGTACTTGTCTGGCGGCAG-3` 
Antisense primer: 
5`-GTGCCGTCCGGGCAACGGCATCACGCGAAGC-3` 
 
yoji pET28_ch_neu_primer: 
Sense primer: 
5`-ATGGAACTTCTTGTACTTGTCTGGCGGCAG-3` 
Antisense primer: 
5`-TGCCGTCCGGGCAACGGCATCACGCGAAGC-3` 
 
 
Zinc transporter ZnuB/C: 
znuB: 
Sense primer: 
5`-GCTAGGGATCCATGATTGAATTATTATTTCC-3` 
Antisense primer: 
5`-GCTAGCTCGAGGCTGGCCTGCTTTTTCATCA-3` 
znuC: 
Sense primer: 
5`-GCTAGGGATCCATGACAAGTCTGGTTTCCCT-3` 
Antisense primer: 
5`-GCTAGCTCGAGTGAGCGATCATTTCCCCGAC-3` 
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Arabinose transporter: AraH/G: 
araG: 
Sense primer: 
5`-GCTAGGGATCCATGCAACAGTCTACCCCGTA-3` 
Antisense primer: 
5`-GCTAGCTCGAGGGCAACAGCCTGGCTGACTT-3` 
 
araH: 
Sense primer: 
5`-GCTAGGGATCCATGATGTCTTCTGTTTCTAC-3` 
Antisense primer: 
5`-GCTAGCTCGAGGACAGTGCGTTTCGCTTTTT-3` 
 
D-xylose transporter XylH/G 
xylG: 
Sense primer: 
5`-GCTAGGGATCCATGCCTTATCTACTTGAAAT-3` 
Antisense primer: 
5`-GCTAGCTCGAGGACGGATTGCTTTTCGACAT-3` 
xylH: 
Sense primer: 
5`-GCTAGGGATCCATGTCGAAAAGCAATCCGTC-3` 
Antisense primer: 
5`-GCTAGCTCGAGAGAACGGCGTTTGGTTGCGG-3` 
 
Glutamine transporter GlnP/Q: 
glnP: 
Sense primer: 
5`-GCTAGGGATCCATGCAGTTTGACTGGAGTGC-3` 
Antisense primer: 
5`-GCTAGCTCGAGCAGGATTTTCATCCTTCTTT-3` 
glnQ: 
Sense primer: 
5`-GCTACGGATCCATGATTGAATTTAAAAACGTC-3` 
Antisense primer: 
5`-GCTACCTCGAGAGAGACGTGCTGCAAAAATT-3` 
 
Taurine transporter: TauC/B 
tauB: 
Sense primer: 
5`-GCTAGGGATCCATGCTGCAAATCTCTCATCT-3` 
Antisense primer: 
5`-GCTAGCTCGAGTGAGAACGCCTCCCGTTGCT-3` 
tauC: 
Sense primer: 
5`-GCATCGAATTCATGAGTGTGCTCATTAATGA-3` 
Antisense primer: 
5`-GCTAGCTCGAGTTGTACTTCTCCATGCCAGG-3` 
 
Macroliden transporter macB: 
Sense primer: 
5`-ATGACGCCTTTGCTCGAATTAAAGGATATT-3` 
Antisense primer: 
5`-CTCTCGTGCCAGAGCATCTACTGGATCCAG-3` 
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Lipid flipase MsbA: 
Sense primer: 
5`-ATGCATAACGACAAAGATCTCTCTACGTGG-3` 
Antisense primer: 
5`-TTGGCCAAACTGCATTTTGTGAAGTTGCGC-3` 
 
Pyrococcus horikoshii 
 
PH1735: 
Sense primer: 
5`-GCTGAGCTCGTGAGGAATATGAGAAATAACG-3` 
Antisense primer: 
5`- GCGATCTCGAGAACTTCCTGAACTTGAGAGG-3` 
 
PH1736: 
Sense primer: 
5`-GCTGAATTCATGGATGGTTCGCTAAGGC-3` 
Antisense primer: 
5`-GCTCACTCGAGTTTCTCATATTCCTCACCTATAGC-3` 
 
Helicobacter pylori 
 
HP 0600: 
Sense primer: 
5`-GCTGGATCCATGCAAACACCAATGGATAC-3` 
Antisense primer: 
5`-GCTACCTCGAGGTATTGCTGCTTCAAAAACA-3` 
 
HP1082: 
Sense primer: 
5`-GCTGAATTCTTGAAACTCTTTTTCAAGCG-3` 
Antisense primer: 
5`-GCTACCTCGAGGCATTCTGTCAAACGC-3` 
 
 
Bacillus subtilis: 
 
YFIB: 
Sense primer: 
5`-GCTGGATCCATGCAAAAGGCTTTGTCGTTTTTAAAACC-3` 
Antisense primer: 
5`-GCTCACTCGAGGCATGACTCGCTCCCCTCCCTTC-3` 
 
YFIC: 
Sense primer: 
5`-GCTGGATCCATGCTAAAAGACATCCGCAAGCCTTTCC-3` 
Antisense primer: 
5`-GCTCACTCGAGTTTCTCAAATTGGCTTTCATATAAGTCACTG-3` 
 
YHEH: 
Sense primer: 
5`-GCTGGATCCATGAAAATAGGAAAAACGTTATGGAGATACGC-3` 
Antisense primer: 
5`-GCTCACTCGAGTGCAATGGAATGTTTCTGTCCCTTTTGC-3` 
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YHEI: 
Sense primer: 
5`-GCTGGATCCATGTTTTCAGTTTTGAAAAAGCTTGGCTGG-3` 
Antisense primer: 
5`-GCTCACTCGAGTGCCCCTGCTCCCCCTTCTTCC-3` 
 
YKNU: 
Sense primer: 
5`-GCTGGATCCATGGAGACATTTAAAAGATTAAAAATGTATTATTGGC-3` 
Antisense primer: 
5`-GCTCACTCGAGTCCGACCTCATGCGGCTC-3` 
 
YKNV: 
Sense primer: 
5`-GCTGGATCCATGAAACAAGCGAAAAAACAGGGGGTTTTAG -3` 
Antisense primer: 
5`-GCTCACTCGAGTTCTATCGCTGTGCTGTATTGCGCTTTC-3` 
 
YWJA: 
Sense primer: 
5`-GCTGGATCCGTGCTGCGGCAATTTTTTTCATATTATAAACC -3` 
Antisense primer: 
5`-GCTCACTCGAGTCGATGCACCATTTGCCCGAATTG-3` 
 
Table 8: Expression Overview 
Constructs BL21(DE3) BL21(DE3) 
cRILplus 
BL21(DE3)
pLysS 
C41 C43 
      
1st round of selection       
      
pET 20 constructs      
TM 0043 pET20 NH - - -+   
TM 0043 pET20 CH +- - -+   
      
TM 0287 pET20 NH - - +   
TM 0287 pET20 CH - + +   
      
TM 0288 pET20 NH - - +   
TM 0288 pET20 CH + ++ +   
      
TM 1256 pET20 NH - - -   
TM 1256 pET20 CH - - -   
      
TM 1310 pET20 CH - - -   
      
TM 1319 pET20 NH - - -   
TM 1319 pET20 CH - - -   
      
TM 1328 pET20 NH      
TM 1328 pET20 CH - - +-   
      
HP 0600 pET20 NH - - -   
HP 0600 pET20 CH - - -   
      
PH 1735 pET20 NH - - -   
PH 1735 pET20 CH - - -   
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Table 8: continued      
PH 1736 pET20 NH - - -   
PH 1736 pET20 CH - - -   
      
YWJA pET20 NH      
YWJA pET20 CH      
      
 
Constructs with pelB 
leader sequence (frame) 
     
      
TM 1256 pET20 frame - - -   
TM 1319 pET20 frame - - -   
TM 1328 pET20 frame - - -   
      
PH 1735 pET20 frame      
PH 1736 pET20 frame      
      
HP 1082 pET20 frame      
HP 1082 pET20 CH NH + + +   
      
pET 21/28 constructs      
      
TM 0043 pET21 CH      
TM 0043 pET21 frame      
TM 0043 pET28 CH + + -   
TM 0043 pET28 frame      
      
TM 287 pET21 CH +++ ++  + + 
TM 287 pET21 frame -     
TM 287 pET28 CH 0 0 0   
TM 287 pET28 frame 0 0 0   
      
TM 288 pET21 CH 0 0 0   
TM 288 pET21 frame 0 0 0   
TM 288 pET28 CH +++ +++ - + + 
TM 288 pET28 frame 0 0 0   
      
TM 1256 pET21 CH 0 0 0   
TM 1256 pET21 frame 0 0 0   
TM 1256 pET28 CH +++ +++ +   
TM 1256 pET28 frame - - -   
      
TM 1319 pET21 CH      
TM 1319 pET21 frame      
TM 1319 pET28 CH - - -   
TM 1319 pET28 frame - - -   
      
TM 1328 pET21 CH      
TM 1328 pET21 frame      
TM 1328 pET28 CH +++ - -   
TM 1328 pET28 frame - - -   
      
PH 1735 pET21 CH      
PH 1735 pET21 frame      
PH 1735 pET28 CH +++ +++ +   
PH 1735 pET28 frame ++ - -   
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Table 8: continued      
      
PH 1736 pET21 CH      
PH 1736 pET21 frame      
PH 1736 pET28 CH + + -   
PH 1736 pET28 frame - - -   
      
HP 1082 pET21 CH      
HP 1082 pET21 frame      
HP 1082 pET28 CH ++ + -   
HP 1082 pET28 frame - - -   
      
      
2nd round of selection      
      
Zink      
B pET21 CH  +   - - 
B pET21 NH      
B pET28 CH      
B pET28 NH       
C pET21 CH -ATP- ++   - - 
C pET21 NH +-     
C pET28 CH ++     
C pET28 NH  +-     
      
Taurine      
B pET21 CH -ATP-      
B pET21 NH      
B pET28 CH      
B pET28 NH  ++   + - 
C pET21 CH  ++   ++ - 
C pET21 NH      
C pET28 CH      
C pET28 NH       
      
Arabinose      
G pET21 CH -ATP- ++   + - 
G pET21 NH      
G pET28 CH      
G pET28 NH       
H pET21 CH       
H pET21 NH      
H pET28 CH +   +- - 
H pET28 NH  +-     
      
Xylose +-     
G pET21 CH -ATP- -   - - 
G pET21 NH -   - - 
G pET28 CH ++   - - 
G pET28 NH  0     
H pET21 CH  -   - - 
H pET21 NH +   - - 
H pET28 CH -   - - 
H pET28 NH  0     
      
Glutamine      
P pET21 CH      
P pET21 NH +   - - 
Appendix - ABC Transporters 
 180 
Table 8: continued      
      
P pET28 CH +     
P pET28 NH       
Q pET21 CH  -ATP-      
Q pET21 NH +     
Q pET28 CH      
Q pET28 NH  +   - - 
      
3rd round of selection      
HLYB      
MACB      
MSBA      
YBIZ      
YDDA ++     
YOJI ++     
-: no expression; 0: very weak expression, +: weak expression; ++: medium expression; +++: 
strong expression. 
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F.4 CitS 
 
Expression and Purification of CitS 
 
The CitS was expressed using freshly transformed C43 E.coli strains. A single 
colony was used to inoculate a 10 ml LB culture, supplemented with 1% 
glucose and ampicillin, and was grown at 30° C overnight. The media of the 
overnight preculture was removed by centrifugation; the cells were 
resuspended in 4 ml buffered TB media (24 g/l yeast extract, 12 g/l tryptone 
peptone, 3.6 ml/l glycerol, 12.6 g/l K2HPO4 and 2.3 g/l KH2PO4) and used to 
inoculate 500 ml TB media. The cells were grown to an OD600 of 0.6-0.7 at 
30°C, cooled down to 18°C in an ice bath for 15-20 min and protein 
expression was started by adding 1.4 mM IPTG and the cells were incubated 
at 25°C for 18 hours. The cells were harvested by centrifugation and 
suspended with twice the amount of lysis buffer (20 mM Tris, 300 mM NaCl, 
20 mM NaH2PO4, pH 7.5) and incubated one hour with lysozyme (1mg /ml), 
DNAse and RNAse. Cells were disrupted by sonification and three passes of 
FrenchPress. 
 
To solubilize the protein, 2 % (w/v) dodecyl β-D-maltopyranoside (DDM) was 
added to the crude extract and the solution was gently shaken for 2 hours at 
4°. The suspension was centrifuged 30 min at 40000 x g to remove non 
solubilized material. The solution was filtered through a 0.22 µm filter and, 
prior to loading it to an equilibrated Ni-NTA affinity column (10 mM Tris, 
300 mM NaCl, 0.1% DDM, pH 7.4), the pH was adjusted to 8.0 with 0.5 M 
NaOH. The column was washed with 10 column volumes of buffer 1 (10 mM 
Tris, 300 mM NaCl, 0.1% DDM, pH 7.4), 10 column volumes of buffer 2 
(10 mM Tris, 1M NaCl, 0.1% DDM, pH 7.4), 10 column volumes of buffer 3 
(10 mM Tris, 500 mm NaCl, 100 mM Imidazole, 0.1% DDM, pH 7.4) and 
finally the protein was eluted with 3-5 column volumes of elution buffer 
(10 mM Tris, 300 mm NaCl, 500 mM Imidazole 0.1% DDM, pH 7.4). 
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The eluted protein was concentrated to 500 µl and applied to an equilibrated 
size exclusion chromatography column (Superose 6 23 ml; 10 mM Tris, 150 
mM NaCl, 0.05% DDM, pH 7.4). Fractions containing CitS were pooled, 
concentrated to 10-30 mg /ml and used for crystallization experiments. 
 
Initial Crystallization of CitS 
 
Initial screening of crystallization conditions was carried out on a small scale 
using the NCCR crystallization facility at the University of Zürich. 100 µl 
protein solution was mixed with 100 µl reservoir solution in 96 well plates and 
incubated at 4°. The crystallization trials were inspected immediately after set 
up and after 1, 3, 7 and 10 days of incubation. After 10 days the wells were 
inspected every 2 weeks for a total of 4 months from the initial set up of the 
plate. The initial screens included pH ranges of 4.5-9.4 in steps of 1 pH unit, 
poly ethylene glycol with a mean molecular weight of 400 or 4000 and the 
following salt conditions: 
 150 mM or 1 M NaCl 
 200 mM (NH4)2SO4 or 50 mM Mg-acetate 
 100 or 200 mM K3PO4 or 50 or 100 mM of each of Li2SO4 and Na2SO4 
 100 mM KCl or 100 mM CaCl2 
 1 M ammonium formate or 50 mM Zn-acetate or 100 mM KI 
 100 mM K-Na-tartrate 
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Table 9: Heavy Metal Derivatives 
Heavy metal 
Crystal number 
Amount (mM) 
Time1 
 
Co-
crystallized 
(mM) 
Fluorescence 
signal 
Resolution 
(Å) 
Anomalous 
signal2 
R-
factor3 
(%) 
Native - - - 3.6 - - 
CsCl 
37 
- 100 nd 6.0 1.20 28.4 
KOsCl4 
23-1 
1 
30m/30m 
- nd 7.0 1.08 11.2 
K2Pt(CN)4 
1041 
1 
1m/- 
-  6.0 1.00 29.1 
Pb(NO3)2 
1043 
1 
1m/- 
-  6.0 1.00 21.0 
TaBr 
1275 
2 
1h/1m 
-  6.0 1.12 22.7 
(H2NCH2CH2NH2)PtCl2 
1280 
2 
1h/1m 
-  5.6 1.16 14.4 
(H2NCH2CH2NH2)PtCl2 
1281 
2 
1h/1m 
-  5.25 1.10 13.0 
Thiomersal 
1321 
0.05 
72h/1m 
- Nd 7.3 1.18 32.1 
Hg(CH3CO2)2 
1337 
- 0.01 Nd 6.9 1.01 26.5 
Ta6Br14 
1424 
0.5 
24h/2m 
-  7.0 1.00 nd 
Thiomersal 
1438 
- 0.01 Nd 7.0 1.11 34.2 
HoCl3 
1444 
- 0.01 Nd 5.5 1.10 16.4 
HoCl3 
1446 
- 0.01 Nd 6.0 1.14 19.9 
K2PtCl6 
1678 
- 0.1 Nd 5.0 1.05 12.0 
KAu(CN)2 
1679 
- 0.1 Nd 5.0 1.30 17.5 
Thiomersal 
1680 
- 0.1 nd 5.0 1.0 15.0 
Pb(NO3)2 
1704 
1 
5m/- 
-  6.9 1.1 Nd 
Dichloro (2,2',6',2'' ter-
pyridine) platinum (II) 
1710 
1 
5m/1m 
-  6.9 1.0 Nd 
Hg(CH3)Cl 
1714 
2 
5m/- 
-  7.0 1.15 Nd 
Hg(CH3)Cl 
1717 
2 
5m/- 
-  7.0 1.1 Nd 
Hg(CH3)Cl 
1802 
0.5 
1h/20m 
-  7.0 1.0 Nd 
Hg(CH3)Cl 
1804 
1 
1h/20m 
- Nd 7.3 1.0 Nd 
HgCl2 
1813 
2 
20m/20m 
-  6.5 1.0 Nd 
HgCl2 
1818 
1 
40m/20m 
-  5.5 1.05 Nd 
K2PtCl6 
1830 
1 
40m/20m 
-  6.0 1.00 Nd 
K2PtCl6 
1834 
2 
40m/20m 
-  6.8 1.00 nd 
1 time of soaking and back soaking (m minutes, h hours, d days); 2 Ratio of  norm/ anomalous 
determined by XSCALE (Kabsch, 1993); 3 compared to the native data set; 
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F.5 β-Catenin 
 
β-Catenin is involved in cell adhesion, transcription and cell signaling in the 
wingless (WNT) pathway; therefore the strict control of its availability during 
normal development is crucial. Inappropriate activation of β-catenin is related 
to several cancer types. The aim of the project was to purify and co-crystallize 
a fragment of β-catenin with several peptides shown to be involved in a 
nuclear complex between β-catenin and TCF. 
 
Introduction 
 
The protein β-catenin consists of 12 armadillo repeats composed of 42 amino 
acids that are flanked by a 150 amino acid N-terminal domain and a 100 
amino acid C-terminal domain. It is found in several complexes including the 
nuclear complex with the transcription factors T-cell factor (TCF), legless and 
pygopus (van Es et al., 2003, Kramps et al., 2002), the complex with cadherin 
and α-catenin involved in cell adhesion (Perez-Moreno et al., 2003) and a 
complex involving the proteins Axin, the adenomatous polyposis coli protein 
(APC) and the two kinases glycogen synthase kinase-3 (GSK3) and casein 
kinase I (CK I) (Rubinfeld et al., 1993, Behrens et al., 1998). The molecules 
axin, APC, TCF and cadherins bind to overlapping but not identical sites 
within the Armadillo repeats of β-catenin (Figure 74) whereas the complex of 
α- and β- catenin uses interactions formed in the N-terminal domain of the 
protein (Huber et al., 1997). 
 
Figure 74: Interaction sites of β-catenin. α-Catenin interacts with the N-terminal domain of 
β-catenin whereas the proteins Axin, APC, TCF, E-cadherin and the C-terminus of β-catenin 
bind to the central 12 armadillo repeats (Harris & Peifer, 2005). 
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Results of β-catenin 
 
Expression 
 
The construct used for expression consisted of amino acids 134-664 of the 
naturally occurring β-catenin protein. This fragment includes the 12 armadillo 
repeats and 17 amino acids of the N terminal domain. It was expressed as C-
terminal fusion protein to GST with a thrombin cleavage site. The construct 
was obtained by Sandipan Chatterjee of the group of Prof. Konrad Basler of 
the University of Zürich. 
A freshly transformed BL21 (DE3) colony was inoculated o/n in 5 ml LB media 
containing Ampicillin (100µg/ml) and grown at 37 °C. 500 ml LB media were 
inoculated with the o/n culture grown to an OD600 of 0.5 and induced with 0.2 
mM IPTG. After 3h the cells were harvested by centrifugation (30 min, 
3500*g, 4°C) and frozen at -20°. 
 
Purification 
 
A 3 g frozen cell pellet was resuspended in 20 ml lysis buffer (50 mM NaCl, 
50 mM Tris, 2mM DTT, pH 7.4) and DNAse and protease inhibitors were 
added. The cell suspension was lyzed by passing the suspension twice 
through a FrenchPress (1200 psi, 4°C) and centrifuged (30 min, 40000*g, 
4°C) to pellet the remaining cell debris. The supernatant was applied to 5 ml 
GST Sepharose FF (Pharmacia) equilibrated in lysis buffer. The suspension 
was gently shaken at 4°C for 90 minutes. The suspension was applied to an 
empty column, washed with 100 ml lysis buffer and the protein was eluted 
with 20 ml elution buffer (25 mM GSH, 50 mM Tris, 50 mM NaCl, pH 7.4). The 
purification process is shown in Figure 75, indicating the high purity of the 
GST-β-catenin fusion protein after the first purification step. 
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Figure 75: Purification and cleavage of GST-β-catenin. Left SDS-PAGE: lane 1: 2.5 µg 
BSA; lane 2: 5 µg BSA; lane 3: 10 µg BSA; lane 4: Marker proteins; lane 5: unbound sample 
of the GST-Sepharose column; lanes 6-7: start and end of the washing step; lanes 8-10: 
fractions of the elution with 25 mM GSH. Right SDS-PAGE: lane 1: elution without thrombin; 
lane 2: elution without thrombin (1/3 load); lane 3: digested protein after 18 h incubation at 
20°C; lane 4: Marker proteins. 
 
The fusion protein was cleaved by diluting the eluate to 50 ml with buffer A 
(25 mM Ethanolamine, 50 mM NaCl, 0.1% β-mercaptoethanol, pH 9.5) and 
incubation with 50 U Thrombin (Sigma) at 20°C o/n. Figure 75 illustrates the 
purity of the protein after cleavage. The three species uncleaved fusion 
protein, free β-catenin and free GST are present in the sample and had to be 
separated.  
Anionic exchange chromatography was used to separate the GST and β-
catenin (Figure 76). The digested solution was dialyzed against buffer A, 
applied to an 8 ml MonoQ column (Pharmacia) previously equilibrated in 
buffer A. The protein was eluted by a liner salt gradient of 0-170 mM NaCl. 
The shallow gradient enabled the separation of β-catenin, the uncleaved 
protein and the cleaved GST fusion protein. β-Catenin eluted at a conductivity 
of ~10 mS, the GST fusion protein at 17-18 mS whereas the uncleaved GST 
β-catenin protein was found to elute at around 15 mS. After SDS-PAGE 
analysis the fractions containing pure β-catenin were pooled and concentrated 
yielding approximately 1-2 mg pure β-catenin per liter of culture. 
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Figure 76: Anionic exchange chromatography and the corresponding SDS-PAGE. The 
absorption at 280 nm, the conductivity and the theoretical gradient are shown in blue, brown 
and green, respectively. A gradient of 0-170 mM NaCl in 17 column volumes was applied. 
Pure β-catenin elutes at ~ 10 mS (star). SDS-PAGE: lane 1: Marker proteins; lane 2: sample 
applied to the column; lane 3: unbound material; lane 4: peak at 150 ml; lane 5: peak at 170 
ml; lane 6: peak at 195 ml; lane 7: peak at 215 ml; lane 8: merged fractions; lane 9: 
concentrated sample; lane 10: concentrated sample after filtration. 
 
Peptides 
 
Several β-catenin protein complexes are known and structurally characterized 
(Daniels et al., 2001, Graham et al., 2002, Graham et al., 2001, Graham et al., 
2000, Huber & Weis, 2001). To gain insights into the binding of β-catenin to 
human legless protein, several peptides were synthesized and co-crystallized 
with purified β-catenin. Binding studies and GST pull down experiments of β-
catenin and armadillo with these peptides revealed the minimal amino acids 
sequence required for a sufficient interaction and binding (Kramps et al., 
2002). 
 
LP-1: legless basic peptide 1 (HD-2, amino acids 515-544) 
N-term: ENLTPQQRQHREEQLAKIKKMNQFLFPENE 
LP-2: BCL9 basic peptide 1 (HD-2) aa 349-378 
N-term: DGLSQEQLEHRERSLQTLRDIQRMLFPDEK 
LP-3: legless extended basic peptide 2 (HD-2) aa 510-549 
N-term: VKVPDENLTPQQRQHREEQLAKIKKMNQFLFPENENSVGA 
LP-4: BCL9 extended basic peptide 2 (HD-2) aa 344-383 
N-term: LGENPDGLSQEQLEHRERSLQTLRDIQRMLFPDEKEFTGA 
LP-6: human TCF-4 aa 1-53 
N-term: MPQLNGGGGDDLGANDELISFKDEGEQEEKSSENSSAERDLADVKS 
  SLVNESE 
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Peptides 1 and 3 are peptides derived of drosophila whereas peptides 2 and 4 
are the human homologues of the product of the B cell lymphoma 9 gene. 5 
amino acids were extended on both sides of the minimal sequence that 
showed binding to the target protein in the two peptides 2 and 4. 
 
Crystallization of β-Catenin and β-Catenin peptide complexes 
 
The protein was concentrated to 5 mg/ml, incubated with the different 
peptides in 1:1 or 1:3 ratio and crystallized in hanging or sitting drop plates. 1 
µl of protein was mixed with 1µl of reservoir solution and stored over 900 µl 
reservoir solution at 20°C. Small crystals could be observed using 16-20% 
PEG 4000, 100 mM Tris pH 8.0, 200 mM NaCl and 10 mM DTT as precipitant 
and two peptides LP4 and LP6 in a 1+1.1 molar ratio. Although the crystals 
could be reproduced, it was not possible to increase their size, neither by 
screening for additives or seeding techniques. Different protein: peptide ratios 
and different combinations of LP6 and LP1-4 as binding partners of β-Catenin 
were screened, but none of the variations produced crystals that were suitable 
to structural studies. 
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Discussion 
 
This part of the thesis establishes the expression and purification protocol of 
the protein β-catenin that has not previously been reported in literature. The 
low solubility of β-catenin around its pKa value of 8.4 required a GST 
containing fusion protein that prevented the aggregation of β-catenin. The 
GST-β-catenin fusion protein behaved well over a wide range of pH values 
and the first purification step yielded protein off sufficient amount and quality 
for biochemical studies (Kramps et al., 2002). For structural studies the 
protein had to be further purified including the cleavage with thrombin at 
pH 9.5 and a subsequently separation of the cleavage products. The 
separation was carried out using anionic exchange chromatography at pH 9.5 
yielding pure β-catenin. Crystallization trials with the various peptides 
revealed small crystals of 10 x 10 x10 µm3 for the peptides LP-4 and LP-6. 
Notably, the addition of LP-6 to β-catenin, before or after cleavage with 
thrombin, increased the solubility and stability of the protein and no 
aggregation or precipitation, even at pH values around the pKa value of 
β-catenin, were observed. The behavior of β-catenin in complex with LP-6 
(TCF4 peptide) might explain the various reported structures of β-catenin that 
were crystallized with this peptide (Daniels et al., 2001, Graham et al., 2001). 
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